<!DOCTYPE html>

<html lang="en">


<!doctype html>
<html lang="en" class="no-js">
  <head>
    
      <meta charset="utf-8">
      <meta name="viewport" content="width=device-width,initial-scale=1">
      
      
      
      
        <link rel="prev" href="../Immunology/">
      
      
      
      <link rel="icon" href="../assets/images/favicon.png">
      <meta name="generator" content="mkdocs-1.5.3, mkdocs-material-9.5.12">
    
    
<title>Literature Survey (VPE)</title>

    
      <link rel="stylesheet" href="../assets/stylesheets/main.7e359304.min.css">
      
        
        <link rel="stylesheet" href="../assets/stylesheets/palette.06af60db.min.css">
      
      


    
    
  <!-- Add scripts that need to run before here -->
  <!-- Add jquery script -->
  <script src="https://code.jquery.com/jquery-3.7.1.js"></script>
  <!-- Add data table libraries -->
  <script src="https://cdn.datatables.net/2.0.1/js/dataTables.js"></script>
  <link rel="stylesheet" href="https://cdn.datatables.net/2.0.1/css/dataTables.dataTables.css">
  <!-- Load plotly.js into the DOM -->
	<script src='https://cdn.plot.ly/plotly-2.29.1.min.js'></script>
  <link rel="stylesheet" href="https://cdn.datatables.net/buttons/3.0.1/css/buttons.dataTables.css">
  <!-- fixedColumns -->
  <script src="https://cdn.datatables.net/fixedcolumns/5.0.0/js/dataTables.fixedColumns.js"></script>
  <script src="https://cdn.datatables.net/fixedcolumns/5.0.0/js/fixedColumns.dataTables.js"></script>
  <link rel="stylesheet" href="https://cdn.datatables.net/fixedcolumns/5.0.0/css/fixedColumns.dataTables.css">
  <!-- Already specified in mkdocs.yml -->
  <!-- <link rel="stylesheet" href="../docs/custom.css"> -->
  <script src="https://cdn.datatables.net/buttons/3.0.1/js/dataTables.buttons.js"></script>
  <script src="https://cdn.datatables.net/buttons/3.0.1/js/buttons.dataTables.js"></script>
  <script src="https://cdnjs.cloudflare.com/ajax/libs/jszip/3.10.1/jszip.min.js"></script>
  <script src="https://cdnjs.cloudflare.com/ajax/libs/pdfmake/0.2.7/pdfmake.min.js"></script>
  <script src="https://cdnjs.cloudflare.com/ajax/libs/pdfmake/0.2.7/vfs_fonts.js"></script>
  <script src="https://cdn.datatables.net/buttons/3.0.1/js/buttons.html5.min.js"></script>
  <script src="https://cdn.datatables.net/buttons/3.0.1/js/buttons.print.min.js"></script>
  <!-- Google fonts -->
  <link rel="stylesheet" href="https://fonts.googleapis.com/icon?family=Material+Icons">
  <!-- Intro.js -->
  <script src="https://cdn.jsdelivr.net/npm/intro.js@7.2.0/intro.min.js"></script>
  <link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/intro.js@7.2.0/minified/introjs.min.css">


  <!-- 
      
     -->
  <!-- Add scripts that need to run afterwards here -->

    
      
        
        
        <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
        <link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Roboto:300,300i,400,400i,700,700i%7CRoboto+Mono:400,400i,700,700i&display=fallback">
        <style>:root{--md-text-font:"Roboto";--md-code-font:"Roboto Mono"}</style>
      
    
    
      <link rel="stylesheet" href="../assets/_mkdocstrings.css">
    
      <link rel="stylesheet" href="../custom.css">
    
    <script>__md_scope=new URL("..",location),__md_hash=e=>[...e].reduce((e,_)=>(e<<5)-e+_.charCodeAt(0),0),__md_get=(e,_=localStorage,t=__md_scope)=>JSON.parse(_.getItem(t.pathname+"."+e)),__md_set=(e,_,t=localStorage,a=__md_scope)=>{try{t.setItem(a.pathname+"."+e,JSON.stringify(_))}catch(e){}}</script>
    
      

    
    
    
  </head>
  
  
    
    
      
    
    
    
    
    <body dir="ltr" data-md-color-scheme="default" data-md-color-primary="white" data-md-color-accent="black">
  
    
    <input class="md-toggle" data-md-toggle="drawer" type="checkbox" id="__drawer" autocomplete="off">
    <input class="md-toggle" data-md-toggle="search" type="checkbox" id="__search" autocomplete="off">
    <label class="md-overlay" for="__drawer"></label>
    <div data-md-component="skip">
      
    </div>
    <div data-md-component="announce">
      
    </div>
    
    
      

<header class="md-header" data-md-component="header">
  <nav class="md-header__inner md-grid" aria-label="Header">
    <a href=".." title="Literature Survey for Swathi" class="md-header__button md-logo" aria-label="Literature Survey for Swathi" data-md-component="logo">
      
  <img src="../assets/VPE.png" alt="logo">

    </a>
    <label class="md-header__button md-icon" for="__drawer">
      
      <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M3 6h18v2H3V6m0 5h18v2H3v-2m0 5h18v2H3v-2Z"/></svg>
    </label>
    <div class="md-header__title" data-md-component="header-title">
      <div class="md-header__ellipsis">
        <div class="md-header__topic">
          <span class="md-ellipsis">
            Literature Survey for Swathi
          </span>
        </div>
        <div class="md-header__topic" data-md-component="header-topic">
          <span class="md-ellipsis">
            
              Oncology
            
          </span>
        </div>
      </div>
    </div>
    
      
        <form class="md-header__option" data-md-component="palette">
  
    
    
    
    <input class="md-option" data-md-color-media="" data-md-color-scheme="default" data-md-color-primary="white" data-md-color-accent="black"  aria-label="Switch to dark mode"  type="radio" name="__palette" id="__palette_0">
    
      <label class="md-header__button md-icon" title="Switch to dark mode" for="__palette_1" hidden>
        <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M17 6H7c-3.31 0-6 2.69-6 6s2.69 6 6 6h10c3.31 0 6-2.69 6-6s-2.69-6-6-6zm0 10H7c-2.21 0-4-1.79-4-4s1.79-4 4-4h10c2.21 0 4 1.79 4 4s-1.79 4-4 4zM7 9c-1.66 0-3 1.34-3 3s1.34 3 3 3 3-1.34 3-3-1.34-3-3-3z"/></svg>
      </label>
    
  
    
    
    
    <input class="md-option" data-md-color-media="" data-md-color-scheme="slate" data-md-color-primary="white" data-md-color-accent="black"  aria-label="Switch to light mode"  type="radio" name="__palette" id="__palette_1">
    
      <label class="md-header__button md-icon" title="Switch to light mode" for="__palette_0" hidden>
        <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M17 7H7a5 5 0 0 0-5 5 5 5 0 0 0 5 5h10a5 5 0 0 0 5-5 5 5 0 0 0-5-5m0 8a3 3 0 0 1-3-3 3 3 0 0 1 3-3 3 3 0 0 1 3 3 3 3 0 0 1-3 3Z"/></svg>
      </label>
    
  
</form>
      
    
    
      <script>var media,input,key,value,palette=__md_get("__palette");if(palette&&palette.color){"(prefers-color-scheme)"===palette.color.media&&(media=matchMedia("(prefers-color-scheme: light)"),input=document.querySelector(media.matches?"[data-md-color-media='(prefers-color-scheme: light)']":"[data-md-color-media='(prefers-color-scheme: dark)']"),palette.color.media=input.getAttribute("data-md-color-media"),palette.color.scheme=input.getAttribute("data-md-color-scheme"),palette.color.primary=input.getAttribute("data-md-color-primary"),palette.color.accent=input.getAttribute("data-md-color-accent"));for([key,value]of Object.entries(palette.color))document.body.setAttribute("data-md-color-"+key,value)}</script>
    
    
    
      <label class="md-header__button md-icon" for="__search">
        
        <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M9.5 3A6.5 6.5 0 0 1 16 9.5c0 1.61-.59 3.09-1.56 4.23l.27.27h.79l5 5-1.5 1.5-5-5v-.79l-.27-.27A6.516 6.516 0 0 1 9.5 16 6.5 6.5 0 0 1 3 9.5 6.5 6.5 0 0 1 9.5 3m0 2C7 5 5 7 5 9.5S7 14 9.5 14 14 12 14 9.5 12 5 9.5 5Z"/></svg>
      </label>
      <div class="md-search" data-md-component="search" role="dialog">
  <label class="md-search__overlay" for="__search"></label>
  <div class="md-search__inner" role="search">
    <form class="md-search__form" name="search">
      <input type="text" class="md-search__input" name="query" aria-label="Search" placeholder="Search" autocapitalize="off" autocorrect="off" autocomplete="off" spellcheck="false" data-md-component="search-query" required>
      <label class="md-search__icon md-icon" for="__search">
        
        <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M9.5 3A6.5 6.5 0 0 1 16 9.5c0 1.61-.59 3.09-1.56 4.23l.27.27h.79l5 5-1.5 1.5-5-5v-.79l-.27-.27A6.516 6.516 0 0 1 9.5 16 6.5 6.5 0 0 1 3 9.5 6.5 6.5 0 0 1 9.5 3m0 2C7 5 5 7 5 9.5S7 14 9.5 14 14 12 14 9.5 12 5 9.5 5Z"/></svg>
        
        <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M20 11v2H8l5.5 5.5-1.42 1.42L4.16 12l7.92-7.92L13.5 5.5 8 11h12Z"/></svg>
      </label>
      <nav class="md-search__options" aria-label="Search">
        
        <button type="reset" class="md-search__icon md-icon" title="Clear" aria-label="Clear" tabindex="-1">
          
          <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M19 6.41 17.59 5 12 10.59 6.41 5 5 6.41 10.59 12 5 17.59 6.41 19 12 13.41 17.59 19 19 17.59 13.41 12 19 6.41Z"/></svg>
        </button>
      </nav>
      
    </form>
    <div class="md-search__output">
      <div class="md-search__scrollwrap" data-md-scrollfix>
        <div class="md-search-result" data-md-component="search-result">
          <div class="md-search-result__meta">
            Initializing search
          </div>
          <ol class="md-search-result__list" role="presentation"></ol>
        </div>
      </div>
    </div>
  </div>
</div>
    
    
      <div class="md-header__source">
        <a href="https://github.com/VirtualPatientEngine/literatureSurvey" title="Go to repository" class="md-source" data-md-component="source">
  <div class="md-source__icon md-icon">
    
    <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 496 512"><!--! Font Awesome Free 6.5.1 by @fontawesome - https://fontawesome.com License - https://fontawesome.com/license/free (Icons: CC BY 4.0, Fonts: SIL OFL 1.1, Code: MIT License) Copyright 2023 Fonticons, Inc.--><path d="M165.9 397.4c0 2-2.3 3.6-5.2 3.6-3.3.3-5.6-1.3-5.6-3.6 0-2 2.3-3.6 5.2-3.6 3-.3 5.6 1.3 5.6 3.6zm-31.1-4.5c-.7 2 1.3 4.3 4.3 4.9 2.6 1 5.6 0 6.2-2s-1.3-4.3-4.3-5.2c-2.6-.7-5.5.3-6.2 2.3zm44.2-1.7c-2.9.7-4.9 2.6-4.6 4.9.3 2 2.9 3.3 5.9 2.6 2.9-.7 4.9-2.6 4.6-4.6-.3-1.9-3-3.2-5.9-2.9zM244.8 8C106.1 8 0 113.3 0 252c0 110.9 69.8 205.8 169.5 239.2 12.8 2.3 17.3-5.6 17.3-12.1 0-6.2-.3-40.4-.3-61.4 0 0-70 15-84.7-29.8 0 0-11.4-29.1-27.8-36.6 0 0-22.9-15.7 1.6-15.4 0 0 24.9 2 38.6 25.8 21.9 38.6 58.6 27.5 72.9 20.9 2.3-16 8.8-27.1 16-33.7-55.9-6.2-112.3-14.3-112.3-110.5 0-27.5 7.6-41.3 23.6-58.9-2.6-6.5-11.1-33.3 2.6-67.9 20.9-6.5 69 27 69 27 20-5.6 41.5-8.5 62.8-8.5s42.8 2.9 62.8 8.5c0 0 48.1-33.6 69-27 13.7 34.7 5.2 61.4 2.6 67.9 16 17.7 25.8 31.5 25.8 58.9 0 96.5-58.9 104.2-114.8 110.5 9.2 7.9 17 22.9 17 46.4 0 33.7-.3 75.4-.3 83.6 0 6.5 4.6 14.4 17.3 12.1C428.2 457.8 496 362.9 496 252 496 113.3 383.5 8 244.8 8zM97.2 352.9c-1.3 1-1 3.3.7 5.2 1.6 1.6 3.9 2.3 5.2 1 1.3-1 1-3.3-.7-5.2-1.6-1.6-3.9-2.3-5.2-1zm-10.8-8.1c-.7 1.3.3 2.9 2.3 3.9 1.6 1 3.6.7 4.3-.7.7-1.3-.3-2.9-2.3-3.9-2-.6-3.6-.3-4.3.7zm32.4 35.6c-1.6 1.3-1 4.3 1.3 6.2 2.3 2.3 5.2 2.6 6.5 1 1.3-1.3.7-4.3-1.3-6.2-2.2-2.3-5.2-2.6-6.5-1zm-11.4-14.7c-1.6 1-1.6 3.6 0 5.9 1.6 2.3 4.3 3.3 5.6 2.3 1.6-1.3 1.6-3.9 0-6.2-1.4-2.3-4-3.3-5.6-2z"/></svg>
  </div>
  <div class="md-source__repository">
    VPE/LiteratureSurvey
  </div>
</a>
      </div>
    
  </nav>
  
</header>
    
    <div class="md-container" data-md-component="container">
      
      
        
          
            
<nav class="md-tabs" aria-label="Tabs" data-md-component="tabs">
  <div class="md-grid">
    <ul class="md-tabs__list">
      
        
  
  
  
    <li class="md-tabs__item">
      <a href=".." class="md-tabs__link">
        
  
    
  
  Home

      </a>
    </li>
  

      
        
  
  
  
    <li class="md-tabs__item">
      <a href="../Immunology/" class="md-tabs__link">
        
  
    
  
  Immunology

      </a>
    </li>
  

      
        
  
  
    
  
  
    <li class="md-tabs__item md-tabs__item--active">
      <a href="./" class="md-tabs__link">
        
  
    
  
  Oncology

      </a>
    </li>
  

      
    </ul>
  </div>
</nav>
          
        
      
      <main class="md-main" data-md-component="main">
        <div class="md-main__inner md-grid">
          
            
              
                
              
              <div class="md-sidebar md-sidebar--primary" data-md-component="sidebar" data-md-type="navigation" hidden>
                <div class="md-sidebar__scrollwrap">
                  <div class="md-sidebar__inner">
                    


  


<nav class="md-nav md-nav--primary md-nav--lifted" aria-label="Navigation" data-md-level="0">
  <label class="md-nav__title" for="__drawer">
    <a href=".." title="Literature Survey for Swathi" class="md-nav__button md-logo" aria-label="Literature Survey for Swathi" data-md-component="logo">
      
  <img src="../assets/VPE.png" alt="logo">

    </a>
    Literature Survey for Swathi
  </label>
  
    <div class="md-nav__source">
      <a href="https://github.com/VirtualPatientEngine/literatureSurvey" title="Go to repository" class="md-source" data-md-component="source">
  <div class="md-source__icon md-icon">
    
    <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 496 512"><!--! Font Awesome Free 6.5.1 by @fontawesome - https://fontawesome.com License - https://fontawesome.com/license/free (Icons: CC BY 4.0, Fonts: SIL OFL 1.1, Code: MIT License) Copyright 2023 Fonticons, Inc.--><path d="M165.9 397.4c0 2-2.3 3.6-5.2 3.6-3.3.3-5.6-1.3-5.6-3.6 0-2 2.3-3.6 5.2-3.6 3-.3 5.6 1.3 5.6 3.6zm-31.1-4.5c-.7 2 1.3 4.3 4.3 4.9 2.6 1 5.6 0 6.2-2s-1.3-4.3-4.3-5.2c-2.6-.7-5.5.3-6.2 2.3zm44.2-1.7c-2.9.7-4.9 2.6-4.6 4.9.3 2 2.9 3.3 5.9 2.6 2.9-.7 4.9-2.6 4.6-4.6-.3-1.9-3-3.2-5.9-2.9zM244.8 8C106.1 8 0 113.3 0 252c0 110.9 69.8 205.8 169.5 239.2 12.8 2.3 17.3-5.6 17.3-12.1 0-6.2-.3-40.4-.3-61.4 0 0-70 15-84.7-29.8 0 0-11.4-29.1-27.8-36.6 0 0-22.9-15.7 1.6-15.4 0 0 24.9 2 38.6 25.8 21.9 38.6 58.6 27.5 72.9 20.9 2.3-16 8.8-27.1 16-33.7-55.9-6.2-112.3-14.3-112.3-110.5 0-27.5 7.6-41.3 23.6-58.9-2.6-6.5-11.1-33.3 2.6-67.9 20.9-6.5 69 27 69 27 20-5.6 41.5-8.5 62.8-8.5s42.8 2.9 62.8 8.5c0 0 48.1-33.6 69-27 13.7 34.7 5.2 61.4 2.6 67.9 16 17.7 25.8 31.5 25.8 58.9 0 96.5-58.9 104.2-114.8 110.5 9.2 7.9 17 22.9 17 46.4 0 33.7-.3 75.4-.3 83.6 0 6.5 4.6 14.4 17.3 12.1C428.2 457.8 496 362.9 496 252 496 113.3 383.5 8 244.8 8zM97.2 352.9c-1.3 1-1 3.3.7 5.2 1.6 1.6 3.9 2.3 5.2 1 1.3-1 1-3.3-.7-5.2-1.6-1.6-3.9-2.3-5.2-1zm-10.8-8.1c-.7 1.3.3 2.9 2.3 3.9 1.6 1 3.6.7 4.3-.7.7-1.3-.3-2.9-2.3-3.9-2-.6-3.6-.3-4.3.7zm32.4 35.6c-1.6 1.3-1 4.3 1.3 6.2 2.3 2.3 5.2 2.6 6.5 1 1.3-1.3.7-4.3-1.3-6.2-2.2-2.3-5.2-2.6-6.5-1zm-11.4-14.7c-1.6 1-1.6 3.6 0 5.9 1.6 2.3 4.3 3.3 5.6 2.3 1.6-1.3 1.6-3.9 0-6.2-1.4-2.3-4-3.3-5.6-2z"/></svg>
  </div>
  <div class="md-source__repository">
    VPE/LiteratureSurvey
  </div>
</a>
    </div>
  
  <ul class="md-nav__list" data-md-scrollfix>
    
      
      
  
  
  
  
    <li class="md-nav__item">
      <a href=".." class="md-nav__link">
        
  
  <span class="md-ellipsis">
    Home
  </span>
  

      </a>
    </li>
  

    
      
      
  
  
  
  
    <li class="md-nav__item">
      <a href="../Immunology/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    Immunology
  </span>
  

      </a>
    </li>
  

    
      
      
  
  
    
  
  
  
    <li class="md-nav__item md-nav__item--active">
      
      <input class="md-nav__toggle md-toggle" type="checkbox" id="__toc">
      
      
      
      <a href="./" class="md-nav__link md-nav__link--active">
        
  
  <span class="md-ellipsis">
    Oncology
  </span>
  

      </a>
      
    </li>
  

    
  </ul>
</nav>
                  </div>
                </div>
              </div>
            
            
              
                
              
              <div class="md-sidebar md-sidebar--secondary" data-md-component="sidebar" data-md-type="toc" >
                <div class="md-sidebar__scrollwrap">
                  <div class="md-sidebar__inner">
                    

<nav class="md-nav md-nav--secondary" aria-label="Table of contents">
  
  
  
  
</nav>
                  </div>
                </div>
              </div>
            
          
          
            <div class="md-content" data-md-component="content">
              <article class="md-content__inner md-typeset">
                
                  

  
  


  <h1>Oncology</h1>

<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="utf-8">
</head>

<body>
  <p>
  <i class="footer">This page was last updated on 2026-02-16 09:44:08 UTC</i>
  </p>

  <div class="note info" onclick="startIntro()">
    <p>
      <button type="button" class="buttons">
        <div style="display: flex; align-items: center;">
        Click here for a quick intro of the page! <i class="material-icons">help</i>
        </div>
      </button>
    </p>
  </div>

  <!--
  <div data-intro='Table of contents'>
    <p>
    <h3>Table of Contents</h3>
      <a href="#plot1">1. Citations over time on Oncology</a><br>
      <a href="#manually_curated_articles">2. Manually curated articles on Oncology</a><br>
      <a href="#recommended_articles">3. Recommended articles on Oncology</a><br>
    <p>
  </div>

  <div data-intro='Plot displaying number of citations over time 
                  on the given topic based on recommended articles'>
    <p>
    <h3 id="plot1">1. Citations over time on Oncology</h3>
      <div id='myDiv1'>
      </div>
    </p>
  </div>
  -->

  <div data-intro='Manually curated articles on the given topic'>
    <p>
    <h3 id="manually_curated_articles">Manually curated articles on <i>Oncology</i></h3>
    <table id="table1" class="display" style="width:100%">
    <thead>
      <tr>
          <th data-intro='Click to view the abstract (if available)'>Abstract</th>
          <th>Title</th>
          <th>Authors</th>
          <th>Publication Date</th>
          <th>Journal/ Conference</th>
          <th>Citation count</th>
          <th data-intro='Highest h-index among the authors'>Highest h-index</th>
          <th data-intro='Recommended articles extracted by considering
                          only the given article'>
              View recommendations
              </th>
      </tr>
    </thead>
    <tbody>

        <tr id="Sustained smouldering, or low-grade activation, of myeloid cells is a common hallmark of several chronic neurological diseases, including multiple sclerosis1. Distinct metabolic and mitochondrial features guide the activation and the diverse functional states of myeloid cells2. However, how these metabolic features act to perpetuate inflammation of the central nervous system is unclear. Here, using a multiomics approach, we identify a molecular signature that sustains the activation of microglia through mitochondrial complex I activity driving reverse electron transport and the production of reactive oxygen species. Mechanistically, blocking complex I in pro-inflammatory microglia protects the central nervous system against neurotoxic damage and improves functional outcomes in an animal disease model in vivo. Complex I activity in microglia is a potential therapeutic target to foster neuroprotection in chronic inflammatory disorders of the central nervous system3. Blocking mitochondrial complex I in pro-inflammatory microglia protects the central nervous system against neurotoxic damage and improves functional outcomes in vivo in an animal disease model.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/21fcaf99ddc745b1c9ce7be98fe589c812c89ddf" target='_blank'>
                Mitochondrial complex I activity in microglia sustains neuroinflammation
                </a>
              </td>
          <td>
            L. Peruzzotti-Jametti, C. Willis, G. Krzak, R. Hamel, L. Pirvan, Rosana-Bristena Ionescu, J. Reisz, H. Prag, M. E. Garcia-Segura, V. Wu, Y. Xiang, B. Barlas, A. Casey, A. V. D. van den Bosch, A. Nicaise, L. Roth, G. R. Bates, H. Huang, P. Prasad, A. E. Vincent, C. Frezza, C. Viscomi, G. Balmus, Z. Takáts, J. Marioni, A. D'alessandro, M. P. Murphy, I. Mohorianu, S. Pluchino
          </td>
          <td>2024-03-13</td>
          <td>Nature</td>
          <td>144</td>
          <td>30</td>

            <td><a href='../recommendations/21fcaf99ddc745b1c9ce7be98fe589c812c89ddf' target='_blank'>
              <i class="material-icons">open_in_new</i></a>
            </td>

        </tr>

        <tr id="The COVID-19 pandemic is an ongoing global health threat, yet our understanding of the dynamics of early cellular responses to this disease remains limited1. Here in our SARS-CoV-2 human challenge study, we used single-cell multi-omics profiling of nasopharyngeal swabs and blood to temporally resolve abortive, transient and sustained infections in seronegative individuals challenged with pre-Alpha SARS-CoV-2. Our analyses revealed rapid changes in cell-type proportions and dozens of highly dynamic cellular response states in epithelial and immune cells associated with specific time points and infection status. We observed that the interferon response in blood preceded the nasopharyngeal response. Moreover, nasopharyngeal immune infiltration occurred early in samples from individuals with only transient infection and later in samples from individuals with sustained infection. High expression of HLA-DQA2 before inoculation was associated with preventing sustained infection. Ciliated cells showed multiple immune responses and were most permissive for viral replication, whereas nasopharyngeal T cells and macrophages were infected non-productively. We resolved 54 T cell states, including acutely activated T cells that clonally expanded while carrying convergent SARS-CoV-2 motifs. Our new computational pipeline Cell2TCR identifies activated antigen-responding T cells based on a gene expression signature and clusters these into clonotype groups and motifs. Overall, our detailed time series data can serve as a Rosetta stone for epithelial and immune cell responses and reveals early dynamic responses associated with protection against infection. A human SARS-CoV-2 challenge study in individuals without previous exposure to the virus or vaccines provides detailed profiles of local and systemic epithelial and immune cell response dynamics over time and infection status.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/380489b0c6f9106219184f0c5fe6612e0b4e165a" target='_blank'>
                Human SARS-CoV-2 challenge uncovers local and systemic response dynamics
                </a>
              </td>
          <td>
            Rik G. H. Lindeboom, Kaylee B. Worlock, L. Dratva, M. Yoshida, David Scobie, Helen R. Wagstaffe, Laura Richardson, A. Wilbrey-Clark, Josephine L. Barnes, Lorenz Kretschmer, K. Polański, J. Allen-Hyttinen, Puja Mehta, D. Sumanaweera, J. M. Boccacino, W. Sungnak, R. Elmentaite, Ni Huang, L. Mamanova, R. Kapuge, L. Bolt, E. Prigmore, B. Killingley, M. Kalinova, Maria Mayer, A. Boyers, Alex J. Mann, Leo Swadling, M. Woodall, Samuel Ellis, Claire M. Smith, V. Teixeira, Sam M. Janes, R. Chambers, M. Haniffa, A. Catchpole, R. Heyderman, M. Noursadeghi, Benjamin M. Chain, Andreas Mayer, Kerstin B. Meyer, Christopher Chiu, Marko Z. Nikolić, Sarah A. Teichmann
          </td>
          <td>2024-06-19</td>
          <td>Nature</td>
          <td>81</td>
          <td>76</td>

            <td><a href='../recommendations/380489b0c6f9106219184f0c5fe6612e0b4e165a' target='_blank'>
              <i class="material-icons">open_in_new</i></a>
            </td>

        </tr>

    </tbody>
    <tfoot>
      <tr>
          <th>Abstract</th>
          <th>Title</th>
          <th>Authors</th>
          <th>Publication Date</th>
          <th>Journal/ Conference</th>
          <th>Citation count</th>
          <th>Highest h-index</th>
          <th>View recommendations</th>
      </tr>
    </tfoot>
    </table>
    </p>
  </div>

  <div data-intro='Recommended articles extracted by contrasting
                  articles that are relevant against not relevant for Oncology'>
    <p>
    <h3 id="recommended_articles">Recommended articles on <i>Oncology</i></h3>
    <table id="table2" class="display" style="width:100%">
    <thead>
      <tr>
          <th>Abstract</th>
          <th>Title</th>
          <th>Authors</th>
          <th>Publication Date</th>
          <th>Journal/Conference</th>
          <th>Citation count</th>
          <th>Highest h-index</th>
      </tr>
    </thead>
    <tbody>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/5f1f74512f2c8fb2837ffe4b5130c19b0f4eb9b9" target='_blank'>
              Primary Human Reactive Microglia Display Mitochondrial Dysfunction and Metabolic Imbalance Upon Lipopolysaccharide Exposure
              </a>
            </td>
          <td>
            Gabriel Fontes, Lívia de Sá Hayashide, Daniel Fernandes Messor, Mariana Marques, Vitor Emanuel Leocadio, Pedro Amorim, A. Minho, Elaine Paiva-Pereira, L. Savio, Patricia Dias Fernandes, Rafael Serafim Pinto, L. P. Diniz
          </td>
          <td>2026-01-07</td>
          <td>Neurochemical Research</td>
          <td>0</td>
          <td>22</td>
        </tr>

        <tr id="The mechanisms driving immune dysregulation in long COVID disease remain elusive. Here we integrated single-cell multiome data, immunological profiling and functional assays to investigate immune alterations across multiple cohorts. A transcriptional state in circulating monocytes (LC-Mo) was enriched in individuals with mild–moderate acute infection and accompanied by persistent elevations of plasma CCL2, CXCL11 and TNF. LC-Mo showed TGFβ and WNT–β-catenin signaling and correlated with fatigue severity. Protein markers of LC-Mo were increased in individuals with pronounced fatigue or dyspnea, and those with severe respiratory symptoms showed higher LC-Mo expression. Epigenetically, LC-Mo exhibited AP-1- and NF-κB1-driven profibrotic programs. LC-Mo-like macrophages in bronchoalveolar lavage samples from individuals with severe respiratory symptoms displayed a profibrotic profile, and individuals with a high LC-Mo transcriptional state showed impaired interferon responses after stimulation. Collectively, our findings define a pathogenic monocyte transcriptional state linking systemic immune dysfunction to persistent long COVID disease, providing mechanistic insights and potential therapeutic targets. Li and colleagues describe a monocyte-specific transcriptional state along with a persistent elevation of inflammatory markers specifically found in individuals with long COVID who had mild-to-moderate disease during acute SARS-CoV-2 infection.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/4437ab41c95bdd52966491c32a1d506d63726938" target='_blank'>
              A distinct monocyte transcriptional state links systemic immune dysregulation to pulmonary impairment in long COVID
              </a>
            </td>
          <td>
            Saumya Kumar, Chaofan Li, Liang Zhou, Qiuyao Zhan, Ahmed Alaswad, Sonja Volland, Bibiana Costa, S. Krooss, Isabel Klefenz, Hagen Schmaus, Antonia Zeuzem, Dorothee von Witzendorff, Helena Lickei, L. Pueschel, Anke R. M. Kraft, Markus Cornberg, A. R. Koczulla, I. Pink, Marius M. Hoeper, Chengbin Xu, Susanne Häussler, M. Wiestler, M. Netea, Thomas Illig, Jie Sun, Yang Li
          </td>
          <td>2026-01-14</td>
          <td>Nature Immunology</td>
          <td>1</td>
          <td>16</td>
        </tr>

        <tr id="Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the third highly pathogenic coronavirus to emerge in humans in recent decades. Although primarily a respiratory virus, SARS-CoV-2 can invade the central nervous system (CNS), leading to severe neurological manifestations such as stroke, encephalopathy, and memory loss. However, the mechanisms by which neural cells control SARS-CoV-2 infection remain poorly understood. Here, we demonstrate that SARS-CoV-2 and its Nucleocapsid (N) and Spike (S) proteins induce classical NLRP3 inflammasome activation in astrocytes. Notably, astrocytes lacking NLRP3 or caspase-1 exhibit higher viral loads, indicating a crucial role of the NLRP3 inflammasome in astrocyte-mediated viral control. Similarly, gasdermin-D (GSDMD)-deficient astrocytes display increased susceptibility to infection, although their LDH release remains unaffected, suggesting that pyroptosis is not required for viral restriction. Instead, GSDMD deficiency leads to markedly reduced IL-1β secretion, and exogenous IL-1β rescues the impaired antiviral response in NLRP3-, caspase-1-, and GSDMD-deficient astrocytes. Our findings reveal that astrocytes autonomously control SARS-CoV-2 infection via the NLRP3-GSDMD-IL-1β axis, underscoring their active role in the neuroimmune response to viral infection.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/136f69bd7deca72975cec306cf3a4c28e3a9afc4" target='_blank'>
              NLRP3 inflammasome activation in astrocytes restricts SARS-CoV-2 through gasdermin-D-driven IL-1β release
              </a>
            </td>
          <td>
            I. S. de Farias, Márcia Duarte-Barbosa, Natalia Salazar, Robert Andreata-Santos, Victoria Weise L. de Lucena, J. Maricato, R. Gazzinelli, L. M. R. Janini, K. Bortoluci
          </td>
          <td>2026-01-20</td>
          <td>Frontiers in Immunology</td>
          <td>0</td>
          <td>24</td>
        </tr>

        <tr id="Severe respiratory infections have imposed an immense burden on healthcare worldwide, which could lead to fatal outcomes. The dysfunctional immune response impacts disease severity of respiratory infections, yet its underlying mechanisms remain largely obscure. We explored the immunologic response underpinning severe respiratory viral infections by performing single-cell transcriptome analysis of peripheral blood mononuclear cells (PBMCs) from 17 patients with coronavirus disease 2019 (COVID-19), including moderate, severe, critical, and convalescent cases. Furthermore, we analyzed the host responses following low- or high-dose vaccination with recombinant protein. We constructed an immunocyte landscape with 299,527 PBMCs. The significant dysregulation of immune homeostasis in severe respiratory viral infections was characterized by an increased ratio of CD14+ monocytes and exhausted CD8+ T cells, and reduced Tregs, memory T cells and cDC2 cells. Notably, highly inflamed CD14+ monocytes overexpressing interleukin (IL)-related genes emerged as central contributor of inflammatory storms in critical patients. Enhanced inflammatory response in exhausted CD8+ T cells, FOS/JUN overexpression in Tregs and Th17 cells, as well as suppressed antigen presentation activity in cDC2 cells were also remarkable features of severe and critical cases. Moreover, the high-dose vaccination with recombinant protein inhibited the inflammatory response of CD14+ monocytes, while enriched the memory T/NK cells to boost protective immunity. In mechanism, activated IL-6-JAK-STAT in CD14+ monocytes and T cells, coupled with impaired interferon (IFN)-α pathway, could drive excessive inflammatory response. Our study creates a high-resolution transcriptomic atlas that uncovers distinct immune signatures across the disease severity of respiratory infections, which provides valuable resource for mechanistic exploration and therapeutic strategies development. Furthermore, we demonstrate that high-dose recombinant protein vaccines might mitigate the severity of illness. This study was prospectively registered at ChiCTR (Registration number: ChiCTR2300067787).">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/31b66cdc5218c0816b0bd18cc296ad74d29aceff" target='_blank'>
              Immune dysregulation triggered by inflammatory cytokines in patients with severe respiratory infections
              </a>
            </td>
          <td>
            Jingwei Li, S. Liang, Yalun Li, Jiayang Wu, Changshu Li, Jiadi Gan, Weimin Li, Chengdi Wang
          </td>
          <td>2026-01-15</td>
          <td>Respiratory Research</td>
          <td>0</td>
          <td>15</td>
        </tr>

        <tr id="Small extracellular vesicles (sEVs) including exosomes play an important role in intercellular communication and can exert immunomodulatory effects in recipient cells. We have shown that a single prophylactic intrathecal injection of sEVs from RAW 264.7 macrophages two weeks prior, promotes faster resolution of mechanical and thermal hypersensitivity in the complete Freund’s adjuvant (CFA) mouse model of inflammatory pain. How this long-term memory develops, and how sEVs regulate immune responses are unknown. Recent studies have shown that priming microglia with inflammatory stimuli can enhance or suppress responses to a delayed secondary insult via epigenetic modifications. We hypothesized that prophylactic intrathecal administration of macrophage-derived sEVs confers accelerated resolution of inflammatory pain by reprogramming epigenetic memory in spinal microglia in recipient CFA model mice. To determine whether prophylactic sEVs could attenuate pain in the absence of microglia when administering sEVs, we ablated microglia using a colony-stimulating factor 1 receptor (CSF1R) inhibitor, PLX5622. sEV-induced pain prophylaxis was completely abolished in PLX5622-fed mice, indicating that microglia are required to be present during sEV administration to confer early resolution of inflammatory pain hypersensitivity. ChIP-seq analysis in spinal microglia 14 days after sEV administration (prior to CFA) revealed an increased number of gene loci enriched for H3K4me1, a hallmark of innate immune memory. Furthermore, inhibiting the H3K4 mono-methyltransferase SETD7 abolished sEV-induced pain attenuation. Our findings indicate that both microglia and its epigenetic reprogramming contribute to pain prophylaxis induced by macrophage-derived sEVs, providing novel insights into the development of non-addictive preventive analgesia.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/004641d73bea924af5da1ac51234020dd29f8b8b" target='_blank'>
              Microglial epigenetic memory is associated with accelerated resolution of inflammatory pain induced by prophylactic macrophage-derived small extracellular vesicles
              </a>
            </td>
          <td>
            Xuan Luo, Jason R. Wickman, Jason T. DaCunza, Yuzhen Tian, Ahmet Sacan, Seena K. Ajit
          </td>
          <td>2026-01-16</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>24</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/1ebc988a2e535f97628e98387b125e8c2474e58f" target='_blank'>
              A CAR-T Cell-Based Strategy for Eliminating Pathogenic Microglia in ALS
              </a>
            </td>
          <td>
            M. Cicardi, Daniela Tejada-Martinez, S. Markandaiah, Karthik Krishnamurthy, Chiara Scopa, Brij Oza, Ivette Martorell Serra, Andrea Feci, Edoardo Manca, Adam E. Snook, A.R. Haeusler, P. Pasinelli, Davide Trotti
          </td>
          <td>2025-12-29</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>37</td>
        </tr>

        <tr id="Traumatic brain injury (TBI) compromises blood-brain barrier integrity, facilitating infiltration of peripheral immune cells into cerebral tissue. While natural killer (NK) cells - key innate lymphocytes - have been established as critical mediators of secondary neuroinflammation in acute brain injuries including ischemic stroke and intracerebral hemorrhage, their precise involvement in TBI pathophysiology remains undetermined. This study systematically elucidates the role of NK cells in TBI progression and proposes novel immunomodulatory therapeutic strategies for post-TBI intervention. Using the controlled cortical impact (CCI) method to generate TBI models, we quantitatively mapped NK cell infiltration patterns through immunofluorescence imaging and flow cytometric analysis. Single-cell RNA sequencing (scRNA-seq) was employed to characterize intracranial-infiltrating NK cells. To delineate NK cell functionality in post-TBI inflammation, we implemented NK1.1 antibody-mediated NK cells depletion followed by multi-modal assessment including: immunofluorescence staining, quantitative real-time polymerase chain reaction (qRT-PCR), flow cytometry, and Western blotting to investigate TBI-induced neuroinflammation; Cortical bulk RNA sequencing to reveal genome-wide transcriptional alterations following NK depletion; And longitudinal evaluation of neurological outcomes using the modified Neurological Severity Score, Morris water maze spatial navigation, and rotarod motor performance tests. Finally, mechanistic insights were further pursued through in vitro neuron-NK cell coculture systems. In the CCI model, NK cells rapidly infiltrated the lesion site, reaching peak infiltration density within 12 h post-TBI. Utilizing single-cell RNA sequencing, we performed the first comprehensive characterization of brain-infiltrating NK cells, revealing a unique regulatory phenotype marked by diminished cytotoxic potential (reduced perforin/granzyme B expression), and enhanced cytokine secretory capacity compared to their peripheral blood counterparts. Pseudotemporal reconstruction delineated NK cell differentiation trajectories originating from their peripheral blood counterparts. Crucially, NK cell depletion significantly attenuated TBI-induced neuroinflammation, as evidenced by transcriptomic profiling showing marked suppression of type I interferon (IFN) signaling in the injured cortex. Microglia-specific isolation and analysis localized this inhibitory effect to the IFNAR-STAT1 axis. This finding suggests that NK cells may regulate microglial IFN-I responses potentially through a pathway involving neuronal interferon-beta (IFN-β) secretion. Mechanistic investigations revealed that NK cells potentiate neuronal ER stress through interferon-gamma (IFN-γ) secretion, thereby triggering neuronal IFN-β release. NK cells rapidly infiltrate brain lesions following TBI and adopt a regulatory phenotype. NK cell depletion significantly attenuates neurological deficits by suppressing microglial type I IFN signaling pathway. NK cell-derived IFN-γ is correlated with neuronal IFN-β upregulation, suggesting a potential indirect mechanism for amplifying microglial type I IFN responses.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/9c9a4ffb0d6ed971464e00fa9af6bfee26423d34" target='_blank'>
              Natural killer cells aggravate neuroinflammation through microglial type I interferon pathway activation after traumatic brain injury
              </a>
            </td>
          <td>
            Meng Nie, Jiangyuan Yuan, Shiying Dong, Zhitao Gong, Z. Sha, Tao Liu, Liang Mi, Xuanhui Liu, Jinhao Huang, Weiwei Jiang, Mingqi Liu, Chuang Gao, Rongcai Jiang
          </td>
          <td>2026-02-02</td>
          <td>Journal of Neuroinflammation</td>
          <td>0</td>
          <td>14</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/79b1d945bce38bd9f93dc15198bc867b0ca62223" target='_blank'>
              Disruption of the hypothalamic orexin system links SARS-CoV-2 infection to persistent cortical neuronal pathology
              </a>
            </td>
          <td>
            G. Yoon, Young-Chul Jeong, J. Choi, Yoon Ha, Se Yeon Seo, K. Ku, Do Yeon Kim, Woo Yeon Hwang, G. Jeong, Dae-Gyun Ahn, Kyun-Do Kim, Je-Keun Rhee, Won-Ho Shin, Young-Chan Kwon
          </td>
          <td>2026-01-23</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>22</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/e65f5c64085c6fc68c98dbdc3df860af53a5b25d" target='_blank'>
              Type I IFN Dynamics Define an Early Checkpoint for Survival and Orchestrate Systemic Neutrophil Heterogeneity in Lethal Viral Infection
              </a>
            </td>
          <td>
            Riho Saito, Akisawa Satomi, Hiroki Sugishita, Yukiko Gotoh, Tomohiko Okazaki
          </td>
          <td>2026-01-24</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>7</td>
        </tr>

        <tr id="N6-methyladenosine (m6A), the most prevalent RNA modification, plays a pivotal role in regulating mRNA metabolism and cellular processes such as immune responses. Although the m6A methyltransferase METTL3 is known to regulate T-cell homeostasis and influence experimental autoimmune encephalomyelitis (EAE, a model for multiple sclerosis (MS)), its function within B cells remains poorly defined. Crucially, we observed that METTL3 expression is significantly downregulated in peripheral blood mononuclear cells (PBMCs) from MS patients and within B cells isolated from EAE mice. To directly investigate the functional consequences of this B-cell-specific METTL3 reduction in neuroinflammation, we generated B cell-specific METTL3 knockout mice (Mettl3flox/floxCD19Cre). Strikingly, this targeted deletion of METTL3 in B cells markedly exacerbated EAE severity, demonstrated by significantly worsened clinical disease scores, increased spinal cord inflammation, and greater demyelination. Further mechanistic dissection revealed how B-cell METTL3 deficiency drives this exacerbated pathology: it promoted B cell apoptosis, inhibited the differentiation of regulatory B cell (Breg) subpopulations, increased the proportion of pro-inflammatory iNOS+ macrophages, and elevated the production of IL-6, BAFF, and BCMA. In the central nervous system, it promotes neurological damage by affecting axonal function and facilitating the loss of neurons. Collectively, these findings demonstrate that METTL3 functions as a critical negative regulator within B cells, restraining their contribution to neuroinflammation in the EAE model. Importantly, therapeutically relevant overexpression of METTL3 specifically in B cells significantly reduced both the clinical severity and incidence of EAE, underscoring its potential as a novel therapeutic target for MS and similar autoimmune disorders involving pathogenic B-cell responses.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/a6ce86ef87ccf6c54308ad57fa29637a1c3c7500" target='_blank'>
              B cell-specific METTL3 depletion exacerbates experimental autoimmune encephalomyelitis
              </a>
            </td>
          <td>
            Xuzhong Pei, Xiying Wang, Jie Ding, Haojun Yu, Chunran Xue, C. Xie, Yi Chen, Xinyu Lin, Hong Yang, Yangtai Guan
          </td>
          <td>2026-01-03</td>
          <td>Cellular and Molecular Life Sciences: CMLS</td>
          <td>0</td>
          <td>10</td>
        </tr>

        <tr id="Background The COVID-19 pandemic, caused by SARS-CoV-2, has highlighted significant variability in disease severity, ranging from asymptomatic cases to severe acute respiratory distress syndrome. Objective Understanding the immune responses that contribute to this variability, particularly among healthcare workers (HCWs) frequently exposed to the virus, is essential. Materials and methods This was a prospective single-center longitudinal cohort study. We included hospitalized COVID-19+ patients, classified as having mild or moderate-to-severe symptoms, and unvaccinated HCWs with low susceptibility. Peripheral blood mononuclear cells (PBMCs) were collected and analyzed using flow cytometry. We measured the frequencies of key immune subsets, including plasmablasts, plasmacytoid dendritic cells (pDCs), and Natural Killer (NK) cells. SARS-CoV-2 neutralizing antibodies (NAbs) were quantified using pseudotyped HIV particles. Results COVID-19+ patients exhibited a significant increase in plasmablasts, a B-cell subset responsible for producing neutralizing antibodies, which correlated with disease severity (p=0.0082). Conversely, uninfected HCWs had low levels of plasmablasts but significantly higher levels of plasmacytoid dendritic cells (pDCs) (p<0.0001), which produce interferons upon activation by viral antigens. Additionally, HCWs had a higher percentage of CD56bright NK cells than the susceptible patients (p=0.02). Conclusion Our findings suggest that immune dysregulation, characterized by increased plasmablasts and reduced pDC and NK cell responses, contributes to COVID-19 severity. Strong pDC and NK cell responses may confer protection against SARS-CoV-2. These insights into immune responses may inform strategies for therapeutic interventions and vaccine development.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/9b2b12f86783468a8a58cf46dfd373285bb90b7e" target='_blank'>
              Contrasting immune responses in COVID-19: insights from healthcare workers and infected patients on plasmablast, pDC, and NK cell dynamics
              </a>
            </td>
          <td>
            Laura Martín-Pedraza, Eulalia Rodríguez-Martín, Erick De La Torre-Tarazona, Elena Moreno, Roberto Pariente-Rodríguez, P. Walo-Delgado, J. García-Pérez, Jorge Díaz, Laura Luna, Mario Rodríguez-Domínguez, Juan Carlos Galán, Claudia Geraldine Rita, Ana Del Amo-de Palacios, Roser Navarro-Soler, María Fons, José Alcamí, Santiago Moreno, L. M. Villar, Sergio Serrano-Villar
          </td>
          <td>2026-01-07</td>
          <td>Frontiers in Immunology</td>
          <td>0</td>
          <td>22</td>
        </tr>

        <tr id="The high mortality caused by severe COVID-19 poses great challenges to the public health. However, the underlying pathogenesis of severe cases remains unclear. Here, we find that SARS-CoV-2 infection boosts CD147 inducible up-regulation in the lung tissues of virus-infected rhesus macaques coupled with down-regulated membrane-bound ACE2, which conduces to extended virus infection and severe pathological lesions. Specifically, SARS-CoV-2 infection enhances the expression of transcriptional factor aryl hydrocarbon receptor and facilitates its nucleus translocation, which causes CD147 gene transcription and its up-regulation in protein level, thereby leading to virus susceptibility of the hosts and extended virus infection. Meanwhile, SARS-CoV-2 infection triggers immune imbalance of lung tissues by promoting cell death of CD4 + T cells and B cells and mediating abnormal cell-cell communications, especially for M2 macrophages. Meplazumab, a humanized anti-CD147 antibody, effectively inhibits virus entry and cytokine level, and restores immune balance in the lung tissues of virus-infected rhesus macaque model. Importantly, we further present the cryo-EM structure of CD147-spike complex, and identify five pairs of functional residues for their interaction, which could be interrupted by Meplazumab via steric hindrance effect. Our findings provide direct evidence for CD147-SARS-CoV-2 spike interaction and uncover the pathogenesis of severe COVID-19 caused by CD147-mediated extended virus infection.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/b05fc6fa77f80e8aaca3b91cbb2020110f9c12bb" target='_blank'>
              Inducible CD147 up-regulation boosts extended SARS-CoV-2 infection triggering severe COVID-19 independent of ACE2
              </a>
            </td>
          <td>
            Ke Wang, Peng Lin, Ruo Chen, Qiang Huang, Yizhen Zhao, Lei Zhang, Yongxiang Zhao, Liping Zhong, Ke Xu, L. Bao, Youchun Wang, Chuan Qin, G. Wu, Hai Zhang, Jiejie Geng, Zheng Zhang, Ding Wei, Xiaochun Chen, Hao Tang, Liu Yang, Xu Yang, Xiuxuan Sun, Rui Yao, Ye Zhao, Weijun Qin, Zhiwei Yang, Liang Chen, Huijie Bian, Zhi-Nan Chen, Ping Zhu
          </td>
          <td>2026-02-03</td>
          <td>Signal Transduction and Targeted Therapy</td>
          <td>0</td>
          <td>39</td>
        </tr>

        <tr id="Epilepsy is a prevalent neurological disease with a third of patients becoming non-responsive to antiepileptic drugs and developing drug-refractory epilepsy (DRE). Here we report that DRE disease progression is contributed by overactive cyclic GMP-AMP synthase (cGAS), a double-stranded DNA sensor that induces type I interferon (IFN-I) signaling. In human DRE microglia, we observe a robust IFN-I signature and the activation of upstream cGAS-STING signaling. Further, in mouse models of Dravet syndrome, a genetic form of DRE, we observe the activation of the cGAS pathway. We show that microglial cGAS can be activated by DNA released from hyperexcitable neurons. Genetic reduction and pharmacological inhibition of cGAS reduces epileptic phenotypes, glial inflammatory signatures, and neuronal transcriptomic changes, underscoring the therapeutic potential of targeting cGAS for DRE treatment.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/fc0cce0d2437138144bc629d9940435a5264cbca" target='_blank'>
              cGAS-mediated IFN-I signaling contributes to disease progression in drug-refractory epilepsy
              </a>
            </td>
          <td>
            Yige Huang, Li Fan, M. Wong, Z. Lei, Balaji Krishnamachary, Daphne Zhu, Mika Cadiz, Ravi Kumar Nagiri, Pearly Ye, Kendra Norman, Maitreyee Bhagwat, Young Jae Lee, Hui Li, Jingjie Zhu, Sadaf Amin, Kelli Lauderdale, Hao Chen, Wenjie Luo, Shiaoching Gong, Benjamin L. Liechty, Jorge J. Palop, Subhash C. Sinha, Junfang Wu, Mingrui Zhao, Li Gan
          </td>
          <td>2026-02-02</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>13</td>
        </tr>

        <tr id="The polarization state of microglia exerts an influence on neuroinflammation and neural tissue repair after injury. Modulating microglial polarization is emerging as a potential therapeutic strategy for various types of neural injuries and neurodegenerative diseases. However, the causal relationship between microglial polarization and mitochondrial dynamics, which include mitochondrial fusion and fission, remains to be fully clarified. Our study demonstrates that mitochondrial fusion promoter M1 promotes mitochondrial fusion in mouse microglial cells, leading to reduced glycolysis and increased fatty acid oxidation, and this metabolic reprogramming impacts microglial polarization. Additionally, in both cellular and animal experiments, it was observed that knocking down mitochondrial transcription factor A (TFAM) results in increased mitochondrial fission, decreased fatty acid β‐oxidation, enhanced glycolysis, and promotes the polarization of microglia toward the pro‐inflammatory M1 phenotype. In conclusion, our study has, for the first time, provided evidence that TFAM may play a role in the regulation of mitochondrial dynamics. Furthermore, we provide a detailed elucidation of the chronological sequence and underlying causal relationships among mitochondrial dynamics, mitochondrial metabolic reprogramming, and microglial polarization. These findings offer novel targets and strategies for the treatment of various neural injuries and neurodegenerative diseases.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/05037872ff9d9a37d399121d354d551c37363356" target='_blank'>
              TFAM‐Associated Mitochondrial Dynamics and Metabolic Reprogramming Regulate Microglial Polarization: Temporal and Causal Perspectives
              </a>
            </td>
          <td>
            Yuxuan Zhang, Ximeng Wang, Dachuan Li, Xiao Lu, Zhaoyang Gong, Zhidi Lin, Hanqiu Sun, Hongli Wang, Zian Lu, Xiaosheng Ma, Guangyu Xu, Jianyuan Jiang
          </td>
          <td>2026-01-22</td>
          <td>The FASEB Journal</td>
          <td>0</td>
          <td>13</td>
        </tr>

        <tr id="Xenotransplantation of gene-edited pig kidneys offers a promising solution to the shortage of kidneys for organ transplantation. We recently performed a gene-edited pig kidney transplantation into a living human recipient with end-stage kidney disease. Here, using transcriptomics, proteomics, metabolomics and multiplexed imaging, we conducted high-dimensional immune profiling in this individual. Despite profound depletion of circulating T cells, early T cell-mediated rejection occurred within 1 week after transplantation, likely driven by subtherapeutic immunosuppression and the presence of residual CD8+ T cells in lymph nodes. This T cell-mediated rejection event was reversed by intensified immunosuppression. After treatment, adaptive immunity remained suppressed, whereas innate immune activation, characterized by sustained monocyte and macrophage activity along with elevated levels of interleukin-1 beta and granulocyte–macrophage colony-stimulating factor, persisted. Comparative transcriptomic analysis showed that xenograft rejection profiles resembled those typically observed in human allograft rejection, while also revealing unique innate immune signatures. We did not detect antibody-mediated rejection. The levels of circulating pig donor-derived cell-free DNA rose during the initial rejection episode and declined with treatment, supporting the potential of cell-free DNA measurements as a noninvasive biomarker of xenograft rejection. These findings define the distinct immune landscape of kidney xenotransplantation and highlight the need for regimens targeting both innate and adaptive immunity to improve outcomes. High-dimensional immune profiling of a living recipient of a pig-to-human xenotransplant provides insight into the immune landscape of xenotransplantation and directions for improved immunosuppression strategies.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/4d98f157c93f6286ac76303fb8e8b35d2f6f44e7" target='_blank'>
              Immune profiling in a living human recipient of a gene-edited pig kidney
              </a>
            </td>
          <td>
            Guilherme T. Ribas, André F. Cunha, Jonathan P Avila, A. Giarraputo, Leela Morena, Karina Lima, R. B. Gassen, Jia-Yun Chen, Jia-Ren Lin, Sandro Santagata, Claire T Avillach, B. Ryback, Martin S Lindner, S. Bercovici, Ivy A. Rosales, Tatsuo Kawai, H. Nakaya, Robert B Colvin, Thiago J. Borges, Leonardo V. Riella
          </td>
          <td>2026-01-01</td>
          <td>Nature Medicine</td>
          <td>0</td>
          <td>34</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/bc4582ef4d32ebea98d3e58a51b8dee416be7466" target='_blank'>
              A reproducible human brain tissue model to study physiological and disease-associated microglia phenotypes
              </a>
            </td>
          <td>
            Julien Klimmt, Carolina Cardoso Gonçalves, Jessica V. Montgomery, Stephan A. Müller, Merle Bublitz, S. Filser, L. Paeger, B. Nuscher, Angelika Dannert, Sigrun Roeber, Veronica Pravata, Martina Schifferer, J. Shrouder, Nathalie Schulz, Judit González Gallego, Silvia Cappello, Thomas Misgeld, Nikolaus Plesnila, Eduardo Beltrán, Jochen Herms, Elena De Domenico, M. Beyer, J. Schultze, Christian Haass, Stefan F. Lichtenthaler, Caterina Carraro, Dominik Paquet
          </td>
          <td>2026-01-21</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>22</td>
        </tr>

        <tr id="Enteroviruses are major causes of neonatal morbidity and mortality, with echovirus infections commonly associated with severe disease, including acute liver failure. The human neonatal Fc receptor (hFcRn) is the primary receptor for echoviruses, and its expression is required for infection of the liver in mouse models. While type I interferons (IFNs) are known to protect against echovirus-induced disease, the specific innate immune cells responsible for initiating this antiviral signaling in the liver remain undefined. To dissect the relative contributions of type I and type III IFNs in protecting the liver during echovirus infection, we combined in vivo mouse models (expressing hFcRn and deficient in Ifnar1, Ifnlr1, or both) with single cell RNA sequencing (scRNA-seq). This approach enabled us to pinpoint the hepatic cell types targeted by echoviruses and to identify the specific cells producing IFNs in response. We found that hepatocytes and Kupffer cells were the most heavily infected cell types. In contrast, early and robust type I IFN responses were primarily driven by Kupffer cells and a subset of dendritic cells. To determine whether type I IFNs act directly on hepatocytes to mediate protection, we generated conditional knockout mice lacking Ifnar1 specifically in hepatocytes. These mice showed similar morbidity, mortality, and hepatic viral titers as whole-body Ifnar1⁻/⁻ animals, indicating that hepatocytes depend on protective IFN signals produced by immune cells during echovirus infection. These findings uncover cell-type-specific mechanisms by which echoviruses subvert host immunity and show how dysregulated IFN responses drive liver pathology and neonatal mortality.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/032f40d193e6c8633f96b47870928590b549cd3f" target='_blank'>
              Tissue-resident macrophage and dendritic cells drive type I IFN immunity to enteroviruses in the liver
              </a>
            </td>
          <td>
            Emma Heckenberg, Jacob G. Davis, Caitlin Hale, Carolyn B. Coyne
          </td>
          <td>2026-01-01</td>
          <td>PLOS Pathogens</td>
          <td>0</td>
          <td>6</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/867efcbe14a63d7bf027c9f54c987f90b3ddddd7" target='_blank'>
              Csf1r-mediated depletion of midbrain microglia prevents dopaminergic neuron loss during chronic colitis
              </a>
            </td>
          <td>
            Rebecca Katharina Kutscherauer, I. Stolzer, E. Neumaier, M. Dedden, Pavel Kielkowski, W. Xiang, Alexander Grotemeyer, Marco Prinz, Takahiro Masuda, K. Knobeloch, V. Rothhammer, Sebastian Zundler, Johannes C. M. Schlachetzki, Jürgen Winkler, Claudia Günther, P. Süß
          </td>
          <td>2026-01-26</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>47</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/34649c6562aa2175c877d0871438b8882a670ac3" target='_blank'>
              Integrated single-cell analysis reveals interferon-driven immune signatures in a DENV1 human infection model
              </a>
            </td>
          <td>
            A. Vermeersch, T. Verdonckt, C. Struyfs, E. De Meester, A. Waickman, S.J. Thomas, K. Ariën, O. Lagatie, F. van Nieuwerburgh
          </td>
          <td>2026-01-05</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>36</td>
        </tr>

        <tr id="Background and Objectives: SARS-CoV-2 produces potentially pathogenic molecules, such as single-stranded RNA and spike proteins, which can potentially activate microglial cells. In this study, we aimed to investigate whether SARS-CoV-2 spike protein S1 and mRNA vaccines can cause neurotoxicity directly or through microglial involvement. Materials and Methods: Primary cerebellar granule cell cultures isolated from Wistar rats and organotypic hippocampal slice cultures from transgenic C57BL/6J mice were used in the experiments. Imaging and quantitative analysis of cell viability, proliferation, and phagocytic activity were performed using light and fluorescence microscopy. Results: The exogenous SARS-CoV-2 S1 protein at 50 µg/mL concentration induced neuronal cell death in neuronal–glial co-cultures and stimulated microglial proliferation during the first 3 days of exposure without an effect on inflammatory cytokine secretion. Single application of Tozinameran/Riltozinameran and Original/Omicron BA. 4–5 vaccines did not affect neuronal viability and total neuronal number in cell co-cultures after 7 days of exposure. In contrast, three repeated treatments with mRNA vaccines at 6 ng/mL caused microglial proliferation without affecting microglial phagocytosis and TNF-α release. In organotypic brain slice cultures, only Tozinameran/Riltozinameran stimulated microglial cell proliferation in female brain slices, while male brain slices remained unaffected by both vaccines, indicating sex-dependent effects. Conclusions: The findings suggest that mRNA vaccines do not exert neurotoxic effects in primary neuronal–glial co-cultures, but induce microglial proliferation, particularly in female brains in the absence of inflammatory cytokine release. SARS-CoV-2 S1 protein at high concentrations directly induces neuronal death.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/567a4aa0a83021d71994ccbaebdd890368722142" target='_blank'>
              Effects of Exogenous SARS-CoV-2 S1 Protein and mRNA Vaccines on Mixed Neuronal–Glial Cell Cultures
              </a>
            </td>
          <td>
            Vytenis Markevičius, Eimina Dirvelytė-Valauskė, Urte Neniskyte, V. Borutaite
          </td>
          <td>2026-01-01</td>
          <td>Medicina</td>
          <td>0</td>
          <td>22</td>
        </tr>

        <tr id="Key to the success of influenza A virus as a pathogen are its numerous tactics of immune evasion. To suppress anti-viral cellular and organismal responses, influenza A virus encodes several immunomodulatory proteins, including the endoribonuclease PA-X. PA-X decreases inflammation and immune responses in in vivo infections by limiting host gene expression. PA-X is conserved in 99% of all influenza A viral strains, pointing to its importance as a crucial immunomodulator. However, it is not yet known how PA-X activity alters the antiviral response in the human airway or how it benefits the virus. To define how influenza A virus uses this protein to evade immune responses, we characterized the impacts of PA-X on the host response to infection in the infected and bystander cells of the airway epithelium using a 3D ex vivo model. We discovered that PA-X exerts a dual action on immune responses, dampening aspects of both the innate and adaptive immune systems. Consistent with reports in model organisms, PA-X significantly decreases secretion of multiple cytokines from airway epithelium, including IFN-λ, which likely plays a role in its ability to reduce inflammation and lung damage. In addition, we revealed that PA-X decreases and delays MHC I antigen presentation from infected cells. This reduction likely aids influenza A virus in hiding from antigen-specific T cells and allows the virus to successfully replicate prior to immune detection. This new function for PA-X highlights how influenza A virus employs active mechanisms to block immune detection, in addition to tolerating high levels of antigen mutations to escape it. Moreover, as evasion of recognition by the adaptive immune system is particularly important during infections of animals and humans with pre-existing immunity, this immunomodulatory activity may be key to the longevity of influenza A viruses and their continued circulation.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/63880aa46134ce1729f72a321b79591f93893ffb" target='_blank'>
              Dual roles for influenza A protein PA-X: limiting inflammatory response and disrupting MHC I antigen presentation in human respiratory epithelium
              </a>
            </td>
          <td>
            Alessandra C. Setaro, Corinne Thomas, M. Gaglia
          </td>
          <td>2026-01-31</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>16</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/b3cf8ccef4f0da2450453bee84f1b777bd397c30" target='_blank'>
              Toll-like receptor 9 contributes in microglial activation and lysosomal dysfunction to promote Alzheimer’s disease
              </a>
            </td>
          <td>
            Moïse de Lavaissière de Lavergne, Lucie Mazzola, Katrina Podsypanina, Cecilia Estrella, Philippe Verwaerde, Irini Evnouchidou, Guillaume Darrasse-Jèze, Marie-Claude Potier, Sheela Vyas, Bénédicte Manoury
          </td>
          <td>2026-01-18</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>19</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/7f17946ac3dbb8efa92226c7ce4112035350abc3" target='_blank'>
              STAT1-Mediated Regulation of IL-17A/CEBPB/NF-κB Axis in HIV-1 Infected Human Cerebral Organoids Reveals Therapeutic Targets for Neuroprotection
              </a>
            </td>
          <td>
            Karthick Chennakesavan, Malaroviyam Samikkannu, Shreyan Gupta, Olasunkanmi Israel Tayo, Arpan Acharya, James J. Cai, S. Byrareddy, T. Samikkannu
          </td>
          <td>2026-01-02</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>36</td>
        </tr>

        <tr id="The emergence of SARS-CoV-2 led to a global pandemic with severe respiratory symptoms and substantial extrapulmonary manifestations. Increasing evidence suggests significant cardiovascular complications associated with SARS-CoV-2 infection, which are critical factors in morbidity and mortality. In this study, we assessed the viral infectivity and viral niche of SARS-CoV-2 using our clinically-amenable in vitro cardiac spheroids (CSs), which have previously been demonstrated to be an optimal tool to recapitulate the complex cardiac pathophysiology. We examined the expression profiles of cardiovascular-related disease genes and pathways involved in inflammation, interferon responses, and antiviral defence following infection. Genes associated with apoptosis, chemotaxis, fibrosis, and contractile function exhibited substantial increases, implicating these pathways in the cardiac response to SARS-CoV-2. Furthermore, our 3D rendering analyses using confocal imaging revealed cell-specific effects mediated by the virus by colocalising SARS-CoV-2 nucleocapsid protein with each cell type, supporting the ability of CSs to facilitate viral replication and contributing to the observed phenotypes. Additionally, SARS-CoV-2 could only infect intact CSs, whereas it did not infect individual cell types cultured individually. The unique ability of CSs to model SARS-CoV-2 in the heart may potentially mirror the pathophysiological changes observed in COVID-19-induced cardiac complications. Altogether, our results suggest that CSs offer a valuable tool for dissecting direct host-viral interactions and advancing our understanding of SARS-CoV-2-related cardiac injury. Our findings underscore the utility of CSs in revealing the mechanisms of SARS-CoV-2-induced cardiac damage and provide a basis for further studies into the long-term cardiovascular consequences of SARS-CoV-2.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/e493a51a3fb6d07e646490a08af4721a5f35f5c7" target='_blank'>
              SARS-CoV-2 infection of 3D in vitro cardiac spheroids models the activation of antiviral, inflammatory, fibrotic, and contractile responses in a dose-dependent manner
              </a>
            </td>
          <td>
            M. Johansen, Clara Liu Chung Ming, P. Hansbro, Carmine Gentile
          </td>
          <td>2026-01-15</td>
          <td>Biofabrication</td>
          <td>0</td>
          <td>22</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/6daf260caa32a66184b89170dbda45728037657f" target='_blank'>
              Injury-induced CTE-like pathology emerges in a human multicellular in vitro brain model and reveals mitochondrial and neurovascular regulation
              </a>
            </td>
          <td>
            Sunghyun Jun, Daniel S Hinrichsen, Sahan BS Kansakar, Charitha C Anamala, Jada Teregeyo, Haiden C. Roberts, Colleen M Arrasmith, Mitchell D Thielen, Volha Liaudanskaya
          </td>
          <td>2025-12-29</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>11</td>
        </tr>

        <tr id="Infection rates involving bacterial and viral pathogens have increased precipitously after the COVID-19 pandemic. While it has been speculated that higher infection rates resulted from increased hospitalizations throughout the pandemic or greater use of antibiotics, precisely why rates remain high today has remained unexplained. Mitochondrial dysfunction is known to occur post-COVID and may disrupt immune responses. Within T cells, SARS-CoV-2 infection is linked to low mitochondrial membrane potential, increased mitochondrial apoptosis, and decreased mitochondrial respiration, which together impact cellular activation and function beyond the acute phase of illness. Here, we demonstrate that decreased mitochondrial function in antigen-specific T cells post-COVID may contribute to higher infection susceptibility by metabolically immobilizing T cell memory responses. Using donor-matched peripheral blood samples from 31 COVID-naïve individuals who subsequently contracted COVID-19, we tracked how influenza A (IAV), Staphylococcus aureus (SA), and Varicella-zoster virus (VZV) T cell responses were impacted by COVID-19 infection. We found that gene expression linked to T cell activation decreased but mitochondrial redox pathways increased in CD4 memory T cells post-COVID. However, mitochondrial flux and reactive oxygen species production were limited in a plurality of post-COVID memory T cells after stimulation with IAV, SA, and VZV. Furthermore, we found a disordered relationship between memory T cell mobilization of glycolysis, fatty acid metabolism, and oxidative phosphorylation pathways post-COVID which resulted in diminished use of catabolic pathways including glycolysis and fatty acid oxidation in antigen-specific T cells. Modulation of mitochondrial function with metformin and ubiquinol partially rescued the post-COVID decline in T cell catabolism. Collectively, these findings indicate that COVID-19 infection may have lasting effects on inhibiting T cell memory responses to commonly encountered community-acquired pathogens which can be corrected with commonly available medications. This has significant implications for the clinical care of immunologically vulnerable populations in the post-pandemic era.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/826971fe690f6be31807f55457f0b21244f3d4b9" target='_blank'>
              Post-COVID impairment of memory T cell responses to community-acquired pathogens can be rectified by activating cellular metabolism
              </a>
            </td>
          <td>
            Daniel D. Carroll, Kamacay Cira, Jack Archer, Jason Shapiro, Ue-yu Pen, David Tieri, Lucia Leonor, Neda D. Roofchayee, Samantha S. Yee, Marc Wahab, Igor J. Koralnik, John C. Alverdy, Arjun S. Raman, L. Visvabharathy
          </td>
          <td>2026-01-02</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>15</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/318a7f7f778b90d55a4455d45bcee8d24b1fc66c" target='_blank'>
              Antibody-Dependent Heterotypic Syncytia Drive COVID-19 Inflammation and Disease Progression
              </a>
            </td>
          <td>
            Yin Yang, Chi Zhou, Tianyi Zhang, Weiqi Hu, Nicholas Magazine, Mariano Carossino, Nannan Jia, Teng Li, Yingdan Wang, Chen Wang, Jinghe Huang, Weishan Huang, Fan Wu
          </td>
          <td>2026-02-12</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>7</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/b09542cf8541c87eb81cd5d350b998bad1880105" target='_blank'>
              Inflammasome activation and oxidative stress in SARS-CoV-2 infection and symptomatic rebound.
              </a>
            </td>
          <td>
            S. Lage, Joseph M. Rocco, Cihan Oguz, Francisco A. Otaizo-Carrasquero, Adam W. Rupert, K. Boswell, Brian P. Epling, Logan Cook, Eduardo Pinheiro Amaral, Elizabeth Laidlaw, Frances Galindo, R. Koup, Princy Kumar, Rita Poon, Glenn W Wortmann, A. Lisco, Maura Manion, I. Sereti
          </td>
          <td>2026-01-20</td>
          <td>The Journal of infectious diseases</td>
          <td>0</td>
          <td>131</td>
        </tr>

        <tr id="Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has a wide range of clinical manifestations modulated by genetic factors. The aim of this study was to identify genetic determinants of severe COVID-19 affecting protein sequence to gain insight into disease pathogenesis. Variants prioritized in two patients requiring lung transplant were tested in the Milan FOGS cohort (487/869 cases/controls), highlighting an independent association between the p.F8S low-frequency variant of interferon alpha receptor 2 gene (IFNAR2) and severe disease (OR = 1.73 [1.24–2.42], p = 0.001), replicated in the COVID-19 Host Genetics Initiative cohort (26,167/2,061,934 cases/controls). In the FOGS cohort, the p.F8S variant was linked to higher circulating IL-6 levels. In keeping, bulk transcriptomic analysis in PBMCs at the peak of infection (n = 57) showed that carriers of the p.F8S variant had upregulation of immune signaling and pathogens response (p < 0.05). Functional flow cytometry experiments in healthy donors (n = 12) revealed that membrane IFNAR2 protein expression was reduced in B lymphocytes, but higher in dendritic cells (p < 0.05). Finally, by interrogating a public scRNAseq resource of PBMC of people with COVID-19, we showed that p.F8S carriers had upregulation of immune pathways specifically in dendritic cells (p < 0.05). These results suggest that the p.F8S variant may influence COVID-19 severity by enhancing adaptive immune response, thereby favoring inflammation.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/26fd134f10d835db7d97829bfbea4ea4fe400a32" target='_blank'>
              IFNAR2 p.F8S Variant Associates with Severe COVID-19 and Adaptive Immune Cell Activation Modulation
              </a>
            </td>
          <td>
            F. Malvestiti, Angela Lombardi, Francesco Gentile, Veronica Torcianti, Elena Trombetta, Alessandro Cherubini, G. Lamorte, S. Uceda Renteria, Daniele Marchelli, Lorenzo Rosso, A. Bandera, F. Peyvandi, F. Blasi, Giacomo Grasselli, L. Porretti, Saleh A. Alqahtani, Daniele Prati, Roberta Gualtierotti, Blagoje Soskic, Valentina Vaira, L. Ronzoni, L. Valenti
          </td>
          <td>2026-01-01</td>
          <td>International Journal of Molecular Sciences</td>
          <td>0</td>
          <td>58</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/7e3390d47a05cc167afea6dd6713ed3857300502" target='_blank'>
              PPARδ activation in microglia drives a transcriptional response that primes phagocytic function while countering inflammatory activation
              </a>
            </td>
          <td>
            Jacob S. Deyell, J. Hasselmann, Linda Stroud, Urmimala Raychaudhuri, Yunzi Guo, Byeonggu Cha, Christopher Karma, Deavin Tendean, Minh-Huy Vu Tran, Anastasia Gromova, Audrey S. Dickey, Mathew Blurton-Jones, A. R. La Spada
          </td>
          <td>2025-12-19</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>17</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/91babd22d3b6b86432a313b4b21fca0bc39e8c82" target='_blank'>
              Single cell RNA sequencing reveals limited effects of Lrrk2 genotype in a mouse model of acute CNS inflammation
              </a>
            </td>
          <td>
            Alice Kaganovich, Liam Horan-Portelance, Natalie Landeck, Dominic J. Acri, Jinhui Ding, R. Langston, Mark R. Cookson
          </td>
          <td>2025-12-22</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>25</td>
        </tr>

        <tr id="Microglial cells exhibit crucial metabolic adaptations to maintain neural homeostasis. However, their dysregulated activation during infections can lead to neurotoxicity and contribute to the development of neuroinflammatory disorders. Understanding the physiological and metabolic changes of microglia during immune activation is crucial for identifying protective targets against neuroinflammation. This study investigates how the Zika virus (ZIKV) alters microglia metabolism during inflammation, highlighting cellular adaptations that sustain oxidative metabolism linked to cell survival during cellular activation and viral replication. After identifying an enriched abundance of proteins related to oxidative phosphorylation and cellular component organization in the global proteomics of mouse brains following ZIKV exposure, we investigated the relevance of these pathways during in vitro infection of human microglia. ZIKV infection led to cytoskeleton remodeling via β-tubulin reallocation, which characterized an ameboid-like phenotype. Despite the indication of a shift toward increased glycolytic activity due to decreased intracellular glucose, which suggests its consumption, and the accumulation of tricarboxylic acid cycle (TCA) intermediates, ZIKV-infected microglia exhibit enhanced respiratory capacity and an abundance of smaller-sized mitochondria in the perinuclear region. The accumulation of citrate, succinate, and malate, while maintaining mitochondrial function, suggests an important metabolic adaptation that supports biosynthetic pathways and sustains cell viability under stress. Decreased intracellular glutamate abundance supports mitochondrial oxidative metabolism. Pre-treatment with the anti-inflammatory docosahexaenoic acid (DHA) mitigates ZIKV-induced metabolic alterations by reducing pro-inflammatory markers, downregulating viral entry receptors, and lowering microglial activation and viral load. This study reveals that while ZIKV induces cell death in neuronal-like cells, the mitochondrial adaptation observed in microglial infection could be a key to maintaining cell survival throughout neuroinflammation. Our findings elucidate a novel cellular adaptation during ZIKV infection involving β-tubulin reorganization and metabolic dynamics, reflecting microglial flexibility and resistance during neuroinflammation, and demonstrating the therapeutic potential of DHA in mitigating ZIKV-induced pathology.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/6d680f6e601874de149962588421e3e6c0a8d4a6" target='_blank'>
              Zika Virus Reprograms Microglial Mitochondrial Metabolism to Support Immune Activation and Viral Replication: Omega-3 DHA Counteracts Neuroinflammation and Viral Persistence
              </a>
            </td>
          <td>
            Heloísa Antoniella Braz-De-Melo, Fernanda Gomes Lago, Rafael Corrêa, I. Santos, P. Bellozi, R. Almeida, Wagner Fontes, Mariana S. Castro, Aline Maria Araújo Martins, R. M. de Oliveira, Nadia Martins Serpa Rossi, Gabriel Pasquarelli-do-Nascimento, Ana Luiza Gouvea, Paulo Sousa Prado, A. D. de Bem, Sônia Nair Báo, B. M. Ribeiro, S. Rehen, Thomas Christopher Rhys Williams, Gary P. Kobinger, Kelly Grace Magalhães
          </td>
          <td>2026-01-01</td>
          <td>Molecular Neurobiology</td>
          <td>0</td>
          <td>41</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/1a7003e81dc9e785e6c921fda274b93fc77f9d6f" target='_blank'>
              Mechanisms of disrupted neurodevelopment after Zika virus infection in infancy
              </a>
            </td>
          <td>
            V. Edara, Sienna Freeman, M. Sampson, Kathryn Moore, Rebecca Richardson, N. Schoof, Divine Burgess, Michelle Lee, G. Tharp, R. Vlasova, Shane Taylor, Ariana Hodjatzadeh, Yihana Melendez-Alejandro, Samia Abdallah, Esther Ndungu, Ava Mascarenhas, Chao-Hsiung Hsu, Tsang-Wei Tu, M. Styner, M. Suthar, Mar M. Sanchez, Steven Bosinger, Mark W. Burke, Steven A. Sloan, J. Raper, A. Chahroudi
          </td>
          <td>2026-01-28</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>69</td>
        </tr>

        <tr id="Group A Streptococcus (GAS) infections can lead to neuropsychiatric sequelae in children, yet the mechanisms driving post-infectious brain pathology remain poorly defined. In a mouse disease model, Th17 lymphocytes induce microglial activation, blood–brain barrier (BBB) dysfunction, and neural circuit impairment; however, the transcriptional programs underlying these effects, and the specific Th17-derived cytokines involved are unclear. Using mouse genetics, single-cell RNA sequencing, and spatial transcriptomics, we show that GAS infections induce inflammatory gene programs in microglia and brain endothelial cells (BECs), accompanied by downregulation of BBB-associated transcripts in BECs. Spatial transcriptomic analyses reveal that GAS-responsive microglia are enriched near infiltrating T cells. Several chemokines upregulated in microglia following GAS infection in mice are elevated in sera from affected patients. Conditional ablation of GM-CSF in CD4+ T cells partially attenuates microglial chemokine gene expression, but does not restore BBB integrity. Neutralization of IL-17A partially rescues BBB transcriptional changes in BECs and reduces microglial chemokine expression; however, compensatory peripheral immune responses associated with persistent infection exacerbate BBB disruption. In contrast, microglia/macrophage-specific deletion of IL-17 receptor A partially rescues BBB deficits following GAS infection. Together, these findings identify IL-17A–IL-17RA signaling in microglia as a critical driver of BBB dysfunction after GAS infections.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/ee117c7510952a86fbf564b504cd76bc033a8401" target='_blank'>
              Th17 effector cytokines induce shared and distinct microglial and endothelial cell responses in post-streptococcal encephalitis
              </a>
            </td>
          <td>
            C. R. Wayne, U. Akcan, Travis E. Faust, Violeta Durán-Laforet, Danny Jamoul, Luca Bremner, Nicole Ampatey, Büşra T. Akcan, , B. Ciric, Shannon L. Delaney, Wendy S. Vargas, Susan Swedo, Vilas Menon, Dorothy P. Schafer, Tyler Cutforth, Dritan Agalliu
          </td>
          <td>2026-02-07</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>44</td>
        </tr>

        <tr id="SARS-CoV-2 infection has raised significant concerns regarding its impact on assisted reproductive technology. We found that oocyte retrieval during acute SARS-CoV-2 infection significantly reduced the rates of good-quality blastocyst formation, but the underlying molecular mechanisms remain poorly understood. To address this, we investigated the effects of maternal acute SARS-CoV-2 infection on preimplantation embryo development and the early offspring hematopoietic system. Using single-cell RNA sequencing (scRNA-seq), we identified developmental delays in morphologically normal blastocysts from infected mothers, characterized by prolonged expression of zygotic genome activation-related genes, downregulation of mTORC1 signaling, and altered energy metabolism, including suppressed oxidative phosphorylation (OXPHOS) and enhanced glycolysis. We further revealed that maternal acute infection induced abnormal methylation/demethylation patterns in preimplantation embryos. To assess the potential long-term impact on offspring, we conducted integrated multi-tissue analyses, including bulk RNA-seq and genome-wide DNA methylation profiling of placental tissues, along with scRNA-seq of umbilical cord blood (UCB) cells from neonates delivered by SARS-CoV-2-infected mothers. Neonates exhibited elevated levels of inflammatory cytokines and an increased abundance of monocytes, indicating an activated myelopoiesis response. In addition, hematopoietic stem and progenitor cells (HSPCs) from UCB showed reduced OXPHOS activity and a skewed differentiation bias toward the myeloid lineage, potentially impacting long-term immune function. Collectively, these findings reveal that maternal acute SARS-CoV-2 infection impairs preimplantation embryo development and leaves a lasting imprint on offspring hematopoietic health through dysregulated energy metabolism, epigenetic modifications, and altered immune responses.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/ee68899890c9e4147b029e7d865633ef259aa9e4" target='_blank'>
              Maternal acute SARS-CoV-2 infection impairs preimplantation embryo development and reprograms the early offspring hematopoietic system
              </a>
            </td>
          <td>
            Meiling Zhang, Di Liu, Songmao Li, Jiansheng Liu, Fanghao Guo, Haibin Zhu, Li Zhang, Di Sun, Yu Yan, Yanquan Li, Rui Qiao, Hai-xia Ding, Qing Zhang, Mengxi Guo, Yongjian Ma, Zhiwei Liu, Wen Li, Yuxuan Zheng
          </td>
          <td>2025-12-01</td>
          <td>Cell Discovery</td>
          <td>0</td>
          <td>17</td>
        </tr>

        <tr id="Although neurological disease is common in people with human immunodeficiency virus (HIV) (PWH), the contributing factors and underlying inflammatory mechanisms remain challenging to identify. Extracellular vesicles (EVs) constitute a relatively uncharacterized modality of intercellular communication and bioactive cargo transport in the setting of viral infection and pathogenesis. EVs carry inflammatory mediators to areas of the periphery during antiretroviral therapy (ART) suppression but are understudied in the brain. Using a biologically relevant simian–human immunodeficiency chimeric virus with a clade D HIV envelope (SHIV.D)-infected rhesus macaque (RM) model of HIV persistence in the central nervous system (CNS), we investigate circulating EV populations and the protein cargo of myeloid-derived EVs during SHIV infection. Using EV flow cytometry to quantify specific EV subpopulations, we found a significant increase in TMEM119+ microglial EVs and CD171+ neuronal EVs in RM plasma during viremia and ART suppression. Using primary RM monocyte-derived macrophages (MDMs), we determined that MDMs increased EV production after SHIV infection. Whole proteomic analysis of these EVs demonstrated that myeloid EVs isolated from SHIV.D-infected MDMs carried significantly increased levels of neuropathogenic and inflammatory proteins. Altogether, these studies improve our understanding of the contribution of myeloid EVs to neurological disease during SHIV/HIV infection.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/cc3683d7fc86b54ee7352b4c7fdd4e87c4f857ea" target='_blank'>
              SHIV.D Infection Alters Production and Protein Composition of Myeloid-Derived Extracellular Vesicles
              </a>
            </td>
          <td>
            Rachel M. Podgorski, Amir Yarmahmoodi, Stephen Baak, Rebecca Warfield, Jake A. Robinson, Jennifer Roof, Maurizio Caocci, Hossein Fazelinia, L. Spruce, Katharine J. Bar, T. Burdo
          </td>
          <td>2026-01-01</td>
          <td>International Journal of Molecular Sciences</td>
          <td>0</td>
          <td>4</td>
        </tr>

        <tr id="SARS-CoV-2 infection typically resolves within weeks, but rare cases of prolonged replication—sometimes exceeding a year—have been documented, particularly in immunocompromised individuals. These persistent infections pose health risks and may give rise to highly divergent variants, yet the underlying biology remains poorly understood. Here, we describe a model of SARS-CoV-2 persistence using transgenic Syrian hamsters (males) lacking the interleukin-2 receptor gamma subunit (IL2rg). Infection with the XBB.1.16 variant led to efficient viral replication in respiratory tissues by two weeks after infection, with dissemination to other sites, including the intestinal tract. Viral titers remained high in multiple tissues at 100 days after infection. Longitudinal oral swab sequencing revealed dynamic shifts in intrahost single-nucleotide variant (iSNV) frequencies, with constellations of iSNVs rising and falling together, consistent with strong genetic linkage. Synonymous and nonsynonymous mutations accumulated at similar rates, suggesting genetic drift as the dominant evolutionary force. Tissue- and swab-derived sequences revealed extensive within-host diversity and hinted at tissue-specific evolutionary trajectories. This model enables detailed investigation of SARS-CoV-2 persistence and within-host viral evolution and provides a controlled system to study how long-term replication in tissue reservoirs may contribute to viral diversification. SARS-CoV-2 persistence in IL2rg-deficient hamsters shows sustained replication, tissue dissemination, and dynamic intra-host evolution, establishing a model to define mechanisms driving long-term infection and its effects.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/291cd1612c50d00cdb88e4ebcedd78749a7bb740" target='_blank'>
              Pathology and viral evolutionary dynamics in a hamster model of persistent SARS-CoV-2 infection
              </a>
            </td>
          <td>
            Wanting Wei, M. Kuroda, Yanan Liu, S. Iida, Sangam Kandel, Heather Machovech, Yuichiro Hirata, Tadaki Suzuki, K. Koelle, Zhongde Wang, T. C. Friedrich, Yoshihiro Kawaoka, P. Halfmann
          </td>
          <td>2026-01-08</td>
          <td>Communications Biology</td>
          <td>0</td>
          <td>57</td>
        </tr>

        <tr id="Zika virus (ZIKV) poses a significant threat to neural tissue, causing substantial damage to unborn children exposed to the virus in utero, with consequences that can manifest even after birth, despite being born with a normal head circumference. Regardless of the extensive research, the interactions between ZIKV and the nervous system cells remain insufficiently understood, particularly regarding how neuronal responses influence broader inflammatory and viral dynamics especially in postnatal stages of development. This study evaluated the susceptibility to ZIKV infection, viral replication, immune response, and survival of neurons, astrocytes and microglial cells during postnatal developmental stages, using both in vivo and in vitro mice models. In vivo, a non-lethal but extensive infection of neurons and microglia was shown. The infection caused a robust but controlled immune response with elevated levels of MCP-1, TNF-α, and IL-6, that prevented severe neuronal damage. In vitro, neurons exhibited high susceptibility to ZIKV, with elevated levels of pro-inflammatory cytokines and IFN-β, indicating a strong inflammatory response. In contrast, astrocytes and microglia displayed varied responses, contributing to a pro-inflammatory feedback loop. These findings offer critical insights into the cellular dynamics of ZIKV infection, enhancing our understanding of its effects during postnatal nervous system development. By clarifying the interactions between ZIKV and neuronal cell types, this study deepens the comprehension of the virus’s pathophysiology and its broader implications for neurodevelopmental outcomes, extending beyond the well-documented association with microcephaly.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/80aee6bf94647ce0fef40ccbfab9270cf8289aa9" target='_blank'>
              In vivo and in vitro susceptibility and inflammatory response of postnatal mouse cortical neurons and glial cells to zika virus infection
              </a>
            </td>
          <td>
            M. Calderón-Peláez, M. Velandia-Romero, Jaime E Castellanos
          </td>
          <td>2025-12-31</td>
          <td>PLOS One</td>
          <td>0</td>
          <td>12</td>
        </tr>

        <tr id="Coronavirus disease 2019 (COVID-19) and other respiratory viral infections, such as influenza and respiratory syncytial virus (RSV), elicit both common and virus-specific host responses. Here, we present an integrative analysis leveraging the COVID-19 Host Genetics Initiative (HGI) GWAS data (freeze 7) and publicly available multi-omics datasets (including influenza/RSV human challenge transcriptomes and plasma proteomics) to construct an explainable AI model for comparing host infection mechanisms between COVID-19 and other viral illnesses. We identified shared antiviral pathways (type I interferon (IFN) signaling) active in host responses to all three viruses, as well as virus-specific mechanisms: for instance, SARS-CoV-2 infection induced uniquely strong coagulation and renin-angiotensin system dysregulation, along with sustained AP-1/MAPK activation, whereas influenza provoked more robust T-cell activation, and RSV triggered an excessive neutrophil-driven inflammatory response. Genetic risk pathway fingerprints from GWAS highlight that COVID-19 severity is associated with variants in IFN and inflammatory pathways, while host genetic effects in influenza point to distinct receptor usage (sialic acid biosynthesis) with minimal overlap. Mendelian randomization (MR) pinpointed key causal proteins for COVID-19 severity, including ABO (blood group glycosyltransferase) and inflammatory mediators, suggesting that host glycomic and immune factors modulate disease outcomes. Our explainable machine learning model integrated these multi-omic features to accurately distinguish COVID-19 from other viral infections, with SHAP interpretation confirming the predominance of the above mechanisms in model predictions. In summary, this cross-omics study provides a comprehensive comparative map of host responses in COVID-19 versus influenza and RSV, yielding biologically interpretable insights into both common antiviral defenses and unique pathogenic pathways. These findings inform the development of targeted therapies (IL-6 or MAPK inhibitors for COVID-19) and broad-spectrum antivirals (enhancing IFN responses) to mitigate severe respiratory viral diseases.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/8e82b97b13d456a0dff65f4dc3232b454a383edd" target='_blank'>
              Explainable AI multiomics analysis reveals shared and divergent host responses in COVID-19 and influenza
              </a>
            </td>
          <td>
            Yan Zhang, Lining Zhang, Zehong Zhang, Yuxi Lin, Zexu Jiang, Fulong Yu
          </td>
          <td>2026-01-27</td>
          <td>NPJ Digital Medicine</td>
          <td>0</td>
          <td>1</td>
        </tr>

        <tr id="Neuroinflammation is a hallmark of both acute and chronic neurodegenerative diseases and is driven, in part, by activated glial cells, including microglia. A key regulator of this inflammatory response is the NLRP3 inflammasome, an immune sensor that can be triggered by diverse, unrelated stimuli such as pathogen-associated molecular patterns, cellular stress, and mitochondrial dysfunction. Despite progress in targeting NLRP3-mediated immune activation, many drug candidates fail, potentially due to the limited availability of physiologically relevant disease models. The SIM-A9 murine microglial cell line, established in 2014, has emerged as a widely used model for studying neuroinflammation; however, its proteome has not yet been systematically characterized. In this study, we investigated the proteomic landscape of SIM-A9 microglia treated with classical pro-inflammatory stimuli, including lipopolysaccharide (LPS) and extracellular ATP and nigericin (NG), to induce NLRP3 inflammasome activation. Using complementary proteomic approaches, we quantified 4903 proteins and observed significant enrichment of proteins associated with immune and nervous system processes. Differentially expressed proteins were consistent with an activated microglial phenotype, including the upregulation of proteins involved in NLRP3 inflammasome signaling. To our knowledge, this is the first comprehensive proteomic analysis of SIM-A9 microglia. These findings provide a foundational resource that may enhance the interpretation and design of future studies using SIM-A9 cells as a model of neuroinflammation.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/59bd3b9c1de0363b2421f1d539e8f44ae1afeb6f" target='_blank'>
              Characterization of the Proteomic Response in SIM-A9 Murine Microglia Following Canonical NLRP3 Inflammasome Activation
              </a>
            </td>
          <td>
            Nicolas N. Lafrenière, Karan Thakur, Gerard Agbayani, Melissa Hewitt, Klaudia Baumann, J. Sandhu, A. Haqqani
          </td>
          <td>2026-01-01</td>
          <td>International Journal of Molecular Sciences</td>
          <td>0</td>
          <td>31</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/d870ebbff2d4f77ea1c9e4d47b31cd42cc80f053" target='_blank'>
              Bioengineered extracellular vesicles mitigate neuroinflammation by neutralizing pneumolysin and delaying disease onset in experimental pneumococcal meningitis
              </a>
            </td>
          <td>
            Kristine Farmen, Miguel Tofiño-Vian, Doste R. Mamand, Xiuming Liang, Houze Zhou, V. W. Hou, S. El Andaloussi, O. Wiklander, Federico Iovino
          </td>
          <td>2026-01-08</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>25</td>
        </tr>

        <tr id="Alzheimer’s disease (AD) is a progressive neurodegenerative disorder and the leading cause of dementia. It is characterized by cognitive decline and accumulation of amyloid beta (Aβ) plaques and neurofibrillary tangles. Accumulating evidence indicates that viral infection may worsen and/or increase development of established AD pathology. The COVID-19 pandemic has brought attention to the link between SARS-CoV-2 infection and neurologic conditions that vary in severity and duration, as well as the worsening of clinical symptoms in elderly people with dementia. To better understand potential mechanisms by which SARS-CoV-2 infection impacts AD neuropathology, aged 5xFAD and wildtype (WT) mice were intranasally infected with mouse-adapted SARS-CoV-2 (MA10). Intranasal infection of aged-matched (10-14 month) 5xFAD or wild type (WT) C57BL/6 mice with MA10 resulted in viral infection of the lungs that correlated with acute viral pneumonia characterized by lymphocyte inflammation and antiviral immune responses. Viral RNA was not detected within the central nervous system (CNS) of either WT or 5xFAD mice at days 7 or 21 post-infection (p.i.), nor were there signs of overt glial activation or neuroinflammation. There were no differences in either Aβ plaque volume or number within the brains of MA10-infected 5xFAD mice compared to uninfected 5xFAD mice. However, bulk RNA sequencing and spatial transcriptomics revealed evidence of altered expression of genes associated with neuronal and glial dysfunction, as well as reduced expression of genes encoding adhesion molecules in vascular endothelial cells. Collectively, these findings demonstrate that MA10 infection did not affect Aβ plaque size or numbers in 5xFAD mice, yet in both WT and 5xFAD mice, there were numerous down-stream effects on gene expression associated with resident CNS cell function.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/084bb27cba7431afa3e3a39d8ed57255e4bc2400" target='_blank'>
              Infection of 5xFAD mice with a mouse-adapted SARS-CoV-2 does not alter Alzheimer’s disease neuropathology yet induces wide-spread changes in gene expression across diverse cell types
              </a>
            </td>
          <td>
            S. Furman, Latifa Zayou, K. Tsourmas, D. Javonillo, Gema M. Olivarria, Yuting Cheng, Collin Pachow, Kellie Fernandez, Lucas Le, Robert A. Edwards, Dequina A. Nicholas, Gabriela Pacheco Sanchez, Ralph S. Baric, Kim N. Green, Thomas E. Lane
          </td>
          <td>2025-12-22</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>15</td>
        </tr>

        <tr id="ABSTRACT Porcine reproductive and respiratory syndrome virus (PRRSV), a major immunosuppressive pathogen, inflicts substantial economic losses on the global swine industry. Despite extensive research into PRRSV pathogenesis, the mechanisms by which PRRSV induces immune dysfunction in vivo remain incompletely understood. Here, we performed single-cell RNA sequencing on cells isolated from the lung of PRRSV-infected piglets, generating transcriptomic profiles for 46,922 single cells encompassing 15 major cell types. We observed a significant reduction in the number of macrophages in lung tissues, which was primarily attributed to the extensive apoptosis of macrophages induced by PRRSV infection. PRRSV infection triggered aberrant differentiation of macrophage, and the SPP1high macrophage subpopulation was identified as the primary target cells for PRRSV infection. Cell-cell communication analysis revealed that PRRSV infection enhanced ligand-receptor interactions between macrophages and other cell types, associated with inflammatory responses, activation of T cells and B cells, and cell adhesion. In addition, monocytes exhibited a tendency to differentiate into macrophages, potentially compensating for the depletion of macrophages caused by PRRSV infection. Moreover, PRRSV infection caused abnormal development of B cells and incomplete activation of cytotoxic T lymphocytes in the lungs. This study provides a comprehensive characterization of how PRRSV perturbs pulmonary immune cell populations, offering valuable insights into the mechanisms underlying PRRSV-induced lung injury. IMPORTANCE Porcine reproductive and respiratory syndrome virus (PRRSV) has consistently posed a significant and enduring threat to the swine industry. However, the virus-host interactions during in vivo infection in vivo remain poorly understood. In this study, we applied single-cell RNA sequencing to characterize the cellular heterogeneity of lung tissues from PRRSV-infected piglets. Through intracellular viral RNA tracking, we identified SPP1high macrophages as the primary reservoir of PRRSV. Furthermore, we analyzed the cell-cell communication between macrophages and other cell types and investigated the immune responses and heterogeneity of monocytes, T cells, and B cells upon PRRSV infection. Our findings provide a comprehensive single-cell landscape of the complex host-pathogen interplay during PRRSV infection. Porcine reproductive and respiratory syndrome virus (PRRSV) has consistently posed a significant and enduring threat to the swine industry. However, the virus-host interactions during in vivo infection in vivo remain poorly understood. In this study, we applied single-cell RNA sequencing to characterize the cellular heterogeneity of lung tissues from PRRSV-infected piglets. Through intracellular viral RNA tracking, we identified SPP1high macrophages as the primary reservoir of PRRSV. Furthermore, we analyzed the cell-cell communication between macrophages and other cell types and investigated the immune responses and heterogeneity of monocytes, T cells, and B cells upon PRRSV infection. Our findings provide a comprehensive single-cell landscape of the complex host-pathogen interplay during PRRSV infection.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/a411b9a7f498fc257495d61e60998a9d94a15046" target='_blank'>
              Deciphering immune features and cellular heterogeneity in PRRSV infection via single-cell RNA sequencing
              </a>
            </td>
          <td>
            Jianda Li, Yue Liang, Yuyu Zhang, Yulin Xu, Fei Liu, Luogang Ding, Yu Wang, Zhihao Zhang, Zhi Chen, Wenbo Sun, Jiang Yu, Jiaqiang Wu
          </td>
          <td>2025-12-30</td>
          <td>Journal of Virology</td>
          <td>0</td>
          <td>14</td>
        </tr>

        <tr id="Nerve Injury-Induced Protein 1 (Ninjurin-1) is an adhesion molecule implicated in inflammation and tissue injury, yet its role in neuroinflammatory diseases such as multiple sclerosis (MS) remains poorly defined. Here, we identify Ninjurin-1 as a key mediator of immune activation and CNS infiltration in relapsing-remitting experimental autoimmune encephalomyelitis (RR-EAE), a model of relapsing-remitting MS (RRMS). Using flow cytometry, gene-expression profiling, and in vivo peptide blockade, we show that Ninjurin-1 is markedly upregulated on CNS-infiltrating myeloid cells during disease progression. Ninjurin-1⁺ myeloid cells display a dual function, as both an adhesion molecule and a marker of inflammatory activation, characterized by increased antigen presentation, cytokine production, and transcriptional enrichment for genes regulating adhesion, migration, and innate immune signaling. Importantly, therapeutic blockade of Ninjurin-1 significantly reduced clinical severity, CNS immune infiltration, and demyelination in RR-EAE. These findings uncover a previously unrecognized role for Ninjurin-1 in myeloid-driven neuroinflammation and highlight its potential as a therapeutic target for relapsing-remitting MS.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/f016d29487af48e626cac97d46f36160ffc4e709" target='_blank'>
              Dual Role of Ninjurin-1 in Myeloid Cell Adhesion and Inflammation in Relapse-Remitting EAE
              </a>
            </td>
          <td>
            Coleen Thompson, Alex Annett, Anastasia Alkhimovitch, Kashish Singh Parihar, Igal Ifergan
          </td>
          <td>2026-01-26</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>2</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/c37496134da1d54a2727e656c638812c00420ed2" target='_blank'>
              S100A8 aggravates sepsis-associated encephalopathy by promoting PFKFB3-dependent glycolysis and microglial neuroinflammation
              </a>
            </td>
          <td>
            Hongjie Hu, Shu Peng, Jingbo Chen, Dayong Li, Shuhui Wu, Hebin Jiang, Yuru Lu, Yaqin Song, Wei Zhu
          </td>
          <td>2026-01-27</td>
          <td>Inflammation Research</td>
          <td>0</td>
          <td>3</td>
        </tr>

        <tr id="Clinical variability in COVID-19 is partly explained by host genetic factors, including inborn errors of immunity. We investigated a patient with a heterozygous nonsense mutation in the TLR3 gene (p.Trp769*) by generating human-induced pluripotent stem cells (hiPSCs) and differentiating them into lung organoids (hLORGs). TLR3-mutated hLORGs showed reduced basal expression of TLR3 and downstream signaling genes. Following infection with a pseudotyped SARS-CoV-2 virus and live SARS-CoV-2, RNA-Seq and qPCR analyses revealed significant upregulation of fibrinogen genes (FGA, FGG), which are associated with severe COVID-19. Interestingly, TLR3 expression remained inducible upon infection, despite the loss-of-function mutation. Our patient-derived hLORG model recapitulates the pathophysiological features of the patient and provides a platform to investigate host–virus interactions and test targeted therapies for genetically at-risk individuals.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/ab1122feba592e78c752f720f21f2f717ed0c328" target='_blank'>
              Modelling severe COVID-19 in TLR3-mutated hiPSCs-derived lung organoids
              </a>
            </td>
          <td>
            A. Latini, P. Spitalieri, F. Centofanti, B. Rizzacasa, Donatella Amatore, G. Grilli, Riccardo De Santis, Lorenzo Vaccaro, V. L. Colona, Giulio Puleri, A. Nardone, M. Biancolella, Elena Campione, L. Sarmati, Paola Rogliani, Davide Cacchiarelli, A. Novelli, Federica Sangiuolo, F. Lista, Giuseppe Novelli
          </td>
          <td>2025-12-26</td>
          <td>Cell Death Discovery</td>
          <td>0</td>
          <td>40</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/13e1f702334b4573a1884e3b676c8b55f48f2598" target='_blank'>
              Diminished EBV-Specific Humoral Immunity is Associated with Neuropsychiatric Long COVID Development up to 12 Months Post-COVID-19 Symptom Onset
              </a>
            </td>
          <td>
            Philip Samaan, P. Budylowski, Victoria Russell, Jeevitha Srighanthan, A. M. Cheung, Mario Ostrowski
          </td>
          <td>2026-01-28</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>16</td>
        </tr>

        <tr id="Abstract Background. Opioid use is disproportionately high among People with HIV (PWH). Although combined anti-retroviral therapy (ART) can dampen HIV-associated dementia, a large fraction of PWH continue to experience neurocognitive deficits which are further exacerbated by opioid use. In the present study, we performed single cell transcriptomic profiling of cerebrospinal fluid (CSF) immune cells to explore their functional characteristics in opioid mediated neurological disorders among PWH using the SIV/rhesus macque model. Methods. In this study, we utilized CSF cells from morphine- and saline-administered, SIV-infected, ART-treated rhesus macaques (RMs). The CSF scRNA-Seq was performed longitudinally at baseline, post ramp-up with morphine (pre-infection), during acute infection, and after suppression of viremia to profile cell-specific transcriptomic signatures that mirror the CNS pathogenesis observed in opioid-dependent PWH. Results. We observed the presence of all major immune cells in CSF, including CD4 + T CM cells, CD4 + T EM cells, CD8+ naïve T cells, CD8 + T CM cells, CD8 + T EM cells, CD14 + Monocytes, CD16 + Monocytes, NK cells, and B cells. Additionally, we also demonstrated morphine-mediated relative increase in CD4 + T CM , T reg, and a reduction in CD8 + T EM cell population prior to SIV infection. Chronic use of morphine was associated with a Th1/Th2 T-cell imbalance with a dominance of the Th2 population. In CSF cells from morphine-dependent RMs, there was dysregulation of genes involved in T-cell receptor signaling pathways, apoptosis, PI3K-Akt signaling pathway, cellular senescence, oxidative phosphorylation, and multiple neurodegenerative disorders. The contribution of different cell populations in these processes evolved along with different stages of disease pathogenesis. In the chronic stage of the disease, the expression of disease-associated microglia (DAM) signature genes were significantly upregulated in monocytes. Further, cell-cell receptor-ligand interaction analysis revealed an altered number of intercellular interactions and signaling strength in morphine vs. saline-administered animals. Specifically, for the CD14 + monocyte populations, the intra/inter-cell communication involving ligand-receptor pairs, including APOE-TREM2, APP(TREM2 + TYROBP), APP-CD74, SPP1−(ITGA4 + ITGB1), and CCL signaling pathways, remains significantly altered in the morphine-dependent macaques. Conclusion. Chronic opioid exposure reprograms CSF monocytes toward a DAM state that persists despite ART-mediated viral suppression, driving maladaptive immune–glial crosstalk and progressive neurocognitive dysfunction in morphine-dependent macaques with possible implications for neuroinflammation and neurodegenerative disorders that are observed in PWH.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/3983f88d405af23a5ba3e319f5687c1c47e45542" target='_blank'>
              Opioid-induced transcriptional reprogramming of cerebrospinal fluid immune cells drives neuroinflammation in SIV-infected rhesus macaques
              </a>
            </td>
          <td>
            Arpan Acharya, Anoop T. Ambikan, U. Neogi, Benjamin G. Lamberty, Shannon E. Callen, Shilpa Buch, Howard S. Fox, S. Byrareddy
          </td>
          <td>2026-02-05</td>
          <td>Research Square</td>
          <td>0</td>
          <td>36</td>
        </tr>

        <tr id="Background: Epstein-Barr virus (EBV) establishes latency in most adults and can be reactivated under conditions of co-infection and immune dysregulation. COVID-19 has been associated with EBV reactivation, primarily in hospitalized cohorts, but EBV shedding in the oral cavity and the extent to which these dynamics trigger a systemic anti-EBV antibody response during acute COVID-19 remain poorly understood. Methods: We conducted a nested cohort study of 69 community-based participants including 56 SARS-CoV-2-positive individuals and 13 uninfected household contacts, enrolled as part of a prospective cohort within 5 days of COVID-19 symptom onset. Participants self-collected saliva and nasal samples daily through day 14, then every 3 days until day 21, and once more at day 28. Blood samples were collected on day 28. SARS-CoV-2 RNA in the saliva and nares and EBV DNA in the saliva were quantified by RT-qPCR and qPCR, respectively. EBV antibody responses against viral capsid antigen IgM and IgG, early (D) antigen IgG, and nuclear antigen IgG were quantified in serum by ELISA. Results: SARS-CoV-2-positive participants tended to be more likely to experience consecutive days of EBV shedding in saliva (p = 0.10) and contributed a higher mean number of EBV DNA-positive specimens compared with uninfected controls (5 vs. 1 per participant; p = 0.018). Among SARS-CoV-2-positive participants with EBV reactivation, a positive correlation was observed between maximum EBV DNA in saliva and SARS-CoV-2 RNA levels in saliva (r = 0.49, p = 0.047) but not with SARS-CoV-2 RNA levels in nasal samples (r = -0.12, p = 0.67). EBV reactivation in saliva was not associated with induction of serological responses to systemic EBV reactivation. Conclusions: This cohort study provides evidence that SARS-CoV-2 infection is associated with prolonged salivary EBV shedding, that concurrent high levels of EBV and SARS-CoV-2 in saliva are correlated, but these salivary EBV shedding dynamics do not drive systemic EBV antibody responses. Further research with larger cohorts and mechanistic assays would be helpful to elucidate the biological pathway triggering systemic EBV antibody responses.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/6bd81e8d0226c927f514f86de21d2debe9548889" target='_blank'>
              Epstein Barr viral shedding dynamics in saliva during acute SARS-CoV-2 infection
              </a>
            </td>
          <td>
            M. Garcia-Knight, Jessica Y. Chen, Amethyst Zhang, M. Tassetto, Scott Lu, Isidro X. Perez‐Añorve, S. A. Goldberg, K. Anglin, Badri Viswanathan, S. Deeks, T. Henrich, Jeffrey N. Martin, M. Peluso, Raul Andino, J. Kelly, Proctor Foundation
          </td>
          <td>2026-01-05</td>
          <td>medRxiv</td>
          <td>0</td>
          <td>47</td>
        </tr>

        <tr id="The innate immune response to viral infection needs to be tightly regulated to ensure effective pathogen clearance while avoiding excessive immune activation. During SARS-CoV-2 infection, however, the immune system often fails to elicit appropriate responses, resulting in cytokine-release syndrome in patients with COVID-19. In this study, we show that reduced expression of Regnase-1, an RNase that negatively regulates immune cell activation, confers resistance to infection with the mouse-adapted SARS-CoV-2 MA10 strain. In Regnase-1+/- mice, altered neutrophil function contributed to the amelioration of MA10-induced pneumonia. Single-cell RNA sequencing of lung tissue during MA10 infection revealed four distinct neutrophil subsets, and among these, a subset characterized by an interferon-stimulated gene (ISG) signature was decreased in Regnase-1+/- mice. Furthermore, Regnase-1+/- neutrophils exhibited reduced ISG expression without corresponding changes in proinflammatory gene expression. Regnase-1 was found to repress the expression of Tsc22d3, a gene involved in the negative regulation of interferon responses, through its 3' untranslated region. Collectively, these findings suggest that Regnase-1 attenuates resistance to SARS-CoV-2 MA10 infection by promoting excessive interferon responses in neutrophils.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/c1164bbdb824ecfd429a901e776a89b93b9c588a" target='_blank'>
              Regnase-1-mediated regulation of neutrophils modulates SARS-CoV-2 pneumonia.
              </a>
            </td>
          <td>
            Keiko Yasuda, Junichi Aoki, Kotaro Tanaka, Shintaro Shichinohe, C. Ono, Alexis Vandenbon, Daiya Ohara, Y. Muramoto, Songling Li, Daisuke Motooka, Hitomi Watanabe, Keiji Hirota, Gen Kondoh, Takeshi Noda, D. Standley, Yuzuru Ikehara, Seiji Okada, Tokiko Watanabe, Y. Matsuura, Osamu Takeuchi
          </td>
          <td>2026-02-09</td>
          <td>PLoS pathogens</td>
          <td>0</td>
          <td>44</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/1cd3b95fc259982e3e29fcd40e71c1ad28df719b" target='_blank'>
              Latent cytomegalovirus disrupts NK cell responses to P. falciparum and impairs parasite control
              </a>
            </td>
          <td>
            Reena Mukhiya, Jessica R. Loughland, Nicholas L. Dooley, Zuleima Pava, D. Oyong, D. Andrew, Julianne Hamelink, Kiana Berry, James S. McCarthy, Bridget E. Barber, J. A. Lopez, C. Engwerda, Michelle J. Boyle
          </td>
          <td>2026-01-28</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>34</td>
        </tr>

        <tr id="Sepsis is a life-threatening condition arising from a dysregulated host response to infection, characterized by a complex interplay between pro-inflammatory and anti-inflammatory immune mechanisms. B cells, that are key components of humoral immunity, are essential for antibody production, antigen presentation, and immune modulation. Sepsis is commonly associated with B cell lymphopenia, particularly in severe cases, as evidenced by a marked reduction in circulating B cells in both adult and pediatric patients. However, the mechanisms driving this depletion have not been completely understood, particularly in pediatric sepsis. In this study, we employed single-cell RNA sequencing (scRNA-seq) to profile peripheral blood leukocytes from pediatric patients with sepsis (three with mild and three with severe condition) alongside four healthy controls. Our analysis revealed a broad depletion of immune cells in sepsis, with B cells showing the most pronounced reduction and the strongest capacity to discriminate between mild and severe disease states. Subset-level analysis identified significant loss and transcriptional reprogramming of natural killer-like B cells (ΝΚΒ), MHC IIhighnaïve, and MHC IIlownaïve B cells in severe sepsis, accompanied by signatures indicative of intrinsic and extrinsic apoptosis, disrupted differentiation, and enhanced migratory potential. Importantly, we identified and validated the population of NKB cells in both pediatric and adult cohorts, broadening the known landscape of B cell phenotypes in human sepsis. We also explored intercellular communications, focusing on B cell-neutrophil interactions, given the notable neutrophilia observed, revealing potential crosstalk that may contribute to the overall immune dysregulation in sepsis. Collectively, these findings offer new insights into the cellular and molecular drivers of immune dysfunction in pediatric sepsis, shedding light on B cell depletion as a central feature of disease severity. This work lays the foundation for future diagnostic and therapeutic strategies targeting B cell-mediated immunity in septic children. The study was registered on ClinicalTrials.gov (NCT04103268), with registration date on 2019-09-23, before the first patient was enrolled.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/bce54efd110fde03077139b1afa9c1f4e6856c6b" target='_blank'>
              Single-cell analysis of B cell dysregulation in pediatric sepsis stratified by disease severity
              </a>
            </td>
          <td>
            Fahd Alhamdan, Stefano Gianoli, Koichi Yuki, S. Koutsogiannaki
          </td>
          <td>2025-12-31</td>
          <td>Scientific Reports</td>
          <td>0</td>
          <td>20</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/92b1464e350c468b0e960f74f8db814fa5f708d3" target='_blank'>
              Molecular signature of COVID-19 prior to its exacerbation by multi-omics survey
              </a>
            </td>
          <td>
            Tomoyuki Suzuki, Yoshihiro Kita, Keisuke Yanagida, Kenji Maeda, T. Hashidate-Yoshida, Hiroki Nakanishi, Takayo Ohto-Nakanishi, J. Terada-Hirashima, Yoshie Tsujimoto, Masayuki Hojo, H. Mitsuya, Takao Shimizu, Hideo Shindou
          </td>
          <td>2025-12-30</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>12</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/0b1d9f79a0aea2296171fb92a1b3d1203b20d46c" target='_blank'>
              IgA-driven neutrophil activation underlies severe dengue disease after primary Zika virus infection in humans
              </a>
            </td>
          <td>
            Jaime A. Cardona-Ospina, Vicky Roy, Dorca E Marcano-Jiménez, S. Bos, Elias M. Duarte, J. V. Zambrana, Agamjot Bal, Boyeong K An, A. G. Dias, Julia A. Zhiteneva, J. Huffaker, C. Montenegro, G. Kuan, M.J. Ramos-Benitez, Á. Balmaseda, G. Alter, Eva Harris
          </td>
          <td>2026-01-01</td>
          <td>Nature Immunology</td>
          <td>1</td>
          <td>67</td>
        </tr>

        <tr id="

 Neurological complications are increasingly recognized as a significant consequence of COVID-19; however, time-resolved, brain-specific characterization of transcriptional alterations underlying SARS-CoV-2–associated neuroinflammation and neuronal injury remain limited. We hypothesized that brain transcriptional responses evolve dynamically during acute SARS-CoV-2 infection, resulting in temporal transcriptional programs.



 KRT18-hACE2 transgenic mice were intranasally inoculated with SARS-CoV-2. Brain was harvested at 4 and 6 days post-infection (dpi) for analyses.



 Immunohistochemical analyses confirmed a broad spectrum of viral neurotropism and gliotropism, accompanied by an increased apoptotic burden, particularly in cortical neurons (ClCas3/SATB2+). Robust activation of myeloid cells (Iba1+/CD68+) provided evidence of neuroinflammation. Cytokine/chemokine profiling demonstrated pronounced upregulation of inflammatory mediators (CXCL10, IL-12p40, CCL12), alongside reduced CX3CL1, suggesting impaired neuron–microglia communication. Whole-transcriptome and gene ontology analyses uncovered stage-dependent molecular programs, with early alterations at 4 dpi enriched in protein ubiquitination, vesicle trafficking, and synaptic processes, followed by intensified innate immune activation and engagement of chromosomal maintenance pathways at 6 dpi. In parallel, pronounced suppression of mitochondrial function at 6 dpi, pointing to energy exhaustion and transcriptional-translational discordance, as supported by digital PCR and a substantial reduction in COXIV protein levels.



 These findings provide a time-resolved molecular landscape of SARS-CoV-2–induced neuroinflammation and metabolic stress, highlighting CNS vulnerability during severe infection and suggesting pathways potentially relevant to COVID-19-associated sequelae.
">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/1b3229642ff69ccfda754d6cb89c9f33fabc517e" target='_blank'>
              Neuroinflammatory and transcriptional dynamics during SARS-CoV-2 infection in KRT18-hACE2 mouse brain
              </a>
            </td>
          <td>
            Dae-Gyun Ahn, Nhu Thi Quynh Mai, Da-Jin Jeong, Byoung-San Moon
          </td>
          <td>2026-02-02</td>
          <td>Frontiers in Immunology</td>
          <td>0</td>
          <td>3</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/1a6c6fb0d7fc812c84dff6e5379a1c49e11b27d9" target='_blank'>
              Targeting HMGB1 in Microglia Alleviates Neuroinflammation and Modulates the Pro-/Anti-inflammatory Balance of Microglia/Macrophages in Experimental Autoimmune Encephalomyelitis
              </a>
            </td>
          <td>
            Yuzhen Li, Haoyu Wang, Siyu Yang, ·. E. Du, Jiapei Dai, Fang Zheng, Jiawen Lei, Huoying Chen, Yan Sun, Yuzhen Li, Ke Lei
          </td>
          <td>2026-01-01</td>
          <td>Molecular Neurobiology</td>
          <td>0</td>
          <td>1</td>
        </tr>

        <tr id="The upper respiratory epithelium protects the airway from microbial exposure, environmental irritants, and viral pathogens such as influenza A virus (IAV). Situated at the airway–gastrointestinal junction, the larynx must integrate this barrier function with fine neuromuscular control under constant immune stimulation. Clinical syndromes such as post-viral vagal neuropathy—marked by chronic cough, throat clearing, dysphonia, and vocal fatigue—highlight critical gaps in our understanding of how the larynx and upper airway remodel after viral injury. To address this, we employed mouse models integrating genetics, imaging, and single-cell transcriptomics to dissect IAV-induced injury and repair in the upper respiratory tract. IAV infection displayed regionally restricted tropism toward ciliated, secretory, neuroendocrine, and basal epithelial cells, eliciting rapid clearance, acute neutrophil invasion, and a sustained intraepithelial population of cytotoxic CD8+ natural killer T (NKT)-like cells. Single-cell analysis revealed injury-induced Myc expression in KRT5+ basal progenitors, which activated a proliferative repair program and an epithelial–immune communication circuit centered on a MYC-dependent CXCL10–CXCR3 axis. Basal-specific Myc deletion preserved viral replication and clearance but blunted injury-induced proliferation, skewed lineage differentiation, and impaired CD8+ NKT cell recruitment. These findings define a coordinated epithelial–immune program governing post-IAV mucosal restoration and offer mechanistic insight into persistent upper airway sequelae.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/561fc69832beac4c1e41655e3f435bfb03fefa41" target='_blank'>
              Oncogene c-Myc Regulates Upper Respiratory Epithelial Repair for Host Immunity During Acute Influenza Infection
              </a>
            </td>
          <td>
            Alexander G. Foote, Le Xu, J. Verheyden, Belle Pan, Nikita Katoch, Xin Sun
          </td>
          <td>2025-12-23</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>4</td>
        </tr>

        <tr id="Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection causes not only acute respiratory illness but also dysregulated immune responses, including autoimmunity and hypersensitivity reactions, which can worsen outcomes. SARS-CoV-2 infection, known publicly as COVID-19 disease, has presented a complex clinical landscape ranging from asymptomatic infection to SARS and multi-organ failure. Beyond direct viral damage, the pathogenesis of COVID-19 is heavily driven by immune dysregulation, which causes allergic-type reactions. Nutritional status and immunonutrition further modulate these processes and play a critical role. Vitamins C and D are essential for immune competence, with vitamin C serving as an antioxidant that supports barrier integrity and leukocyte function. In contrast, vitamin D regulates innate and adaptive responses. The intake of essential nutrients could be a strategic approach to bolster the innate and adaptive immune systems, aiming to prevent infection and mitigate disease severity. Saliva and oral health are increasingly recognized as central to COVID-19 immunopathology, both as diagnostic media and as immunological barriers. This review synthesizes recent findings on autoimmune phenomena, hypersensitivity reactions, immunonutrition, and oral health in SARS-CoV-2 infection, highlighting mechanisms and clinical implications.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/9cd7d982a49e201c0783b28ad3d1e949e2b88e75" target='_blank'>
              Immune Dysregulation and Nutrition in SARS-CoV-2 Infection: An Integrated Review with Oral Health Perspectives
              </a>
            </td>
          <td>
            Bernadeth Vindi Januarisca, Imme Kris Wicaksono, Cindy Karina Hartono, Ivan Djuarsa
          </td>
          <td>2026-01-31</td>
          <td>International Journal of Science and Research Archive</td>
          <td>0</td>
          <td>2</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/be316b7552e536304be839d20de8c62880a02aea" target='_blank'>
              A framework for reparative CAR T engineering in the CNS
              </a>
            </td>
          <td>
            Rotem Shalita, Maya Ben Yehuda, Pavle Boskovic, Yasmin Frid, Yuri Kuznetsov, Michael Tsoory, V. Kalchenko, O. Brenner, Eyal David, Kfir Mazuz, R. Majzner, Jonathan Kipnis, I. Amit
          </td>
          <td>2026-02-11</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>106</td>
        </tr>

        <tr id="Infections in the central nervous system result in immune cell trafficking into the brain and microglial activation, which may influence Alzheimer’s Disease neuropathology. Toxoplasma gondii infection induces a robust neuroimmune response and a reduction in amyloid plaques in the brains of Alzheimer’s model mice. We investigated the myeloid cell response in the immediate vicinity of amyloid plaques in the brain by injecting 3-month-old 5xFAD mice with T. gondii or PBS as a control. T. gondii chronic infection (6 weeks) resulted in reduced amyloid plaque area, volume, and intensity in the cortex, and plaques with decreased circularity based on 6E10 and Thio-S staining. The brains of T. gondii-infected mice also had increased AIF1, AXL, and CLEC7A transcripts for disease-associated microglia (DAM), and elevated IBA1, MAC2, and CD68 phagolysosomal colocalization with amyloid, indicating myeloid cell activation around plaques. CD4 and CD8 T cells were also increased near amyloid and IBA1+ cells in T. gondii-infected mice. To determine the extent of peripheral myeloid cell recruitment to amyloid, bone marrow from CAG-CFP mice was transplanted into irradiated, head-shielded 5xFAD mice prior to infection. Cyan+ cells were found surrounding plaques in the brains of T. gondii-infected mice and were comprised predominantly of Ly6Clo patrolling monocytes, followed by Ly6Chi inflammatory monocytes and T cells. In addition, the majority of myeloid cells and T cells recruited to the brain were derived from skull bone marrow. These data demonstrate that T. gondii infection increases the infiltration of monocytes and T cells from the skull bone marrow niche and the recruitment of highly activated myeloid cells surrounding amyloid plaques in the brains of 5xFAD mice.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/aded3e2e84898c27d438f6b8e606ed9448a697da" target='_blank'>
              Toxoplasma gondii drives myeloid immune cell recruitment to amyloid plaques in Alzheimer’s model mice
              </a>
            </td>
          <td>
            Katherine Olivia Yanes, Christina T Bui, Julia Tomasello, Heba Morsy, Emilie Kim, Toan Lam, K. Tsourmas, L. A. Ayala, Kim N. Green, M. Inlay, Melissa B Lodoen
          </td>
          <td>2026-01-17</td>
          <td>Journal of Neuroinflammation</td>
          <td>0</td>
          <td>29</td>
        </tr>

        <tr id="Dogs play a major role in sustaining transmission of Leishmania infantum to people, thus prevention and treatment of canine leishmaniosis (CanL) to reduce transmission represents an unmet public health need. Although advances have been made in understanding how immunopathology correlates to infectiousness as CanL progresses, the immune mechanisms underlying transition between disease stages and terminal decline remain ill-defined. To address this knowledge gap, we generated a comprehensive atlas of peripheral immune cells from control dogs and naturally-infected dogs using single-cell RNA sequencing. The LeishDog Atlas captures the cellular and transcriptional complexity underlying CanL, tracing shifts in immune composition and gene expression across progressive, well-defined disease stages. Notably, we identified distinct myeloid, CD4+ and CD8+ T cell phenotypes and transcriptional states associated with disease progression. This resource provides a valuable framework for understanding systemic immune dysregulation in CanL, including determinants of T cell exhaustion and myeloid cell activation, and establishes a foundation for comparative, translational, and mechanistic studies of CanL immunopathology and transmissibility.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/8412687f28e64e4d6b2558529c494e2ee4440eca" target='_blank'>
              A single-cell transcriptomic atlas of peripheral blood immune cells spanning progressive canine leishmaniosis
              </a>
            </td>
          <td>
            Danielle P. Uhl, Daniel J. Holbrook, Max C Waugh, S. Dey, Najmeeyah Brown, Karen I. Cyndari, Jacob J. Oleson, Paul M. Kaye, Christine A. Petersen
          </td>
          <td>2025-12-21</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>22</td>
        </tr>

        <tr id="Memory T cell inflation is a distinctive immunological phenomenon observed during persistent viral infections, such as Cytomegalovirus (CMV). Unlike conventional memory T cell responses, which contract after infection resolution, a subset of CMV-specific T cells undergoes a progressive and sustained expansion, termed “inflation”, which is thought to be critical for long-term immune surveillance. The molecular mechanisms that govern memory T cell inflation remain incompletely understood, yet they are pivotal for understanding immune persistence and designing strategies against chronic viral infections. In this study, we investigate the role of MAP kinase-activated protein kinase 2 (MK2), a key downstream effector of p38 MAPK signaling, in regulating T cell responses during murine CMV (MCMV) infection. Using MK2 knockout (MK2-KO) mice, we demonstrate that MK2 deficiency alters the dynamics of MCMV-specific CD8⁺ T cell responses without impairing viral control or tissue replication. MK2 deficiency led to a reduction in non-inflationary MCMV-specific CD8⁺ T cells during the acute phase, followed by enhanced expansion of inflationary CD8⁺ T cell subsets during persistence. Furthermore, MK2-KO mice exhibited impaired effector differentiation, as evidenced by decreased expression of the terminal differentiation marker KLRG1 on MCMV-specific CD8⁺ T cells. Collectively, these findings identify MK2 as a pivotal regulator of CD8⁺ T cell magnitude, kinetics, and phenotype during both acute and chronic MCMV infection. By elucidating the role of MK2 in the regulation of memory T cell inflation, this study provides new mechanistic insight into immune regulation with implications for vaccination, chronic infection, and immune aging. Graphical abstract The graphical abstract was created using BioRender (https://biorender.com/).">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/648fff5e794cabf595a6a989b3a6fca738f1f3d2" target='_blank'>
              MAPKAP Kinase 2 Orchestrates Memory T Cell Inflation in Cytomegalovirus Infection
              </a>
            </td>
          <td>
            Eleni Panagioti, Xueyang Yu, Yi Wen Kong, Kristina Makakova, Noe B. Mercado, Sean E. Lawler, Michael B. Yaffe, Charles H. Cook
          </td>
          <td>2026-01-20</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>2</td>
        </tr>

        <tr id="Zika virus (ZIKV) infection can cause severe neurological complications, yet the role of CD8+ T cells in controlling viral pathogenesis in the brain remains unclear. Using Ifnar1−/− mice, which lack type I interferon signaling, we demonstrate that ZIKV infection triggers significant infiltration of CD8+ T cells into the brain, accompanied by neurological defects. ZIKV-experienced CD8+ T cells exhibit enhanced cytotoxic potential, and adoptive transfer of these cells improves survival. In contrast, blocking their infiltration exacerbates brain inflammatory and injury-associated signatures, highlighting their protective contribution. Furthermore, PD-1 blockade worsens ZIKV pathology, suggesting that PD-1 expression reflects an activated rather than exhausted state. These findings underscore an important role of infiltrating CD8+ T cells in reducing ZIKV-induced CNS inflammation and suggest that modulating their response could serve as a potential therapeutic strategy for ZIKV-associated neurological disease.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/59f92671db8b5cab99c311a3e29cd0630772d86c" target='_blank'>
              Brain-infiltrating CD8 T cells retain functional activity to protect against acute Zika virus infection
              </a>
            </td>
          <td>
            Jaehui Kim, Wooseong Lee, Do Yeon Kim, K. Ku, Young-Chan Kwon, Kyun-Do Kim, Chonsaeng Kim, Dae-Gyun Ahn, Seong-Jun Kim, Sungjun Park
          </td>
          <td>2026-01-05</td>
          <td>Scientific Reports</td>
          <td>0</td>
          <td>22</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/ebd7c1c95a72fa42446be74525f1dfe8c58ae064" target='_blank'>
              Decoding acute neuroinflammatory states from the 3D architecture of in vitro microglia
              </a>
            </td>
          <td>
            Anthoula Chatzimpinou, Johanna Huber, Xenia Podlipensky, J. Cairns, Ayse Erozan, Jian-Hua Chen, V. Loconte, M. Le Gros, Carsten Hopf, Carolyn A Larabell, V. Weinhardt
          </td>
          <td>2025-12-22</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>29</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/1ebef12370aba49b0c9a0e8c7f942ab6de71a9e9" target='_blank'>
              Pharmacological intervention targeting neuroimmune axis in the aging hypothalamus prevents age-associated physiological decline
              </a>
            </td>
          <td>
            Min-Jong Seok, Na-Kyung Lee, In-Seop Sim, Jumi Kim, Kelvin Pieknell, T. Stein, Jung-Hee Lee, Hoon Ryu, Seung-Hyup Song, J. Seong, Il-Yong Kim, Eun Ha Ko, Yanuar Alan Sulistio, Sang-Hun Lee
          </td>
          <td>2026-01-12</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>56</td>
        </tr>

        <tr id="Background and Objectives Interleukin-9 (IL-9) is an immune molecule with multiple roles in a variety of cell types. IL-9–induced cell responses are mediated by the IL-9 receptor (IL-9R). Recent evidence demonstrates that expression of IL-9R in post mortem brain tissues of patients with multiple sclerosis (MS) is associated with a protective, anti-inflammatory role of IL-9 in MS. In this study, we investigated the expression of IL-9R in cells resident in the CNS of patients with MS. We found that astrocytes express IL-9R, indicating their expected responsiveness to IL-9. Astrocytes play a critical role in MS, where the inflammatory environment turns them into reactive cells, which actively contribute to the disease. The transcription factor nuclear factor-kB (NF-kB) regulates the response of reactive astrocytes and their potential pathogenic activities during CNS inflammation. Methods To address the role of IL-9 in proinflammatory astrocytes, we used 3 different human in vitro models: (1) human astrocytoma cell line (U-373 MG), (2) primary normal human astrocytes, and (3) induced pluripotent stem cell–derived astrocytes. We used interleukin-1β for their conversion into proinflammatory astrocytes. Results We found that IL-9 contributes to the switch of astrocytes from an inflammatory to an anti-inflammatory profile by downregulating NF-kB activation. Moreover, we demonstrated that IL-9 inhibits granulocyte-macrophage colony-stimulating factor (GM-CSF) expression driven by NF-kB. Discussion Because GM-CSF production by astrocytes is linked to microglial activation and CNS inflammation, these results indicate that IL-9 regulates the astrocyte-microglia axis and has potential therapeutic anti-inflammatory implications in MS.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/68caea23e18c5a4cd499ee0619116e5884afc207" target='_blank'>
              Interleukin-9 Regulates NF-kB-Mediated Activation of Astrocytes in Multiple Sclerosis Brain
              </a>
            </td>
          <td>
            Miriam Cinotti, Susanna Amadio, Daniele Tidei, Gloria Donninelli, Costanza Stacchiotti, Veronica De Paolis, Emanuela Colombo, Anthea De Angelis, F. Ruffini, Gianvito Martino, Cinthia Farina, Chiara Parisi, C. Volonté, Elisabetta Volpe
          </td>
          <td>2026-01-13</td>
          <td>Neurology® Neuroimmunology & Neuroinflammation</td>
          <td>0</td>
          <td>43</td>
        </tr>

        <tr id="In an attempt to identify markers that better characterize microglial states and to search for potential therapeutic targets, we performed a study using the IMG cell line as an in vitro microglial model. Specifically, we tested its response to several pro-inflammatory stimuli (lipopolysaccharide, interferon gamma, and tumor necrosis factor) and an anti-inflammatory stimulus (Interleukin-4) after 12 and 24 h of incubation. We performed RNA sequencing to identify genes modified at both incubation times (i.e., genes with sustained changes in the window between 12 and 24 h) that could reflect sustained microglial transcriptional responses. We also used Gene Ontology (GO) analysis to identify the most relevant pathways modified by these stimuli. RNA sequencing revealed four gene sets: (1) common genes that respond similarly to IL-4 and LPS, (2) specific LPS responders, (3) specific IL-4 responders, and (4) genes that exhibit LPS-induced upregulation and IL-4-induced downregulation, and vice versa (opposite responders). We hypothesize that the common gene set represents a general microglia response to pathological conditions, while the LPS- and IL-4-responder gene sets define specific microglial states under pro- and anti-inflammatory stimuli, respectively. We further propose that opposite responder genes act as metabolic switches between certain microglial states. The GO analysis indicated that LPS strongly upregulates biological processes related to the innate immune response, while IL-4 upregulates pathways related to repair, metabolic reprogramming, and cellular cooperation. Finally, the transcriptional response of IMG cells closely mirrored that of primary microglia, revealing highly similar gene expression and GO term profiles under LPS stimulation.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/7f19e2e4dd5058799eba35f9afc27589ba8e54aa" target='_blank'>
              Sustained Transcriptional Response to Lipopolysaccharide and Interleukin-4 in an Immortalized Mouse Microglial Cell Line
              </a>
            </td>
          <td>
            Herrero-González Amanda, Puente-Sanz Alba, Pérez-Rodríguez Diego, Anuncibay-Soto Berta, Letek Michal, Regueiro-Purriños Marta, Fernández-López Arsenio
          </td>
          <td>2026-01-01</td>
          <td>Molecular Neurobiology</td>
          <td>0</td>
          <td>0</td>
        </tr>

        <tr id="ABSTRACT Rift Valley fever virus (RVFV) is a Phlebovirus causing febrile and haemorrhagic illness in ruminants and humans. The viral protein NSs is a major virulence factor that suppresses the IFN-β response in various hosts. Hence, RVFV variants lacking functional NSs, such as Clone 13, are highly attenuated. It is speculated that from the sites of infection, the virus disseminates to the target organs via the bloodstream. We hypothesized that primary infection of circulating immune cells and their response to infection are critical factors determining systemic RVFV spread and pathogenesis. Human PBMC from healthy blood donors were exposed to both wild-type (WT) RVFV and Clone 13 strains. Flow cytometric analysis revealed that monocytes expressing LRP1, a known RVFV receptor, are target cells for RVFV. RNA-seq analysis of monocytes exposed to WT and Clone 13 strains showed a large number of differentially expressed genes compared to mock-exposed cells. Various genes involved in antiviral immune mechanisms were specifically modulated in monocytes either in response to WT or Clone 13 infection. Expression of genes encoding key inflammatory mediators, such as CCL2, CD40, and CD83, was only upregulated in Clone 13-infected monocytes, whereas IFNB1 and NFKB1 were downregulated specifically in WT-infected monocytes. Taken together, our findings suggest that RVFV NSs dampen the innate immune responses in monocytes which may be critical not only in RVFV pathogenesis but also in the induction of virus-specific immune response.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/9bbf32c5fcf87eba5101e9e1046f41aebb58c18c" target='_blank'>
              Differential innate immune activation by wild-type and NSs-deficient RVFV strains in human blood monocytes
              </a>
            </td>
          <td>
            Niranjana Nair, Julia Friese, P. J. Wichgers Schreur, A. Osterhaus, G. Rimmelzwaan, C. K. Prajeeth
          </td>
          <td>2025-12-29</td>
          <td>Emerging Microbes & Infections</td>
          <td>0</td>
          <td>96</td>
        </tr>

        <tr id="Background During the COVID-19 pandemic, it became evident that an infection with SARS-CoV-2 is associated with an increased predisposition for thrombembolic events. Recent studies suggest an excessive neutrophil extracellular trap (NET)-formation in response to SARS-CoV-2, which is considered a hallmark in immunothrombosis. A better understanding of the (dys)regulation of NET-formation in COVID-19 may provide the basis for new therapeutic strategies. Methods We conducted a pilot study with a total of 84 patients in three groups matched in a 1:1:1 fashion: Group 1: patients with acute ischemic stroke (AIS) or transient ischemic attack (TIA) and SARS-CoV-2 infection, Group 2: patients with AIS and no SARS-CoV-2 infection and Group 3: patients with SARS-CoV-2 infection and no AIS or TIA. Venous blood samples were collected from all patients and subsequently analyzed for NET-specific markers, NET regulators (Deoxyribonuclease (DNase) activity) and a panel of cytokines. Results Citrullinated histone3 (H3cit) and elastase levels were higher in groups with SARS-CoV-2 infection (Groups 1 and 3) compared to patients without ((group 1: H3cit = 2.9 (1.11–6.89) ng/mL, elastase = 312.1 (162–435.4) ng/mL and group 3: H3cit = 3.31 (2.03–7.97) ng/mL and elastase = 433.1 (281–783.8) ng/mL) vs. group 2: H3cit = 1.17 (0.61–2.15) ng/mL), elastase = 195.1 (91.99–386.9) ng/mL). No relevant differences were found regarding other measured NET-marker (myeloperoxidase, LL-37). DNase activity was lower in group 1 (6.12 (4.97–6.78) pmol/mL/min) compared to both other groups (group 2: (7.16 (5.88–7.85) pmol/mL/min) (p=0.018) and group 3 (7.19 (5.52–8.54) pmol/mL/min) (p=0.013). Conclusion This pilot data suggest that a disturbed regulation of NETs in patients with SARS-CoV-2 infection may play a role in SARS-CoV-2 associated cerebral ischemia. These results highlight the importance of further investigating the role of NETs in immunothrombosis in the context of viral infections, to better understand its potential as a target for therapeutic strategies.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/02ea051bb7193e24e5a7fbf922a5dd16ac43e2d3" target='_blank'>
              Disturbed regulation of immunothrombosis in cerebral ischemia associated with SARS-CoV-2 infection
              </a>
            </td>
          <td>
            Richard Plem, N. de Buhr, Rabea Imker, Silke Akhdar, Marita Meurer, Christine S. Falk, Johanna Ernst, M. Gabriel, J. Keil, Verena Kopfnagel, Thomas Illig, Karin Weissenborn, Sabine Blaschke, Isabel Bröhl, Christoph Römmele, Gerrit M. Grosse, R. Schuppner
          </td>
          <td>2026-01-29</td>
          <td>Frontiers in Immunology</td>
          <td>0</td>
          <td>18</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/08675f023f46e57b4799eab3ce3a5d2a469ca17b" target='_blank'>
              Spatiotemporal Atlas of Pro-Inflammatory (NF-κB) and Anti-Inflammatory (STAT6) Signalling Using Reporter Mice during mRNA Vaccination
              </a>
            </td>
          <td>
            Electra Brunialti, Alessia Panzeri, N. Rizzi, A. Villa, C. Meda, Chiara Sfogliarini, Stefano Persano, Federico Arlati, Maria L Guevara Lopez, C. Martelli, Gaetano Cannavale, Monica Rebecchi, C. Di Vito, Letizia Venturini, Luisa Ottobrini, Domenico Mavilio, Susanna Fagerholm, S. Minucci, Elisabetta Vegeto, Paolo Ciana
          </td>
          <td>2026-02-02</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>74</td>
        </tr>

        <tr id="Mycoplasma pneumoniae pneumonia (MPP) is a common respiratory infection characterized by significant inflammatory responses and lung tissue injury. However, the precise immunological mechanisms and temporal dynamics of key cytokines driving pulmonary inflammation in MPP are still unclear. This study aimed to investigate the underlying immunological mechanisms and cytokine dynamics in MPP. We established an acute MPP murine model via intranasal administration of M. pneumoniae. This model recapitulates key features of human MPP, such as robust airway inflammation and cytokine production. Comprehensive analyses were conducted, including histopathology, flow cytometry, and cytokine profiling. Results showed severe inflammatory responses with prominent infiltration of neutrophils and macrophages in lung tissue, whereas monocyte populations were significantly reduced, indicating a shift towards myeloid cell predominance. Notably, 36 cytokines, including pro-inflammatory interleukins (IL-1β, IL-6, IL-17A) and chemokines, were statistically significantly upregulated in bronchoalveolar lavage fluid compared to the normal group, highlighting a cytokine storm associated with lung inflammation and tissue damage. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) signaling pathway analysis further revealed enriched pathways related to cytokine-cytokine receptor interactions and IL-17 signaling, suggesting potential therapeutic targets. In conclusion, this study preclinical provides insights into the innate immune response and cytokine-driven pathology in acute MPP, underscoring the pivotal roles of myeloid cells and pro-inflammatory cytokines. Future research should focus on clinical validation of these findings to assess their translational potential and the exploration of immunomodulatory strategies informed by this model to mitigate MPP severity.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/3b4aa4f5489f5f2ba68052c781dace2e27e9c387" target='_blank'>
              Immune Dysregulation and Cytokine Profiling in Acute Mycoplasma pneumoniae Pneumonia
              </a>
            </td>
          <td>
            Ying Wen, Y. Zhai, Shuli Sang, Chen Cao, Yunyun Mao, Enbo Hu, Lina Zhai, Xuanqi Ye, Kai Li, Yanchun Wang, Rui Yu
          </td>
          <td>2026-01-01</td>
          <td>Microorganisms</td>
          <td>0</td>
          <td>5</td>
        </tr>

        <tr id="Neuroinflammation, an immune process in the central nervous system (CNS), is a key contributor to a range of neurological diseases, including neurodegenerative disorders (e.g., Alzheimer’s and Parkinson’s disease), stroke, and depression, underscoring its significant pathological relevance. While maackiain (MAA) exhibits potent anti-inflammatory activity, its potential to mitigate neuroinflammation remains poorly understood. This study investigated the therapeutic effects of MAA on lipopolysaccharide (LPS)-induced neuroinflammation and its underlying mechanisms. In vitro, MAA significantly improved BV2 cell viability and reduced nitric oxide (NO) expression in LPS-treated cells, decreased the expression of reactive oxygen species (ROS), and it also inhibited the accumulation of Ferrous ion (Fe2+) and lipid peroxides as well as the damage to mitochondria. Higher concentrations of MAA were more effective, consistent with subsequent animal experiments. In vivo, mice treated with MAA showed improved memory in the Morris water maze compared to the LPS group. Nissl staining revealed fewer IBA-1 positive cells and a decrease in COX-2 and IL-6 levels in the hippocampus and cortex. This compound also increased the number of normal neurons in the cortex and CA3 region. The results of this study highlight the inhibitory effects of MAA on neuroinflammation, suggesting its potential as an effective therapeutic agent for treating neuroinflammation.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/84ce3340bdd20e82dcb7bf45431dcc26b99f2cb3" target='_blank'>
              Maackiain Reduces Neuroinflammation by Modulating Inflammatory Signals in LPS-Induced In Vitro and In Vivo Models
              </a>
            </td>
          <td>
            Tianchan Yun, Yue Xiao, Yanmei Gong, Yanxian Lai, Shiya Huang, Yanqing Ma, Yixi Zeng, Lanyue Zhang, Cong Deng
          </td>
          <td>2026-02-05</td>
          <td>Journal of Microbiology and Biotechnology</td>
          <td>0</td>
          <td>2</td>
        </tr>

        <tr id="This review explores the interplay between SARS-CoV-2 and HIV-1 infections within the human brain, highlighting the significant neurological implications of these viral infections. SARS-CoV-2 can infect the central nervous system (CNS), with evidence of the virus detected in various brain regions, including the hypothalamus, cerebellum, and olfactory bulb. This infection is linked to microglial activation and neuroinflammation, which can lead to severe neurological outcomes in affected individuals. Autopsy studies revealed microglial changes, including downregulation of the P2RY12 receptor, indicating a shift from homeostatic to inflammatory phenotype. Similar changes in microglia are found in the brains of people with HIV-1 (PWH). In SARS-CoV-2, the correlation between inflammatory cytokines, such as IL-1, IL-6, and MCP-1, found in cerebrospinal fluid and brain tissues, indicates significant neurovascular inflammation. Astrogliosis and microglial nodules were observed, further emphasizing the inflammatory response triggered by the viral infections, again in parallel to those found in the brains of PWH. Epidemiologic data indicate that although SARS-CoV-2 infection rates in PWH mirror those in People without HIV (PWoH) populations, Long-COVID prevalence is markedly higher among PWH. Evidence of overlapping cognitive impairment, mental health burden, and persistent neuroinflammation highlights diagnostic complexity and therapeutic gaps. Despite plausible mechanistic synergy, direct neuropathological confirmation remains scarce, warranting longitudinal, biomarker-driven studies. Understanding these interactions is critical for developing targeted interventions to mitigate CNS injury and improve outcomes.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/5a0ebece59d92a56c77aa4f6d9df14d6fa82e5c4" target='_blank'>
              Synergy of SARS-CoV-2 and HIV-1 Infections in the Human Brain
              </a>
            </td>
          <td>
            Rajnish S. Dave, Howard S. Fox
          </td>
          <td>2026-01-01</td>
          <td>Pathogens</td>
          <td>0</td>
          <td>6</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/f07503d0b86a50035590b1eaaf023d9368332643" target='_blank'>
              Specific deletion of interleukin-1 beta in microglia improves acute outcome and modulates neurogenesis after ischemic stroke
              </a>
            </td>
          <td>
            Alba Grayston, Margarida Baptista, Kelly Wemyss, Ruby Taylor, Grace Cullen, Syeda S Jafree, Nadim Luka, Joshua R. Cox, Joanne E. Konkel, David Brough, S. Allan, E. Pinteaux
          </td>
          <td>2025-12-22</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>41</td>
        </tr>

        <tr id="SARS-CoV-2 has emerged as the 5th endemic coronavirus and immunological cross protection between coronaviruses will influence their infectivity and clinical impact. We determined adaptive immunity against the spike protein of each human coronavirus during the course of the COVID-19 pandemic. A characteristic pattern of HCoV immunodominance, dominated by OC43 and 229E, was apparent prior to SARS-CoV-2 and was largely unaffected by SARS-CoV-2 infection, which itself elicited moderate antibody titre. Vaccination or hybrid immunity elicited supraphysiological levels of coronavirus-specific antibodies, only a proportion of which was cross-reactive with SARS-CoV-2 spike indicating substantial backboosting of HCoV-specific responses. SARS-CoV-2 vaccination focused antibody responses against the S1 domain of SARS-CoV-2 spike whilst T cell responses recognised peptides equivalently across S1 and S2. Coronavirus-specific T cells exhibited strong production of IFN-γ, IL-2 and CXCL8. In summary, the entry of SARS-CoV-2 into its ecological niche has impacted marginally on relative immunity against other human coronaviruses although vaccination provides a modest antibody increment which is unlikely to be maintained. Further, although SARS-CoV-2 vaccination elicits spike-specific adaptive immune responses that are focused against the S1 domain, thereby favouring neutralising antibodies, the natural history of HCoV immunity indicates that adaptive responses may transition towards S2 recognition across the life course. A prospective analysis reveals that emergence of SARS-CoV-2 has had only a marginal impact on the immune response to spike protein of other endemic human coronaviruses and predicts limited cross protection against infection.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/e8e9609b466f56f69d3155aa00f4b98ab8b0c4f6" target='_blank'>
              Endemic penetrance of SARS-CoV-2 has impacted marginally on immunity to spike protein of human coronaviruses
              </a>
            </td>
          <td>
            T. Lancaster, G. Tut, P. Sylla, David Bone, Christopher Bentley, E. Spalkova, A. Jadir, R. Bruton, Katie Spencer, Soumyajit Mallick, Ahmed Elzaidi, Siobhan Plass, N. Kaur, M. Butler, Samuel Hulme, Alexander C. Dowell, Maria Krutikov, Oliver T. Stirrup, B. Azmi, Andrew Hayward, A. Copas, L. Shallcross, P. Moss
          </td>
          <td>2026-01-03</td>
          <td>Communications Biology</td>
          <td>0</td>
          <td>28</td>
        </tr>

        <tr id="Immune-mediated intraocular inflammation, called uveitis, is a leading cause of global blindness, with the highest burden of visual impairment falling on older individuals. Immunosenescence, the functional changes in immune cells with aging, impacts the age-associated immune response, but how immunosenescence and the molecular regulators of the age-associated immune response affect the clinical course of uveitis remains unclear. In the murine model of experimental autoimmune uveitis (EAU), aged mice demonstrated a delayed onset and peak of intraocular inflammation compared to young mice. In contrast to the canonical monophasic inflammation that rapidly resolves in young mice, aged mice developed persistent, chronic inflammation. Transcriptomic and flow-cytometric analyses of immune cells and the receptor-ligand interactome revealed a dominant macrophage-CD4+ T cell signature. This signaling pathway was functionally altered on both ends: macrophages from aged mice had an impaired capacity to generate peripherally induced regulatory T cells (pTreg) through an IL-6 regulated pathway, while CD4+ T cells co-cultured with aged macrophages demonstrated increased proliferation. Our study establishes aging as a key regulator of the effector immune response in uveitis. Regulatory T cells, specifically pTreg, are essential for resolving inflammation in uveitis and an impaired ability to induce pTreg led to a sustained, chronic inflammatory uveitis phenotype in old mice, thereby linking immunosenescence to persistent neuroinflammation. These findings highlight potential therapeutic avenues for vision-threatening uveitis, especially in older patients.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/c884624194df8c0680f4019f2ac1093daf979a9b" target='_blank'>
              Macrophage immunosenescence prolongs intraocular inflammation in aged mice via impaired induction of regulatory T cells
              </a>
            </td>
          <td>
            Taku Yamamoto, Keitaro Hase, Joseph B. Lin, Shinobu Yamaguchi, Norihiko Misawa, Jiayi Li, Kenta Kato, Ryo Terao, Brian S. Sohn, Daniel Du, Mitsukuni Yoshida, Charles W Pfeifer, Tae Jun Lee, Jason J. Colasanti, A. Santeford, James T. Walsh, R. Apte
          </td>
          <td>2026-01-20</td>
          <td>bioRxiv</td>
          <td>1</td>
          <td>51</td>
        </tr>

        <tr id="While it is clear that inflammation contributes to Parkinson’s disease (PD) and prevalence is higher in males, sex remains an underexplored determinant of immune responses in PD. Using the 3KL transgenic mouse model, which expresses three E to K α-synuclein mutations, we investigated how sex and age shape peripheral and central immunity and behavior in synucleinopathy. Male and female 3KL mice were aged to 8- and 14-months. At these ages animals underwent motor and cognitive assessment, followed by assessment of the peripheral immune response using flow cytometry and analysis of microglial transcriptional profiles by bulk RNA sequencing. Male 3KL mice exhibited earlier onset and greater severity of motor and cognitive impairments, which was linked to a pro-inflammatory peripheral immune profile marked by increased cytotoxic CD8⁺ T cells and IFNγ-producing CD4 Th1 cells. In contrast, female mice displayed delayed symptom onset, preserved cognition, along with early elevations in regulatory IL-10⁺ CD4 and γδ T cells. RNA sequencing of microglia revealed broad sex differences at 8 months. Males demonstrated early upregulation of microglia neurodegenerative signatures, MHC class I/II signaling, ceramide signaling, and pronounced lipid dysregulation, while females showed upregulation of microglial pathways related to protein, metabolic, and neuronal maintenance, including phagosome formation, docosahexaenoic acid signaling, and synaptogenesis pathways. Microglial transcriptional differences were nearly absent by 14 months, suggesting sex-specific trajectories converge during late-stage disease, which is concurrent with a decrease in estrogen in aged female mice. Together, these findings reveal distinct immune signaling in male and female 3KL mice and identify coordinated changes in T cell and microglial responses that may contribute to sex differences in PD vulnerability and progression. This work underscores the importance of incorporating sex as a biological variable in neurodegeneration research and provides mechanistic insight into immune-mediated modulation of synucleinopathy. Parkinson’s disease (PD) affects millions of people worldwide and is more common in men than women. Scientists believe that differences in the immune system may help explain this, but little is known about how sex and age shape these responses during the disease. In this study, we used a mouse model of PD that develops symptoms similar to those seen in people, including problems with movement and memory. We compared male and female mice at two ages: middle age (8 months) and older age (14 months). We looked at both behavior and how the immune system in the body and brain responded. Male mice showed earlier and more severe movement and memory problems. Their immune systems were more inflammatory, with high levels of aggressive immune cells. Female mice were protected for longer, performing better on memory tests, and had more “regulatory” immune cells that help keep inflammation in check. When we studied microglia, the immune cells of the brain, we found striking sex differences. In males, microglia turned on genes linked to nerve cell damage and inflammation. In females, microglia activated genes that support brain health. These differences were strongest at 8 months but faded with age, coinciding with the natural drop in estrogen in older females. Overall, our results show that sex strongly shapes the immune response in PD. Understanding these differences may lead to more personalized approaches to treatment and prevention. Male 3KL mice exhibited earlier and more severe motor and cognitive decline, linked to a pro-inflammatory peripheral immune profile. Female mice showed delayed symptom onset and preserved cognition, associated with early increases in regulatory IL-10⁺ CD4 and γδ T cells. Microglial RNA sequencing revealed broad sex differences at 8 months: males upregulated neurodegenerative and lipid dysregulation pathways, while females upregulated protein maintenance, phagosome formation, DHA signaling, and synaptogenesis. These sex-specific microglial transcriptional programs diminished by 14 months, coinciding with decreased estrogen in aged females. Findings identify coordinated differences in T cell and microglial responses that may underlie sex-specific vulnerability and resilience in Parkinson’s disease. Male 3KL mice exhibited earlier and more severe motor and cognitive decline, linked to a pro-inflammatory peripheral immune profile. Female mice showed delayed symptom onset and preserved cognition, associated with early increases in regulatory IL-10⁺ CD4 and γδ T cells. Microglial RNA sequencing revealed broad sex differences at 8 months: males upregulated neurodegenerative and lipid dysregulation pathways, while females upregulated protein maintenance, phagosome formation, DHA signaling, and synaptogenesis. These sex-specific microglial transcriptional programs diminished by 14 months, coinciding with decreased estrogen in aged females. Findings identify coordinated differences in T cell and microglial responses that may underlie sex-specific vulnerability and resilience in Parkinson’s disease.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/40c18f0c8c2558267619fc6e940cf9ae9e6d0f16" target='_blank'>
              Sex-dependent immune activation shapes disease progression in a model of Parkinson’s disease
              </a>
            </td>
          <td>
            Leah C. Beauchamp, Lily A Palumbo, Toby B Lanser, Mariam Baig, Laura M. Cox
          </td>
          <td>2025-12-24</td>
          <td>Biology of Sex Differences</td>
          <td>0</td>
          <td>8</td>
        </tr>

        <tr id="As a first line of defence for the central nervous system (CNS), microglia play a critical role in maintaining homeostasis within the brain. Upon detection of damage or threats, activated cells release factors to communicate and potentiate immune responses. This activation also increases activity of the kynurenine pathway (KP) and alters expression of key KP enzymes such as indoleamine 2,3-dioxygenase (IDO-1) and kynurenine 3-monooxygenase (KMO), both major contributors in the pathology of several neurodegenerative and psychiatric disorders. This study investigated the impact of pro-inflammatory stimuli on the C20 human microglial cell line, focussing on the regulation of KMO and IDO-1 expression, and the production of cytokines. Additionally, we explored whether the anti-inflammatory effects of dexamethasone (DEXA) influenced these outcomes. This additional characterisation of a physiologically relevant human microglial cell line offers a novel and reliable platform for investigating human-specific microglial biology and function. C20 were challenged for 24 hours with cytokines or lipopolysaccharide (LPS). Gene expression was measured by RT-qPCR and excreted cytokines were quantified using a multiplex array. Our results showed up-regulation of IDO-1 and KMO transcripts, and increased release of pro- and anti-inflammatory cytokines. Notably, these effects were significantly dampened by pre-incubation with DEXA. Furthermore, transcriptomic analyses supported these data by highlighting TNF-α-activated enriched pathways, as well as those down-regulated in samples co-treated with DEXA. This study contributes to the understanding of key mechanisms regulated in human microglia by immune challenges and supports the crucial role of synthetic glucocorticoids (GCs) in moderating the microglial immune response induced by pro-inflammatory signals. These data support the use of GCs as possible therapeutic interventions for diseases associated with neuroinflammation, particularly those with altered KP metabolism.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/52d0499ab0c59fa1b0cba53d288ecb025258b527" target='_blank'>
              Glucocorticoid Treatment Dampens Kynurenine Pathway Activation and Cytokine Release in Immune Stimulated Human Microglia
              </a>
            </td>
          <td>
            Martina Esposito Soccoio, Robert P. Mason, Julien Devilliers, Roberto Feuda, Mary E W Collier, F. Giorgini
          </td>
          <td>2026-01-01</td>
          <td>International Journal of Tryptophan Research: IJTR</td>
          <td>0</td>
          <td>42</td>
        </tr>

        <tr id="ABSTRACT During the COVID-19 pandemic, multiple SARS-CoV-2 variants emerged, each with distinct pathogenicity and transmissibility. This study investigated the role of the viral spike (S) protein in disease progression, focusing on the highly virulent S variant. The Delta S protein exhibited enhanced cleavage efficiency at the S1/S2 junction, resulting in partial dissociation of the S1 subunit, with detectable levels of extracellular S1. Unexpectedly, transient expression of Ancestral and Delta S protein induced by a recombinant vesicular stomatitis viral vector caused mild pulmonary inflammation, neutrophil activation, microthrombosis, and ~40% mortality in transgenic K18-hACE2 mice between 8 and 16 days, similar to post-COVID sequelae. The diseased mice displayed splenic atrophy and systemic inflammation, with elevated serum IGFBP-1 and CXCL13 levels. Consistent with the animal findings, serum samples from long COVID patients showed significantly elevated IGFBP-1 levels. CXCL13 levels were particularly elevated in patients with more severe long COVID symptoms. Notably, treatment with the antiplatelet agent aspirin significantly reduced both mortality and weight loss in mice exposed to Delta S protein expression. These findings suggest that SARS-CoV-2 S protein-associated coagulation and systemic inflammation during infection may contribute to the development of post-acute sequelae of COVID-19. IMPORTANCE Our study investigates the distinctive pathogenic properties of the SARS-CoV-2 spike (S) protein from highly virulent variants, with a particular focus on its delayed pathological effects in mice. Using a vesicular stomatitis virus (VSV) vector to transiently express the Ancestral and Delta variant S proteins in K18-hACE2 mice, we observed minimal acute symptoms initially; however, approximately 40% of the mice developed mild pulmonary inflammation, neutrophil activation, and microthrombosis, leading to death between 8 and 16 days post-infection. This delayed pathology was accompanied by elevated circulating levels of CXCL13 and IGFBP-1. Consistent with these findings, serum samples from long COVID patients also showed significantly increased IGFBP-1 levels, while CXCL13 levels were particularly elevated in individuals with more severe long COVID symptoms. These findings provide important observational evidence that may guide future mechanistic studies on long COVID and inform the development of potential therapeutic approaches. Our study investigates the distinctive pathogenic properties of the SARS-CoV-2 spike (S) protein from highly virulent variants, with a particular focus on its delayed pathological effects in mice. Using a vesicular stomatitis virus (VSV) vector to transiently express the Ancestral and Delta variant S proteins in K18-hACE2 mice, we observed minimal acute symptoms initially; however, approximately 40% of the mice developed mild pulmonary inflammation, neutrophil activation, and microthrombosis, leading to death between 8 and 16 days post-infection. This delayed pathology was accompanied by elevated circulating levels of CXCL13 and IGFBP-1. Consistent with these findings, serum samples from long COVID patients also showed significantly increased IGFBP-1 levels, while CXCL13 levels were particularly elevated in individuals with more severe long COVID symptoms. These findings provide important observational evidence that may guide future mechanistic studies on long COVID and inform the development of potential therapeutic approaches.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/df20b77bf296aeeec28956534f7acfcfef3b6afd" target='_blank'>
              SARS-CoV-2 spike protein expression drives post-acute coagulopathy
              </a>
            </td>
          <td>
            Chih-Feng Tien, En-Ju Lin, Wei-Hsiang Tsai, W. Tsai, Ming-Yu Chen, Yu-Siang Su, Hangshen Wu, Yueh-Tzu Chiu, Wan-Ju Tung, Yi-Ping Kuo, Yu-Wen Su, Hsin-Wei Chen, Feng-Jui Chen, Tsung-Hsien Chuang, Hsiang-Tsui Wang, Guann‐Yi Yu
          </td>
          <td>2026-01-21</td>
          <td>Journal of Virology</td>
          <td>0</td>
          <td>22</td>
        </tr>

        <tr id="

 Advanced age is associated with increased morbidity and mortality following acute viral infections, including SARS-CoV-2. Despite this, most preclinical models rely on young animals and fail to account for age-related immune remodeling. How advanced aging alters antiviral immune responses and contributes to immune-mediated pathology remains incompletely understood.



 Young (2–6 months), aged (15–18 months), and advanced aged (20–29 months) mice were infected with murine cytomegalovirus (MCMV) or influenza virus. Survival, viral burden, cytokine production, immune cell phenotypes, and tissue pathology were assessed using flow cytometry, histology, serum cytokine analysis, and RNA sequencing. Mouse findings were compared with publicly available transcriptomic datasets from SARS-CoV-2–infected human cohorts across age groups.



 Advanced aged mice exhibited markedly increased mortality and organ pathology following viral infection despite maintaining viral loads comparable to younger mice. These outcomes were associated with heightened systemic and tissue inflammatory cytokine production, reduced antigen-specific T cell responses, and increased frequencies of NK cells and non-antigen-specific bystander T cell activation. Coagulopathy with thrombolytic clot formation was observed exclusively in advanced aged mice. Transcriptomic analysis revealed enrichment of inflammatory and coagulation pathways in influenza-infected advanced aged mice, paralleling findings in elderly humans with SARS-CoV-2 infection, who also displayed reduced expression of T cell–associated genes.



 These findings demonstrate that advanced age profoundly alters antiviral immune responses, shifting immunity away from effective antigen-specific T cell responses toward inflammatory and innate pathways that contribute to immune-mediated pathology. The results highlight the importance of modeling advanced aging in preclinical studies and suggest that age-dependent immune imbalance may underlie increased inflammation, coagulopathy, and mortality during viral infection in both mice and humans.
">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/dce25967733c8fd86e8ae90dfc02224ab104dac8" target='_blank'>
              Age-driven shifts in T and NK cell responses amplify inflammation and coagulopathy during viral infection in mice and humans
              </a>
            </td>
          <td>
            Craig P. Collins, C. Dunai, L. Vick, Lam T. Khuat, A. Merleev, , Jonathan Lam, E. Maverakis, A. Monjazeb, , Nicole Baumgarth, Robert J. Canter, William J. Murphy
          </td>
          <td>2026-02-09</td>
          <td>Frontiers in Immunology</td>
          <td>0</td>
          <td>48</td>
        </tr>

        <tr id="


 Elevated inflammation and immune dysregulation are the main consequences of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. The dysregulated inflammatory state persists after coronavirus disease 2019 (COVID-19), establishing the post-acute sequelae of SARS-CoV-2 infection in individuals with long COVID (LC). The role of CD169
 +
 monocytes in the early diagnosis of SARS-CoV-2 infection and their association with severe outcomes were demonstrated in COVID-19 patients (COV). We aimed to delineate specific myeloid activation that characterizes the acute and post-acute phases of SARS-CoV-2 infection, evaluating the correlation between cellular and extracellular vesicles (EVs).




 Blood samples from COV, LC, and healthy donors (HD) were collected at Tor Vergata University Hospital in Rome. Plasmatic EVs were isolated by differential centrifugation and evaluated by flow cytometry and atomic force microscopy (AFM). Leukocyte subpopulations and different sizes of circulating EVs (100–200, 240–500, >500 nm) were characterized for HLA-DR and CD169 expression in COV, LC, and HD through flow cytometry. Serum inflammatory markers were assessed by the ELLA immunoassay system. The analyzed markers were associated with clinical and biochemical parameters in COV and LC.




 The analysis of HLA-DR
 +
 , CD169
 +
 , and HLA-DR
 +
 CD169
 +
 leukocytes confirmed our previous results in which the activated monocytes CD169
 +
 HLA-DR
 +
 were found significantly high in COV, persisting in LC, and correlated differently with coagulation markers and inflammatory cytokines. Similar to cellular levels, the percentage and number of HLA-DR
 +
 CD169
 +
 EVs were significantly elevated in COV and persisted in LC compared to HD. Different HLA-DR and CD169 expressions were found according to EV size in COV, LC, and HD, and correlations with biochemical parameters and circulating inflammatory markers were found. A positive correlation of HLA-DR and CD169 expression among monocytes and circulating EVs was found, supporting a possible connection between the two compartments and circulating inflammatory mediators. Moreover, the characterization by flow cytometry of EV cell derivation and cytokine cargo revealed EVs as sensitive indicators of both acute and persistent immune perturbations, bridging viral antigen persistence with inflammatory signaling in long COVID.




 Myeloid activation markers and inflammatory cytokines are dynamically expressed between blood cells and circulating extracellular vesicles, underlining multilevel cell-to-cell communications, opening new possibilities to monitor COVID-19 and long COVID-associated sequelae.
">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/3d1d81a43a44ce77c5595dbe6e28e44176869a7e" target='_blank'>
              CD169+ and HLA-DR+ extracellular vesicles are highly represented in human plasma and dynamically expressed in SARS-CoV-2 infection and long COVID-associated sequelae
              </a>
            </td>
          <td>
            Marialaura Fanelli, Vita Petrone, Rossella Chirico, Luigi Coppola, Chiara Sorace, C. Cipriani, Giovanni Longo, Marco Girasole, Federica Collacchi, C. M. Radu, M. Miele, Alexandre Lucas, E. Teti, V. Malagnino, Marco Iannetta, Fabrice Malergue, S. Bernardini, E. Balestrieri, L. Sarmati, S. Grelli, A. Minutolo, Claudia Matteucci
          </td>
          <td>2026-02-11</td>
          <td>Frontiers in Cellular and Infection Microbiology</td>
          <td>0</td>
          <td>40</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/7fcd6ac198b7a5cb5b78187fc9822fa3e83bc8c9" target='_blank'>
              Long-term rapamycin treatment suppresses IL-17-producing gamma delta T cells and blunts neuroinflammation in aging
              </a>
            </td>
          <td>
            Clement Torrent, Caterina Gagliardi, Nina Fülle, Ignazio Antignano, M. E. Bernis, Miriam Stork, Daniele Bano, Melania Capasso, Lily Keane
          </td>
          <td>2026-02-09</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>21</td>
        </tr>

        <tr id="Introduction Coronavirus disease 2019 (COVID-19) has been widely associated with intense systemic inflammation, endothelial injury, and a high incidence of thrombotic complications, which together contribute to disease severity and poor clinical outcomes. While endothelial dysfunction, dysregulated cytokine production, and oxidative stress are recognized features of severe COVID-19, the direct impact of circulating factors from infected individuals on endothelial cell behavior remains insufficiently characterized. Here, we examined how serum from patients with severe COVID-19 and from convalescent individuals modulates endothelial activation, inflammatory responses, and oxidative stress using human umbilical vein endothelial cells as an in vitro model. Methods Venous blood samples were collected from individuals with severe COVID-19 (n = 13), convalescent patients (n = 11), and healthy volunteers (n = 7) during the initial phase of the COVID-19 pandemic. Human umbilical vein endothelial cells (HUVEC) were maintained in culture and exposed to 15% serum from each study group after a period of serum deprivation. The expression of genes associated with endothelial activation, thrombosis, inflammation, and oxidative stress was analyzed by quantitative real-time PCR at defined time points. In addition, the endothelial secretory profile was evaluated in cell culture supernatants using multiplex bead-based immunoassays. Statistical analyses were performed using one-way ANOVA followed by appropriate post hoc tests, receiver operating characteristic (ROC) curve analysis to assess the discriminatory capacity of biomarkers, and multivariate linear regression to identify factors associated with disease severity. Results and discussion We investigated the role of the endothelium in modulating the cytokine storm in severe COVID-19. HUVEC were stimulated with serum from patients with severe COVID-19, convalescent individuals, and healthy volunteers. Stimulation with serum from severe cases induces significant increases in VCAM1, F3, PROCR, IL6, IL12A, NFE2L2, HMOX1, GPX1, and GSR expression within 60 minutes. Antioxidant genes SOD1 and CAT were upregulated later, after 120 minutes. HUVEC stimulated with severe COVID-19 sera showed increased levels of sICAM-1, sVCAM-1, P-selectin, sE-selectin, PECAM-1, tissue factor, thrombomodulin, and a broad range of cytokines and growth factors, such as IL-1α, IL-1Ra, IL-5, IL-6, IL-10, IL-12(p40), IL-18, IL-27, TNF-α, TGF-α, FGF-2, G-CSF, M-CSF, FLT-3L, fractalkine, eotaxin, MIG, IP-10, MIP-1β, MDC, GROa and PDGF-AB/BB. In contrast, convalescent sera induced fewer markers, specifically IL-12(p40), IL-18, FGF-2, MIP-1β, MDC, GROa, and PDGF-AB/BB, while HV sera induced significant increases in IL-12(p40), IL-27, TNF-α, VEGF, MDC, eotaxin, and GROa. ROC curve analysis revealed that P-selectin and MIP-1β levels clearly distinguish severe cases from HV. When comparing severe and convalescent groups, we observed increases in IL-27, TGF-α, sVCAM-1, IL-1α, and G-CSF levels. Furthermore, Multivariable logistic regression analysis associated disease severity with decreased IL-10 and increased MIP-1β, sICAM-1, and P-selectin. Conclusion These findings suggest that HUVEC serves as a promising biological sensor for detecting inflammatory responses in COVID-19 patients and shows the crucial role of the endothelium in sustaining the cytokine storm that contributes to patient severity and mortality.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/60fcceeacb96bb3cf6d83c4dae27c5972db20b1d" target='_blank'>
              Assessing the endothelium’s role in COVID-19 severity using the HUVEC model
              </a>
            </td>
          <td>
            S. S. Santana, S. Yahouédéhou, Corynne Stéphanie Ahouéfa Adanho, Jéssica Rebouças Silva, Hayna Malta Santos, C. Barbosa, T. N. Pitanga, Valéria Matos Borges, V. Fortuna, I. Lyra, Marilda Souza Gonçalves
          </td>
          <td>2026-01-08</td>
          <td>Frontiers in Immunology</td>
          <td>0</td>
          <td>16</td>
        </tr>

        <tr id="ABSTRACT The recently identified alphacoronavirus swine acute diarrhea syndrome coronavirus (SADS-CoV) has a high fatality rate in neonatal piglets. Currently, no vaccines or treatment strategies for SADS-CoV infection are available. The stimulator of interferon genes (STING) pathway plays a critical role in initiating innate immune responses against RNA viral infections; however, its role in host defense against SADS-CoV infection remains unexplored. We assessed the pathogenicity of SADS-CoV in 3-day-old, 7-day-old, and 3-week-old mice, revealing striking age-dependent susceptibility—a pattern mirroring clinical observations in piglets. Additionally, SADS-CoV infection activated the STING-dependent pathway, which resulted in significant interferon responses in infected mice. In vitro experimental findings confirmed that STING pathway activation inhibited SADS-CoV replication by modulating the NF-κB and IRF3 signaling pathways and mediating the production of inflammatory cytokines, which underscores the importance of the STING pathway in antiviral defense mechanisms. In vivo studies revealed that the STING inhibitor C176 significantly promoted viral replication, whereas activation of the STING pathway using the STING agonist diABZI increased antiviral immune responses and reduced viral replication. Notably, diABZI protected mice from SADS-CoV infection by reducing viral replication through mechanisms involving both type I interferon-dependent and -independent pathways. These results represent the first demonstration of the in vivo therapeutic efficacy of pharmacological STING activation against SADS-CoV. These findings demonstrate that the STING pathway serves as a critical regulator of host defense against SADS-CoV and suggest that STING-targeted intervention has therapeutic potential. IMPORTANCE Swine acute diarrhea syndrome coronavirus (SADS-CoV) is an emerging zoonotic pathogen with significant implications for veterinary and public health; it has a high mortality rate in piglets and the potential for cross-species transmission. Currently, there are no approved vaccines or specific antiviral agents available for this pathogen. In this study, we demonstrated that the stimulator of interferon genes (STING) pathway serves as a critical mediator of host defense against SADS-CoV infection. STING activation inhibits viral replication by coordinating interferon responses and modulating NF-κB/IRF3 signaling, and its inhibition exacerbates infection. Importantly, pharmacological activation of the STING pathway using the agonist diABZI significantly inhibited viral replication in vivo in a STING-dependent manner, with contributions from both type I interferon-dependent and -independent antiviral mechanisms, highlighting its therapeutic potential. These results advance our understanding of antiviral defense strategies against SADS-CoV and identify STING pathway regulation as a viable therapeutic approach for this emerging pathogen. Swine acute diarrhea syndrome coronavirus (SADS-CoV) is an emerging zoonotic pathogen with significant implications for veterinary and public health; it has a high mortality rate in piglets and the potential for cross-species transmission. Currently, there are no approved vaccines or specific antiviral agents available for this pathogen. In this study, we demonstrated that the stimulator of interferon genes (STING) pathway serves as a critical mediator of host defense against SADS-CoV infection. STING activation inhibits viral replication by coordinating interferon responses and modulating NF-κB/IRF3 signaling, and its inhibition exacerbates infection. Importantly, pharmacological activation of the STING pathway using the agonist diABZI significantly inhibited viral replication in vivo in a STING-dependent manner, with contributions from both type I interferon-dependent and -independent antiviral mechanisms, highlighting its therapeutic potential. These results advance our understanding of antiviral defense strategies against SADS-CoV and identify STING pathway regulation as a viable therapeutic approach for this emerging pathogen.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/a05a2e5279a634fa785ee9b0dff3bb87703a347f" target='_blank'>
              STING agonist diABZI confers protection against swine acute diarrhea syndrome coronavirus in neonatal mice by activating antiviral immunity
              </a>
            </td>
          <td>
            Yuying Li, Wei Chen, Xinyu Zhang, Jiyong Zhou, Yanqing Hu, Yi-min Zhou, Tian Lan, Haixin Huang, Lu-lu Xie, Yan Qin, Lin Zhou, Wen-chao Sun, HuiJun Lu
          </td>
          <td>2025-12-29</td>
          <td>Journal of Virology</td>
          <td>0</td>
          <td>5</td>
        </tr>

        <tr id="Background Microglia are emerging as critical regulators of neurovascular function in health and Alzheimer’s disease (AD), yet their interactions with the human neurovascular unit (NVU), particularly brain endothelial cells, remain incompletely understood. Current in vitro NVU platforms typically exclude microglia and lack perfusable vascular networks with physiologically relevant architecture. Here, we established complementary two-dimensional (2D) and three-dimensional (3D) NVU models to investigate microglia-endothelial and microglia-neurovascular interactions. Methods Human induced pluripotent stem cell derived-neurons (iNs), astrocytes (iAs), and microglia-like cells (iMGLs) were incorporated into a soft-lithography based engineered microvessel system to establish a multicellular neuroimmune-vascular model. To specifically evaluate iMGL-endothelial cell (EC) interactions, iMGL were co-cultured with primary human brain microvascular endothelial cells (HBMECs) and junctional protein localization was evaluated using immunofluorescence. The barrier integrity of engineered microvessels containing iMGL was evaluated using dextran permeability. Our 2D and 3D systems were stimulated with tumor necrosis factor-α (TNFα) to evaluate whether iMGL would promote or attenuate EC inflammation and barrier breakdown. Results Incorporation of iNs, iAs, and iMGLs into a perfusable vascular model enabled a more complete representation of NVU cellular diversity and promoted neuronal health. In monolayer co-culture with iMGL, HBMECs enhanced the junctional localization of tight and adherens junction proteins through both contact-dependent and paracrine mechanisms. Following an inflammatory challenge, iMGLs reduced endothelial inflammatory activation, suggesting a protective role in response to AD-relevant inflammatory conditions. Finally, when embedded in 3D collagen matrices surrounding perfusable endothelialized lumen networks, iMGLs reduced dextran permeability and preserved endothelial barrier integrity following TNFα challenge. Conclusions Together, these findings establish a 3D perfusable neuroimmune-vascular model that enables the dissection of microglial contributions to neurovascular function in health and disease.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/7f1a2748118fa49050854b64846bdcb191d2fee0" target='_blank'>
              Evaluating Microglial Contributions to the Neurovascular Unit in Health and Neurodegeneration Using Human In Vitro Models
              </a>
            </td>
          <td>
            Kira M. Evitts, Emily Turschak, Charles A. Williams, Chizuru Kinoshita, Aleah Rosner, Willow Battista, Katherine Hui, Ian Beck, Aquene Reid, Ying Zheng, Jessica E. Young
          </td>
          <td>2025-12-22</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>13</td>
        </tr>

        <tr id="Long COVID (LC) or Post-Acute Sequelae of SARS-CoV-2 infection (PASC) syndrome represents a widespread health challenge that necessitates the development of novel diagnostic approaches and targeted therapies that can be readily deployed. Immune dysregulation has been reported as one of the hallmarks of LC, but the extent of LC immune dysregulation in patients over time remains unclear. We therefore assessed SARS-CoV-2-specific antibody responses, peripheral immune cell profiles, autoantibody profiles and circulating cytokines for up to 6 months in participants with a SARS-CoV-2 infection who either convalesced or developed LC. Compared to convalescent, LC participants with a broad range of LC phenotypes exhibited persistently elevated IgG titers for SARS-CoV-2 Envelope and Nucleocapsid proteins over the 6 months of study duration. In contrast, the IgG responses to Spike protein were significantly lower in the LC cohort with predominantly IgG1 and IgG3 class-switched bias. Using CyTOF analysis we show elevated numbers of circulating T follicular helper cells (cTFH) and mucosa-associated invariant T cells (MAIT), which also correlated with high anti-Envelope IgG titers. Persistent immune activation was accompanied by augmented serum cytokine profiles with LIF, IL-11, Eotaxin-3, and HMGB-1 in LC participants, who also demonstrated significantly higher rates of autoantibodies. These findings highlight the persistence of immune dysregulation in LC, underscoring the need to explore targeted therapies addressing viral persistence, dysregulated antibody production, and autoimmunity.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/c4f9def96ecd7623891e3f4b4f5c72c22acebf31" target='_blank'>
              Persistent Immune Dysregulation during Long COVID is Manifested in Antibodies Targeting Envelope and Nucleocapsid Proteins
              </a>
            </td>
          <td>
            Jalees Rehman, Marcin Kwissa, Manikannan Mathayan, Satyajeet S. Salunkhe, Velavan Bakthavachalam, Zijing Ye, Mark A. Sanborn, Samantha Condo, Aditi Upadhye, Athulith Nemakal, Haoyang Wang, James Chan, Justin M. Richner, Sanjib Basu, Richard Novak, Jeffrey R. Jacobson, Balaji B Ganesh, Martha Cerda, Hassan Brim, Nathaniel Erdmann, Bruce Levy, Gailen D. Marshall, Grace A. McComsey, Torri Metz, Megumi Okumura, M. Peluso, Tiffany Walker, P. Utz, Jerry A. Krishnan, Bellur S. Prabhakar
          </td>
          <td>2026-01-08</td>
          <td>Research Square</td>
          <td>0</td>
          <td>11</td>
        </tr>

        <tr id="Coronavirus disease 2019 (COVID-19) pneumonia is prevalent in the elderly infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); however, the mechanisms underlying its age-dependent pathogenesis remain unclear. In this study, we established a mouse-adapted SARS-CoV-2 strain infected Nr4a3-Tocky mouse model to examine T-cell dynamics associated with disease severity. Nr4a3-Tocky mice allow the analysis of the dynamics and induction of antigen-reactive T cells following antigen recognition in vivo using fluorescent Timer protein. SARS-CoV-2-infected adult mice exhibited transient body weight loss and recovery, whereas aged mice developed severe pneumonia. BALF viral RNA was comparable between 1–4 days post-inoculation (d.p.i.), but declined in adults at 5 d.p.i. Aged mice displayed stronger inflammation as indicated by scRNA-seq, and higher levels of inflammatory cytokines (TNF-α, CCL2, CXCL10 and IL-6) in BALF correlated with weight loss. Timer analysis revealed induction of antigen-reactive T cells in the adult lungs at 5 and 8 d.p.i., which inversely correlated with disease severity. Additionally, S-specific IFN-γ ⁺ CD8 ⁺ T cells were detected at 5 d.p.i. in adults, whereas detection of antigen-specific T cells was delayed in aged mice. These results suggest that the coexistence of age-related lung inflammation and delayed induction of antigen-specific T cells is linked to more severe pneumonia, while earlier T-cell responses are associated with improved viral control and milder disease. In this study, we utilized a novel mouse model enabling characterization of antigen-reactive T cells in the local tissue, and investigated inflammatory responses in the lung together with lung-infiltrating virus-specific T cells, finding the dynamics of these immunological parameters associated with the age of the mice. Our analysis provides new insights into understanding how age-related T-cell dysfunction is associated with the severity of SARS-CoV-2 pneumonia.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/26d80e657921afbee11ed57efcbb48ed233ef470" target='_blank'>
              Dynamics of lung-infiltrating virus-specific T cells associated with age-dependent SARS-CoV-2 pneumonia severity
              </a>
            </td>
          <td>
            Rise Kurokawa, Chatherine Silas Mtali, Innocent John Daniel, Thorbjorg Einarsdottir, Omnia Reda, Nobuko Irie, Wajihah Sakhor, Koki Niimura, Mitsuyoshi Takatori, Kenji Sugata, C. A. Tye, Yorifumi Satou, Masahiro Ono, Takushi Nomura
          </td>
          <td>2026-01-01</td>
          <td>PLOS Pathogens</td>
          <td>0</td>
          <td>9</td>
        </tr>

        <tr id="Background/Objectives: The molecular cascades involved in the induction and maintenance of neuroinflammation resulting from chronic compression of the cervical spinal cord in the setting of degenerative cervical myelopathy (DCM) have yet to be defined. Here, we determined the role of the fractalkine receptor, CX3CR1, during the neuroinflammatory response in a novel mouse model of DCM and demonstrated the relevance of this mechanism with human DCM tissue. Methods: Using our murine DCM model alongside the CX3CR1-knockout mice and a neutralizing antibody of CX3CR1 in wild-type mice, we examined protein, neurobehavioural and immunohistochemical readouts. The animal data were then complemented with immunohistochemical results from human post-mortem spinal cord tissue from individuals with DCM. Results: Humans and mice with DCM exhibited an up-regulation of CX3CR1 as well as markers of activated microglia/macrophages in the cervical spinal cord. Knockout and neutralization of CX3CR1 hindered microglia/macrophage activation and accumulation at the site of spinal cord compression. DCM mice exhibited decreased body speed and increased stance phase duration, which mirrors human DCM gait deficits. Strikingly, both CX3CR1 deficiency and CX3CR1 neutralization alleviated these gait deficits in DCM mice. Conclusions: Collectively, these data provide strong evidence that CX3CR1 plays a critical role in the secondary injury of neural structures in the setting of DCM. Further, targeting of CX3CR1 represents a promising therapeutic strategy to enhance neurological outcomes in DCM.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/2268c228ba1fc9b9436b04f3da83f5c32be4049e" target='_blank'>
              An Examination of the Role of CX3CR1 in the Pathobiology of Degenerative Cervical Myelopathy: Evidence from Human and Mouse Tissue
              </a>
            </td>
          <td>
            W. Yu, Spyridon K. Karadimas, James Hong, Sarah Sadat, S. Brockie, Pia M. Vidal, T. Kiehl, Noah Poulin, A. Andreopoulou, J. Kallitsis, Michael G. Fehlings
          </td>
          <td>2025-12-22</td>
          <td>Journal of Clinical Medicine</td>
          <td>0</td>
          <td>36</td>
        </tr>

        <tr id="Background: Immune aging is a complex process involving various cellular changes, such as a myeloid bias, decreased functional activity of immune cells, accumulation of senescent cells, and alterations in serum levels of bactericidal humoral factors. As believed, these changes contribute to increased susceptibility of older adults to infectious diseases. Myeloid cells are considered the first line of defense against bacterial invasion. However, it remains unclear whether the protective functions of myeloid cells diminish in active older adults and whether potential age-related changes are evolutionarily conserved across primates. Methods: In this study, myeloid cell populations from peripheral blood and bone marrow of cynomolgus macaques and human peripheral blood were analyzed across a broad age range for phenotypic and functional characteristics, e.g., E. coli phagocytosis, secretion of proinflammatory factors, genetic instability, and signs of cellular aging. Results: Despite minor interspecies phenotypic differences in granulocyte populations, both the quantity and functions of myeloid cells were remarkably stable during aging in both species. Myeloid cells maintained genetic stability, and high SA-β-Gal activity was observed, likely reflecting metabolic traits rather than age-related changes. Importantly, a predominant and age-independent role of humoral factors, rather than cellular mechanisms, was identified in the initial control of bacterial infection. Conclusions: These findings suggest that innate immune functions remain stable for a long time during aging in both species.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/d8a987a1816f32ee1e3963ce13efb0c477c73470" target='_blank'>
              Stability of Myeloid Cell Phenotype and Function Across a Broad Age Range in Humans and Cynomolgus Monkeys, and a Dominant Contribution of Humoral Factors in the Control of Bacterial Infection
              </a>
            </td>
          <td>
            Elena V. Lysakova, Marina Y. Burak, Ilya Larin, Sergey A. Chuvpilo, Victor S. Laktyushkin, A. Shumeev, Igor E. Pismennyi, Vladimir Y. Toshchakov, M. Bobrov, S. Rybtsov
          </td>
          <td>2025-12-29</td>
          <td>Biomedicines</td>
          <td>0</td>
          <td>3</td>
        </tr>

        <tr id="mRNA vaccines have shown high efficacy against SARS-CoV-2, yet orchestration of innate and adaptive responses in infection-naïve individuals remains incompletely characterized. Understanding these dynamics in people without prior infection is essential for defining baseline immune trajectories and providing a reference for future studies. We conducted a longitudinal study in SARS-CoV-2-naïve adults who received two doses of the BNT162b2 vaccine. Peripheral blood was analyzed by flow cytometry to quantify monocyte, NK, T, and B cell subpopulations, and serum cytokines were measured by multiplex assays. Data were evaluated with Z-score normalization and paired comparisons. Monocyte subsets segregated into two groups: one with progressive decline and another with transient activation. NK cells displayed multiphasic activation, particularly after booster. CD4+ and CD8+ T cells differentiated toward central and effector memory phenotypes, while B cells showed evidence of germinal center engagement followed by memory refinement. Cytokine fluctuations, including interferon-related signals, paralleled cellular dynamics. The booster was associated with re-engagement of innate components and amplification of adaptive responses. BNT162b2 vaccination in naïve individuals induces a coordinated sequence in innate and adaptive compartments, culminating in memory T and B cells. These findings align with current literature and provide trajectories to inform immune monitoring and optimization strategies.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/ec63f2d70eca68584542e62e194ff95891698efb" target='_blank'>
              Primary immune trajectories following a single BNT162b2 vaccination scheme in SARS-CoV-2-naïve individuals.
              </a>
            </td>
          <td>
            Miguel Leonardo Méndez Rodríguez, A. Ponciano-Gómez, Myriam Campos-Aguilar, Wilfrido David Tapia-Sánchez, Carlos Leonardo Duarte-Martínez, Jesús Salvador Romero-Herrera, Sandra Olivas-Quintero, A. Saucedo-Campos, Jaciel Ivan Lopez-Sanchez, A. René Méndez-Cruz, Rafael Jiménez-Flores, Héctor Romero-Ramírez, Leopoldo Santos-Argumedo, V. Rosales-García, Vianney Ortiz-Navarrete
          </td>
          <td>2026-01-13</td>
          <td>European journal of microbiology & immunology</td>
          <td>0</td>
          <td>6</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/a80bbb3790bf37a49652e840f00b66c360bfe299" target='_blank'>
              Monomeric C-reactive Protein Exacerbates Neuronal Injury and Enhances Microglial Activation after Global Cerebral Ischemia in Mice
              </a>
            </td>
          <td>
            Gaowei Pan, Xiaoling Liu, Xiaoyue Zhang, Hao Gao, Ting Xu, Kemin Li, Lei Wang, Shangrong Ji, Ting Li, Shengxiang Zhang
          </td>
          <td>2025-12-29</td>
          <td>Molecular Neurobiology</td>
          <td>0</td>
          <td>10</td>
        </tr>

        <tr id="Japanese encephalitis virus (JEV) preferentially targets brain regions rich in dopaminergic neurons, including the thalamus, midbrain, and striatum, leading to severe neuroinflammation. However, the underlying pathological mechanisms remain unclear. This study hypothesizes that JEV-induced pyroptosis exacerbates neuroinflammation by activating the NLRP3/caspase-1/GSDMD signaling pathway. In vivo experiments using JEV-infected mice revealed virus-specific targeting of dopaminergic neurons, concurrent activation of the NLRP3 inflammasome, and induction of inflammatory responses. In vitro studies with mouse midbrain dopaminergic cells showed significant viral replication, progressive cell membrane damage, and colocalization of JEV with pyroptotic markers. The pharmacological inhibition of NLRP3, while suppressing viral load and NLRP3 inflammasome activation, fails to delay the onset of neuroinflammation, potentially due to the activation of glial cells. This suggests that glial cell-mediated inflammatory pathways independent of NLRP3 may drive neuroinflammation despite NLRP3 inhibition. The unimpeded activation of glia could sustain pro-inflammatory responses, highlighting the need to target glial activation alongside NLRP3 to effectively mitigate neuroinflammation.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/a8875e532cc8e80ffdb13005ea1a541bed62a823" target='_blank'>
              Japanese encephalitis virus activates the NLRP3/caspase-1/GSDMD signaling pathway in dopaminergic neurons
              </a>
            </td>
          <td>
            Xiaoyan Guo, Siyuan Lu, Zhiwei Huang, Jiahuan Li, G. Cheng, Xueying Hu, Wanpo Zhang, Changqin Gu
          </td>
          <td>2026-01-01</td>
          <td>PLOS Neglected Tropical Diseases</td>
          <td>0</td>
          <td>16</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/4aac0aaca436c5bc7203a87d69b89b490cdfd76a" target='_blank'>
              Mucosal-Associated Invariant T Cells Promote Atherosclerosis Through Monocyte-Driven Inflammation
              </a>
            </td>
          <td>
            Tobias Radecke, Thomas Nipoti, Louise Z. Wang, N. Mouttoulingam, Marc Diedisheim, M. Chajadine, E. Bacquer, Coraline Heron, P. Alayrac, Charles Caër, L. Laurans, Camille Knosp, Pierre Liénart, Kenza Damache, Rida Al-Rifai, Stéphane Camus, Mathilde Lemitre, Marie Piollet, Oliver Soehnlein, Pierre Julia, J. Alsac, S. E. Batti, F. Letourneur, C. Cochain, Alain Tedgui, H. Ait-Oufella, T. Mirault, Z. Mallat, Olivier Lantz, Jean-Sébastien Silvestre, Sophie Lotersztajn, S. Taleb
          </td>
          <td>2026-01-21</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>94</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/bd34010aa1ea1210d34d9e69c2b56f53fe420294" target='_blank'>
              TLR3 Activation of Microglia-Containing Cerebral Organoid Induces Antiviral Factors against HIV-1 Infection
              </a>
            </td>
          <td>
            Qianhao Xiao, Xu Wang, Priyanka Sarkar, Xiao-Long Wang, Li Song, Binhua Ling, Wenhui Hu, Wen-Zhe Ho
          </td>
          <td>2025-12-19</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>18</td>
        </tr>

        <tr id="Background Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) causes a highly infectious disease characterized by fever, acute respiratory illness, and pneumonia, known as coronavirus disease 2019 (COVID‐19). SARS‐CoV‐2 infects host cells through the interaction of its spike glycoprotein (S protein) with human angiotensin‐converting enzyme 2 (hACE2). Structural studies have shown that hACE2 interacts exclusively with the receptor‐binding domain (RBD) of the spike. A high binding affinity between spike and hACE2 has been linked to increased viral infection. Disrupting this interaction can reduce viral infectivity. Methods This study aimed to assess infection using Omicron variant pseudovirus in a stable HEK‐293 cell line expressing hACE2 (HEK‐293/ACE2), treated with bromhexine hydrochloride. First, immunofluorescence and Western blot confirmed the presence of hACE2 in the stable line. Then, bromhexine concentrations for treatment were determined by cytotoxicity assays. Next, infection was evaluated using Omicron pseudoviruses carrying GFP and luciferase reporter genes. Infection levels were measured through fluorescence or luciferase activity. Results Bromhexine reduced infection with an IC50 of 17.3 ± 0.9 μM. About 40% inhibition was also observed against Alpha, Beta, and Delta variants at 40 μM. Computational docking followed by molecular dynamics simulations showed that bromhexine binds to the extracellular domain of hACE2, with recurrent contacts near Phe40, Phe390, and Asn394. Conclusion Consistent with this model, our findings support an entry‐inhibition mechanism whereby bromhexine destabilizes the SARS‐CoV‐2 spike–ACE2 interface, preventing viral entry. Overall, these results suggest bromhexine as a potential repurposing candidate and support its inclusion in therapeutic strategies aimed at both current and emerging SARS‐CoV‐2 variants.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/e991f931c2839f085c108cb8ba64a96c52f958c7" target='_blank'>
              Bromhexine inhibits SARS-CoV-2 Omicron and variant pseudovirus infection via ACE2-targeted mechanisms
              </a>
            </td>
          <td>
            Rafael Zúñiga, W. Venturini, Natalia González, Paulina Valenzuela-Hormazábal, Laura Sánchez-Aros, David Ramírez, Angel Cayo, Cristian Vilos, Leandro Zúñiga
          </td>
          <td>2026-01-12</td>
          <td>Frontiers in Pharmacology</td>
          <td>0</td>
          <td>9</td>
        </tr>

        <tr id="Background: The intolerance of the body to neutrophil antigens drives the pathogenesis of childhood anti-neutrophil cytoplasmic autoantibody-associated vasculitis (AAV), making neutrophils a central focus of research on the disease’s underlying mechanisms. Methods: We performed single-cell RNA sequencing on 18 peripheral blood samples (including three healthy human samples, twelve samples from patients with different types of AAV, and three samples from patients after AAV treatment) to investigate neutrophil heterogeneity in AAV. These bioinformatics findings were subsequently validated through comprehensive experimental approaches, including in vitro cellular assays, in vivo animal studies, clinical sample analyses, and correlation with patient clinical data. Results: In AAV, neutrophils were reclassified into seven distinct clusters, Neutrophils2 (N2, CD10 + CD11B ++ ) exhibited significant expansion (P<0.01), while Neutrophils5 (N5, CD10 − CD11B ++ ) showed a trend toward increase (P>0.05). This phenomenon has been confirmed by the experimental autoimmune vasculitis model (CD10 + CD11B ++ , P<0.001; CD10 − CD11B ++ , P<0.05). The bioinformatics results indicated that both CD10 + CD11B ++ neutrophils and CD10 − CD11B ++ neutrophils exhibited dominant pro-inflammatory activities, including neutrophil activation, reactive oxygen species production, neutrophil extracellular trap formation, and degranulation. Pseudotime trajectory and RNA velocity analyses indicated direct differentiation of CD10 + CD11B ++ neutrophils from CD10 − CD11B ++ neutrophils. Experiments using HL-60 cells demonstrated that the peripheral blood microenvironment of AAV promotes the generation of CD11B ++ neutrophils (P<0.001). Functionally relevant metabolic profiling revealed a substantial reduction in glutamine metabolism in the CD10 + CD11B ++ neutrophils of AAV patients compared to controls (P<0.001), which was restored following treatment (P<0.001). Experimental results demonstrated that increasing glutamine concentration in the microenvironment of HL-60 cells can decrease the production of CD11B ++ neutrophils (P<0.001). Clinical data demonstrate that peripheral blood GGT concentrations increase in patients following treatment (P<0.01). Conclusion: These findings identify two novel pathogenic neutrophil subsets and suggest that modulation of glutamine metabolism is a promising avenue for further investigation as a potential therapeutic strategy in childhood AAV.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/b232707b05daa7d5d54e63555850a808b6e7d5cb" target='_blank'>
              Single-Cell RNA-Sequencing of Peripheral Blood Reveals Neutrophil Heterogeneity in Childhood ANCA-Associated Vasculitis
              </a>
            </td>
          <td>
            Shengsen Wei, Liwen Tan, Lin Tang, Huaying Xiong, Qin Yang, J. Jiao, Zilin Liu, Gaofu Zhang, Haiping Yang, Qiu Li, Aihua Zhang, Mo Wang
          </td>
          <td>2026-01-01</td>
          <td>Journal of Inflammation Research</td>
          <td>0</td>
          <td>16</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/fa071288b65837d6091f6362b521ac0ceff46810" target='_blank'>
              Single-Cell Dissection of the SPP1-CD44 Axis Reveals Microglia-Astrocyte Crosstalk Driving Neuroinflammation in Temporal Lobe Epilepsy
              </a>
            </td>
          <td>
            Yijia Xu, Miaoran Zhang, Kaiping Zhou, Lei Wang
          </td>
          <td>2026-01-01</td>
          <td>Molecular Neurobiology</td>
          <td>0</td>
          <td>0</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/c515ee3e9e86703752ec072206a806bfdf0f76b3" target='_blank'>
              SLAMF1-peptide mediated epigenetic priming reprograms innate immune responses in sepsis
              </a>
            </td>
          <td>
            Sindre Ullmann, Birgitta Ehrnström, Jørgen Stenvik, S. Pinto, Yashwanth Subbannayya, Victor Boyartchuk, I. Mestvedt, Mahamaya Dhaware, Siddhesh S. Kamat, L. Ryan, Hilde Vagle, T. Dahl, B. Halvorsen, J. K. Damås, T. Espevik, Maria Yurchenko
          </td>
          <td>2025-12-29</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>72</td>
        </tr>

        <tr id="Intracerebral hemorrhage (ICH) causes high morbidity and mortality, with neurotoxic inflammation driven by infiltrating monocytes. Therapeutic options remain limited. Here we performed single-cell RNA sequencing and plasma cytokine analysis on peripheral blood samples from ICH patients treated with the immunomodulatory drug BAF312 (Siponimod) or placebo at days 1, 3, and 7 post ICH. In the absence of treatment, the inflammatory response peaked at day 3 post ICH. BAF312 markedly reduced peripheral blood T and B lymphocyte numbers by day 3. BAF312 also impacted the myeloid response, suppressing TNF signaling in classical and non-classical monocytes. Multiple cytokine signaling pathways were decreased, though BAF312 did not impact plasma cytokine or chemokine concentrations. Notably, increased monocyte TNF signaling correlated with better functional outcome, possibly related to the positive role of monocytes during the subacute stage of ICH. These findings suggest that BAF312 suppresses peripheral immune responses after ICH and supports a complex role of monocytes in this disease.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/7f0867e93c74fc54ab8ca6cbb04e883a50d06d0a" target='_blank'>
              Intracerebral hemorrhage induces monocyte TNF signaling that is suppressed by Siponimod (BAF312): a single-cell transcriptomics study in patients
              </a>
            </td>
          <td>
            Jonathan DeLong, Sebastián Díaz-Pérez, K. Sheth, , CJ Malanga, Patricia GM Wagner, Nicole Pezous, Aurelie Hanin, Kyle B. Walsh, , L. Sansing
          </td>
          <td>2026-01-27</td>
          <td>medRxiv</td>
          <td>0</td>
          <td>11</td>
        </tr>

        <tr id="ABSTRACT In the context of COVID-19, macrophages are primarily responsible for sensing and responding to the virus, significantly influencing disease outcomes. They are involved in early pathogen recognition, immune activation, and tissue repair. Heterogeneity and phenotypic plasticity of macrophages are dynamically shaped by microenvironmental cues, including metabolites, hypoxia, and pathogen-derived signals. Notably, emerging evidence underscores that cellular metabolism, particularly in macrophages, dictates immune responses to viral infection. This metabolic-immune crosstalk critically determines COVID-19 severity, ranging from viral clearance to hyperinflammation or fibrosis. In this review, we systematically dissect how cell-intrinsic metabolic nodes and extrinsic factors modulate macrophage effector functions, while illustrating the complications associated with macrophage metabolic dysregulation in SARS-CoV-2 infection. These mechanistic insights provide a rational foundation for therapeutic strategies targeting macrophage metabolism to rebalance immune responses and mitigate COVID-19 complications.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/8a2e1bb8d0dab5824b185f810e0cd5ef78deac45" target='_blank'>
              Metabolic control of macrophages in coronavirus disease 2019
              </a>
            </td>
          <td>
            Li An, Houxi Xu, Qiaoling Fan, Mengjiang Lu, Dongdong Sun
          </td>
          <td>2025-12-23</td>
          <td>Virulence</td>
          <td>0</td>
          <td>10</td>
        </tr>

        <tr id="Introduction Airborne particulate matter (PM), particularly fine (PM2.5) and coarse (PM10) particles, is a major environmental health concern linked to increased respiratory morbidity and mortality. During the COVID-19 pandemic, epidemiological studies suggested that PM exposure may worsen SARS-CoV-2 infection outcomes; however, cellular mechanisms underlying this association remain incompletely understood. Here, we investigated how pre-exposure to PM2.5 and PM10 impacts SARS-CoV-2 infection dynamics in Calu-3 human epithelial cells. Methods Calu-3 cells were pre-exposed to PM for 72 h prior to infection with either the wild-type Wuhan strain or the more virulent Delta variant for additional 48 h. Viral infection, receptor expression, apoptosis and cytokine responses were assessed. Results PM10, but not PM2.5, enhanced Delta variant infection, increasing the proportion of infected cells by 13.7% and viral titers by 2.6-fold compared with controls. This enhancement was not attributable to changes in ACE2 receptor expression or viral entry efficiency but instead impaired antiviral defenses. PM10 pre-exposure suppressed apoptosis and reduced the expression of pro-inflammatory cytokines including IFN-γ, IP-10, and TNF-α during Delta infection. Discussion These findings suggest that PM10 compromise epithelial antiviral response by dampening apoptotic cell clearance and inflammatory responses, thereby creating a cellular condition more permissive to viral replication. Our study provides a mechanistic basis by which particulate air pollution may amplify SARS-CoV-2 pathogenicity in a variant-specific manner. These results underscore further validation in physiologically relevant systems and highlight the potential public health implications of air pollution during viral pandemics.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/ac9a796dc8ff736d95d72734234fedf3e2cf1ff5" target='_blank'>
              Particulate matter exposure potentiates SARS-CoV-2 delta variant infection by suppressing epithelial antiviral responses
              </a>
            </td>
          <td>
            Supasek Kongsomros, Jiraporn Paha, Phayungsap Prasara-a, Sopita Visamol, Pinnakarn Techapichetvanich, Apisada Jiso, Kwanchanok Uppakara, Ardythe L. Morrow, Alexander W. Thorman, S. Chutipongtanate, Phisit Khemawoot, A. Thitithanyanont
          </td>
          <td>2026-01-05</td>
          <td>Frontiers in Cellular and Infection Microbiology</td>
          <td>0</td>
          <td>26</td>
        </tr>

        <tr id="The COVID-19 pandemic has profoundly affected societies around the world. Although the emergency phase of coronavirus disease 2019 (COVID-19) has ended, the threat it poses remains persistent. This review aims to clarify the mechanisms of SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) infection to support effective management of the disease. A central focus is the host cellular response to the viral infection, with particular emphasis on the role of cytokines. Cytokines play a dual role in antiviral defense: they contribute to the inhibition of viral replication and facilitate the clearance of pathogens, yet dysregulated cytokine responses can result in severe immunopathology. Interferons (type I, type II, and type III) and other cytokines are pivotal in activating intracellular antiviral mechanisms and in orchestrating the recruitment of immune cells through extracellular signaling. Effective immune responses to viral infections are governed not only by primary immune cells—such as dendritic cells, T lymphocytes, and B lymphocytes—but also by the local cytokine milieu shaped by infected and neighboring cells. Given the presence of endogenous inhibitors and autoantibodies in vivo, it is essential to evaluate the functional activity of cytokines in clinical samples. We propose a novel approach to quantify biologically active cytokine levels.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/549a84778c011cc8c3e8f33bdfcaf598bd26756a" target='_blank'>
              Host Responses to SARS-CoV-2 with an Emphasis on Cytokines
              </a>
            </td>
          <td>
            Hideki Hayashi, Yoshinao Kubo, Yoshimasa Tanaka
          </td>
          <td>2026-01-01</td>
          <td>International Journal of Molecular Sciences</td>
          <td>0</td>
          <td>2</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/e1ef193e4ddeac0c1d6e0a6d600cf0e2aaf662ba" target='_blank'>
              Systemic administration of PD-L1 blocking antibodies leads to removal of senescent microglia
              </a>
            </td>
          <td>
            Yuliya Androsova, A. Kertser, Hannah Partney, Bar Nathansohn, Angham Ibraheem, Miguel Abellanas, T. Croese, T. Salame, H. Akiva, V. Krizhanovsky, Michal Schwartz
          </td>
          <td>2025-12-24</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>28</td>
        </tr>

        <tr id="RNaseT2-deficient cystic leukoencephalopathy (CLE) presents with severe psychomotor retardation, cystic brain lesions, white matter alterations, and cerebral atrophy. The Rnaset2−/− mouse mirrors key features of this disease and represents the first murine model with a distinct neurological phenotype for type I interferonopathies. Rnaset2−/− mice exhibit activated microglia, perivascular monocyte and CD8 + T cell infiltration, and hippocampal accentuated atrophy. However, the mechanisms linking interferon-driven neuroinflammation to neurodegeneration remain unclear, underscoring the need to clarify which molecular processes contribute to tissue injury in a time-dependent manner. We found a sustained upregulation of interferon-stimulated genes (IRF9, RIG-I) over three to 28 weeks of age in the brains of Rnaset2−/− mice compared to controls. Expression of the chemokines Ccl2, Ccl5, and Cxcl10 peaked early but declined thereafter. Pyroptosis-related markers (ASC, CASP1, GSDMD) were significantly increased already at three to 6 weeks of age and decreased thereafter, whereas apoptotic markers such as Bax, Bad, Bid, CASP3, CASP8, and PARP were not differentially expressed compared to controls. Finally, Cd3e as well as Tnf peaked later (at 17 weeks of age) and declined at 28 weeks. Interestingly, double IHC confirmed the co-localization of the pyroptosis-related marker ASC with the microglia marker IBA-1. Taken together, these findings support the notion that pyroptosis is an early, disease-associated event restricted to microglia that likely contributes to establishing a proinflammatory milieu prior to T cell infiltration and brain atrophy. Targeting pyroptosis could therefore represent a potential strategy to attenuate neurodegeneration in type I interferon–driven neuroinflammatory disorders.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/d58f387f3c18568bd820843e48e0afe54e5f4acc" target='_blank'>
              Unlocking microglia pyroptosis in a model of type I interferon-driven neuroinflammation: lessons from Rnaset2−/− mice
              </a>
            </td>
          <td>
            Kristin Wendland, Milena Irsfeld, Kathrin Schreiber, Katharina Ternka, C. Stadelmann, S. Nessler, Jutta Gärtner, Matthias Kettwig
          </td>
          <td>2025-12-27</td>
          <td>Cell Death & Disease</td>
          <td>0</td>
          <td>9</td>
        </tr>

        <tr id="After antigen encounter, long‐lived antibody‐secreting cells (ASC) secrete high‐affinity circulating antibodies. In addition, memory B cells (MBC) are quickly reactivated upon antigen re‐exposure and predominantly generate shorter‐lived ASCs. Studies have suggested that MBC can differentiate into ASCs without recognizing their cognate antigen, a process known as “bystander activation”. This antigen‐independent reactivation of MBC could help maintain circulating antibody levels, thereby protecting against future infections. To elucidate whether SARS‐CoV‐2 mRNA vaccination leads to bystander activation of B cells, the dynamics of antibody concentrations against six pathogen‐specific antigens not encountered during the sampling period were analyzed over time. Deep profiling of antigen‐specific B cell responses was simultaneously performed using multiparameter high‐dimensional spectral flow cytometry. Antibody concentrations against tetanus toxoid (TT), respiratory syncytial virus (RSV), and influenza hemagglutinin (HA) unexpectedly increased 6 weeks after the first SARS‐CoV‐2 vaccination. Deep profiling of B cell differentiation stages demonstrated a short‐term increase in influenza‐specific IgG+ DN3 B cells, RSV‐specific IgG+ CD11c+ activated B cells, and TT‐specific IgG+ MBC following vaccination. In this study, we demonstrated at both the antibody and cellular levels that SARS‐CoV‐2 mRNA vaccination transiently activates distinct early activated B cell compartments directed against influenza HA, RSV, and TT.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/f900c073d1085623f61904044b055568f8e6e7fd" target='_blank'>
              SARS‐CoV‐2 mRNA Vaccination Leads to Transient Humoral and B Cell Bystander Responses in Adults
              </a>
            </td>
          <td>
            L. Kuijper, L. Kummer, Laura Fernandez Blanco, K. Straten, M. Claireaux, A. Bos, Miranda C Dieker-Meijer, T. Jorritsma, M. Duurland, M. Steenhuis, Juan J. Garcia Vallejo, Koos P. J. Dam, E. Stalman, L. Wieske, S. Tas, L. Boekel, Gert-Jan Wolbink, T. Rispens, T. Kuijpers, F. Eftimov, M. J. Gils, A. ten Brinke, S. M. Ham
          </td>
          <td>2026-01-01</td>
          <td>European Journal of Immunology</td>
          <td>0</td>
          <td>26</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/72ab104798fbb6437548d1ffdd9ac3dcb78c2a1c" target='_blank'>
              Pathological characteristics of SARS-CoV-2 variants and immune responses induced in a COVID-19 macaque model.
              </a>
            </td>
          <td>
            Emiko Urano, T. Okamura, Mahoko Higuchi, Mugi Furukawa, Kayoko Ueda, Satoshi Nagata, Haruhiko Kamada, Yasuhiro Yasutomi
          </td>
          <td>2026-02-13</td>
          <td>Communications biology</td>
          <td>0</td>
          <td>7</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/90da1ee452acf882cacf6295d7c27d08be0bbc43" target='_blank'>
              Joint mechanistic modeling of viral and antibody responses to vaccines in non-human primates to quantify SARS-CoV-2 mechanistic correlates of protection
              </a>
            </td>
          <td>
            M. Alexandre, R. Marlin, Laetitia Bossevot, M. Cavarelli, N. Dereuddre-Bosquet, Francis Relouzat, M. Centlivre, R. Le Grand, R. Thiébaut, Yves Lévy, M. Prague
          </td>
          <td>2026-01-16</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>39</td>
        </tr>

        <tr id="Although the SARS-CoV-2 pandemic no longer poses a global emergency, the virus continues to diversify and acquire immunoevasive properties. Understanding the molecular pathways that shape SARS-CoV-2 pathogenesis has become essential. In this paper, we summarize the most recent current evidence on how the spike protein structurally evolves, on changes in key non-structural proteins, such as nsp14, and on host factors, such as TMPRSS2 and neuropilin-1. These changes, together, shape viral entry, replication fidelity and interferon antagonism. Given the emerging Omicron variants of SARS-CoV-2, recent articles in the literature, cryo-EM analyses, and artificial intelligence-assisted mutational modeling were analyzed to infer and contextualize mutation-driven mechanisms. It is through these changes that the virus adapts and evolves, such as optimizing angiotensin-converting enzyme binding, modifying antigenic surfaces, and accumulating mutations that affect CD8+ T-cell recognition. Multi-omics data studies further support SARS-CoV-2 pathogenesis through convergent evidence linking viral adaptation to host immune and metabolic reprogramming, as occurs in myocarditis, liver injury, and acute kidney injury. By integrating proteomic, transcriptomic, and structural findings, this work presents how the virus persists and dictates disease severity through interferon antagonism (ORF6, ORF9b, and nsp1), adaptive immune evasion, and metabolic rewiring. All these insights underscore the need for next-generation interventions that provide a multidimensional framework for understanding the evolution of SARS-CoV-2 and guiding future antiviral strategies.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/470c3ee53d5264abc99bc0f49675bd9d3f08a23a" target='_blank'>
              Molecular Aspects of Viral Pathogenesis in Emerging SARS-CoV-2 Variants: Evolving Mechanisms of Infection and Host Response
              </a>
            </td>
          <td>
            Sofia Teodora Muntean, A. Cozac-Szőke, A. Tinca, Irina-Bianca Kosovski, Silviu Vultur, Mara Vultur, O. Cotoi, Anca-Ileana Sin
          </td>
          <td>2026-01-01</td>
          <td>International Journal of Molecular Sciences</td>
          <td>0</td>
          <td>6</td>
        </tr>

        <tr id="ABSTRACT Mammalian orthoreovirus (reovirus) is a well-established model for studying viral pathogenesis. Although studies of reovirus have largely been focused on central nervous system disease, reoviruses can also cause myocarditis. Reovirus strain type 1 Lang (T1L) causes mild myocarditis in neonatal mice. However, many highly myocarditic reoviruses are reassortants between T1L and the serotype 3 (T3) Dearing strain that is non-myocarditic. Although cardiac immune responses to T1L are well described, many open questions remain regarding cardiac immune responses to T3 reoviruses. To better understand the effects of T3 reoviruses on the heart, we investigated the long-term cardiac impact of reovirus strain T3 Dearing (T3D) in neonatal C57BL/6 mice. Oral infection with T3D resulted in subclinical myocarditis that was non-lethal but still produced persistent histological myocardial alterations. Echocardiographic analysis revealed a mild decrease in diastolic left ventricular anterior wall thickness in mice infected with 10⁴ PFU, though no consistent dose-dependent functional impairments were observed. Histological examination identified myocardial lesions characterized as replacement fibrosis that developed independently of the inoculating dose. Flow cytometry showed an early immune response at 8 days post-infection, with increased CD4 T cells, CD8 T cells, B cells, and innate immune cells. By 26 days post-infection, the inflammation had largely resolved, but low-level immune infiltration persisted, characterized by CD4 T cells, CD8 T cells, and B cells. These findings suggest that T3D induces subclinical myocarditis with lasting histopathological changes. The presence of fibrosis raises concerns about potential long-term cardiac effects, emphasizing the need for further research into the myocardial impact of non-myocarditic reoviruses. IMPORTANCE Viral infections that cause myocarditis are a significant cause of morbidity and mortality worldwide, particularly in children and young adults. Mammalian orthoreoviruses (reoviruses) are an established model for studying viral myocarditis in mice and are also under development as a cancer therapeutic due to their capacity to kill cancer cells. Here, we describe the long-term myocardial effects of the type 3 Dearing (T3D) reovirus strain, which is classically considered neurotropic. Our findings indicate that T3D causes subclinical myocarditis that is non-lethal but produces histopathological changes indicative of fibrosis. Thus, although T3D does not cause overt acute cardiac pathology, it can have long-term effects on the myocardium. This work will inform future studies on reovirus tropism and is relevant to ongoing efforts to harness the oncolytic properties of reoviruses for therapeutic applications. Viral infections that cause myocarditis are a significant cause of morbidity and mortality worldwide, particularly in children and young adults. Mammalian orthoreoviruses (reoviruses) are an established model for studying viral myocarditis in mice and are also under development as a cancer therapeutic due to their capacity to kill cancer cells. Here, we describe the long-term myocardial effects of the type 3 Dearing (T3D) reovirus strain, which is classically considered neurotropic. Our findings indicate that T3D causes subclinical myocarditis that is non-lethal but produces histopathological changes indicative of fibrosis. Thus, although T3D does not cause overt acute cardiac pathology, it can have long-term effects on the myocardium. This work will inform future studies on reovirus tropism and is relevant to ongoing efforts to harness the oncolytic properties of reoviruses for therapeutic applications.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/3a7e2e6f61f6ab53bbd91550c332e91a9d6a4555" target='_blank'>
              Long-term effects of reovirus strain T3D on the myocardium
              </a>
            </td>
          <td>
            Maryam Ebadi Fard Azar, M. D. Zita, Kshipra S. Keole, S. Rousseau, Charles Cohen, Dao-Fu Dai, K. Boehme, L. Adamo
          </td>
          <td>2026-01-09</td>
          <td>Microbiology Spectrum</td>
          <td>0</td>
          <td>19</td>
        </tr>

        <tr id="Neutrophils have been reported to have protective and detrimental functions in viral infections. However, the role of neutrophils remains unexplored in Japanese encephalitis virus (JEV) infection. In this study, we elucidated the dynamics of neutrophils and their influence on immune cell recruitment in subclinical and severe encephalitis in mouse models. Further, we depleted neutrophils from 3–4 week-old C57BL/6 mice using mAb1A8 (anti-Ly6G) antibody and studied their association with inflammation, viral replication, immune cell infiltration and disease outcome. We observed that an increase in JEV replication is associated with increased infiltration of neutrophils in the spleen and brain. Further studies confirmed that depletion of neutrophils at an early stage of JEV infection reduced CD8 abundance in the infected brain and accelerated death in mice. We also observed that inhibition of the CXCL12-CXCR4 signalling axis by antagonist AMD3100 reduced CD8 abundance in the brain and augmented inflammasome activation, leading to fatal encephalitis. Reduced CXCR4 levels in the spleen and blood of CD8+T cells correlated with enhanced Granzyme B level, indicating CD8 cells differentiated more into effector phenotypes in neutrophil-depleted mice. Furthermore, CD8 depletion delayed the death of mice infected with a sublethal strain compared to neutrophil-depleted mice, suggesting that neutrophils play a vital role in the early restriction of viral replication, whereas CD8 is essential later in clearing the virus. Taken together, our study sheds new light on the role of neutrophils in the pathogenic mechanisms of JEV encephalitis and highlights the importance of neutrophils and CD8 cells associated with disease outcomes.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/00211782be429017f9a0d2eb2b4ef8d277862b82" target='_blank'>
              Neutrophil depletion at the early stage of Japanese encephalitis virus infection affects CD8+ T cell infiltration into the mouse brain and causes severe encephalitis
              </a>
            </td>
          <td>
            Prasanjit Rohit Soni, B. Kusuma, Arup Banerjee, Jacques Robert, Kai Hu
          </td>
          <td>2026-01-21</td>
          <td>Frontiers in Immunology</td>
          <td>0</td>
          <td>1</td>
        </tr>

        <tr id="Myocardial and vascular injury secondary to SARS-CoV-2 infection and vaccination has emerged as a clinically relevant phenomenon, with distinct but overlapping mechanisms. Myocardial injury in COVID-19 results from a complex interplay between direct viral effects and immune-mediated inflammation, supported by histopathological studies revealing macrophage-rich infiltrates, microthrombosis, and supporting fibrosis in isolated areas. In contrast, vaccine-associated myocarditis—reported predominantly following mRNA vaccines—has a self-limiting clinical course, with mechanisms likely involving molecular mimicry, aberrant immune activation, or hypersensitivity reactions, although these pathways require further validation. Although mRNA vaccines have been associated with a small increase in myocarditis, particularly in young men, the risk is significantly lower than that associated with COVID-19 infection, and the cardiovascular benefits of vaccination far outweigh these rare adverse events in most populations. After the end of the pandemic, the number of patients with severe forms of COVID-19 has decreased significantly, but we consider that cardiac involvement remains an important issue for the acute and long-term prognosis of patients with SARS-CoV-2 infection. Our paper synthesizes the latest epidemiological and mechanistic evidence on the link between COVID-19, vaccination, and myocardial and/or vascular injuries, highlighting the clinical implications and providing practical recommendations for management, as well as future perspectives on risk assessment, targeted immunotherapy, advanced diagnostic tools, and long-term monitoring.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/776712cb4e74a115d1e34468ecd6a6cb67b1f2a3" target='_blank'>
              Myocardial and Vascular Involvement in COVID-19 and Post-Vaccination States: Understanding Injury Pathways and Clinical Implications
              </a>
            </td>
          <td>
            R. Siliște, S. Benea, Corina Homentcovschi, Teodora Deaconu, Constantin Căruntu, I. Savulescu-Fiedler
          </td>
          <td>2026-02-04</td>
          <td>Life</td>
          <td>0</td>
          <td>12</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/1babe6054c4059128d610e6cfbc8906c8e8c1b18" target='_blank'>
              IFNγ-Driven Inflammatory Responses in the Nasal Mucosa Drive Influenza Virus Shedding and Transmission
              </a>
            </td>
          <td>
            Stacey Bartlett, Hedy L. Rocha, Leon L. Hsieh, Stephen T. Yeung, Chan Wang, Grace O. Ciabattoni, Cynthia A. Loomis, Huilin Li, B. tenOever, M. Ortigoza
          </td>
          <td>2026-01-07</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>64</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/077d61a2f5398bd9d9325e4f8f0c44e0a25878aa" target='_blank'>
              Flu Virus Infection in Juvenile Mice Leads to Lifelong Multi-Organ Damage and Parkinsonian Pathological Changes in Aging
              </a>
            </td>
          <td>
            Ruina You, Cuicui Liu, Xun Liu, Xinglian Wang, Zhuoya Xu, Qian Huang, Guolin Dong, Chaoqun Liang, Na Wang, Zhichao Miao, Taijiao Jiang, Dayan Wang, Lei Deng, Yousong Peng
          </td>
          <td>2025-12-25</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>3</td>
        </tr>

        <tr id="Long COVID (LC) is a multisystem, post-infectious conditions diagnosed ≥3 months after acute SARS-CoV-2 infection and marked by relapsing, persistent, or progressive symptoms, especially fatigue, post-exertional symptom exacerbation and neuropsychiatric syndromes. We synthesized evidence suggesting that LC arises from intersecting pathways including viral persistence, intestinal dysbiosis and barrier compromise with microbial translocation, innate immune activation with neutrophil extracellular traps (NET) and thromboinflammation, and immune dysregulation with features of exhaustion and autoimmunity. These processes adversely impact blood-brain barrier (BBB) function and lead to neuroinflammation. We propose a mechanistic model in which viral antigens and translocated microbial products amplify pro-inflammatory networks promoting immunothrombosis and tissue hypoperfusion. Hematogenous and gut-brain pathways may then deliver inflammatory mediators to the central nervous system (CNS), resulting in BBB disruption and glial activation that underpin nervous system disorders in LC. Treatment regimens aimed at lowering antigen load, restoring mucosal barrier integrity and modulating myeloid/coagulation pathways may warrant investigation as novel therapeutic strategies to treat LC.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/ceb2aaf0ce2883d4089bc9aa0d5a8d1565fe9dfa" target='_blank'>
              Intestinal barrier compromise, viral persistence, and immune dysregulation converge on neurological sequelae in Long COVID
              </a>
            </td>
          <td>
            Laurence Leclerc, Johanne Poudrier, Christopher Power, Grace Y. Lam, E. L. Falcone
          </td>
          <td>2026-01-20</td>
          <td>Frontiers in Aging Neuroscience</td>
          <td>0</td>
          <td>6</td>
        </tr>

        <tr id="Microglia, the primary immune cells of the brain, orchestrate immune responses to both external and internal stimuli in health and disease. Although several cell culture methods exist to model microglia in vitro, isolating loosely adherent microglia from primary murine mixed glial cultures remains valuable for recapitulating in vivo cell states from complex transgenic lines at relatively low cost. However, these methods are constrained by limited temporal control and scalability. To address these challenges, we established a protocol for generating microglia from frozen mixed glial cultures. While freezing introduced measurable differences in microglial morphology and lipid droplet content, microglia derived from frozen cultures responded to environmental stimuli (high glucose and LPS) in the same way as those from fresh cultures. Thus, while frozen primary microglia exhibit similar functional responses, maintaining consistency in using fresh or frozen cells within a given experiment is strongly recommended. Motivation Although our understanding of microglia’s role in brain development and disease continues to grow, a standardized in vitro model of primary mouse microglia remains absent in the field. Primary cell culture systems are essential for studying microglia, enabling the empirical assessment of gene function in transgenic models and testing novel interventions before committing to time- and cost-intensive in vivo studies. However, mixed glial culture-derived primary microglia (pMG) systems are constrained by the timing of animal availability and have limited scalability. In this study, we sought to establish a protocol for freezing and subsequently reviving primary mixed glial cultures from which responsive pMG could be isolated for downstream analysis. We validated this approach by quantifying microglia responses to distinct environmental stimuli before and after a freeze-thaw cycle. Research topics CP: Cell biology Graphical Abstract">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/599f014c864763319d1af92f023cb734c54c3f41" target='_blank'>
              A validated method for banking mixed glial cultures that yield responsive microglia
              </a>
            </td>
          <td>
            Annalise M. Sturno, James E. Hassell, Katelyn M. Baker, Garrett J. Potter, Kimberley D. Bruce
          </td>
          <td>2025-12-20</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>6</td>
        </tr>

        <tr id="ABSTRACT Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of coronavirus disease 2019 (COVID-19), remains a major public health threat, particularly in vulnerable populations. SARS-CoV-2 spike proteins interact with the human angiotensin-converting enzyme 2 (ACE2) receptor, together with accessory molecules that facilitate viral entry, through its spike receptor-binding domain (RBD). Although ACE2 is the primary receptor required for viral replication, its expression patterns do not fully correlate with viral distribution or tissue pathology. Moreover, SARS-CoV-2 has been shown to infect cells and tissues lacking detectable ACE2 expression. Viral entry via ACE2-independent pathways may also confer resistance to some monoclonal antibodies (Abs) targeting the spike RBD that block ACE2-mediated binding. These observations highlight the potential significance of ACE2-independent entry factors in SARS-CoV-2 infection, particularly in vaccinated individuals with Abs directed against ACE2-dependent viral entry. In this review, we discuss the emerging roles of ACE2-independent entry factors in SARS-CoV-2 infection and the immune responses. These factors include CD147, AXL, CD169/Siglec-1, CD209L, CD209, CLEC4G, ASGR1, LDLRAD3, TMEM30A, TMEM106B, transferrin receptor 1, GPR78, integrin α5β1, KREMEN1, LFA-1, and CD4. While ACE2 remains central to viral replication, ACE2-independent entry appears sufficient to elicit immune responses. Therefore, future investigations are warranted to elucidate the roles of ACE2-independent mechanisms in immune-mediated pathology and viral evolution, independent of immune pressure targeting ACE2-mediated entry in previously infected or vaccinated individuals.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/416f126df60ac30115fcfb6b97329efa70fd8c23" target='_blank'>
              ACE2-independent entry factors for SARS-CoV-2 infection and immune activation
              </a>
            </td>
          <td>
            Yiyu Sun, L. Wong, Theresa L. Chang
          </td>
          <td>2025-12-22</td>
          <td>mBio</td>
          <td>0</td>
          <td>17</td>
        </tr>

        <tr id="Exaggerated immune responses to respiratory viruses may contribute to increased morbidity in older adults. To investigate virus-specific immune activation in this population, we developed an ex vivo whole blood stimulation model using samples from 30 healthy individuals aged ≥65 years. Whole blood was stimulated with UV-inactivated influenza A virus (IAV), respiratory syncytial virus (RSV), and SARS-CoV-2, and the expression of 22 immune-related genes was assessed by quantitative RT-PCR array. All three viruses elicited responses with marked variability across individuals, as well as differences in the magnitude and distribution of cytokine expression across stimuli. RSV stimulation was associated with relatively higher expression of inflammatory mediators, while IAV and SARS-CoV-2 induced greater expression of Type I interferon. SARS-CoV-2 also led to an increased expression of regulatory cytokines. Although individual responses varied, correlation analysis indicated coordinated gene expression within functional categories, and Uniform Manifold Approximation and Projection (UMAP) showed distinct grouping of cytokine responses by virus and function. These findings describe differential immune mRNA expression profiles in response to viral stimuli in older adults and may support future studies aimed at understanding age-related differences in host–virus interactions.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/186205a878f8f030c29402ed3fafa2c9c330cedb" target='_blank'>
              Distinct Cytokine Landscapes Induced by Influenza a Virus, RSV, and SARS-CoV-2 in Older Adults (65+) Using an Ex Vivo Whole Blood Stimulation Model
              </a>
            </td>
          <td>
            A. Palmieri, I. Schiavoni, Eleonora Olivetta, P. Leone, Alessandra Fallucca, Anita Muglia, A. Carfì, A. di Paola, G. Onder, Giorgio Fedele
          </td>
          <td>2026-01-27</td>
          <td>Pathogens</td>
          <td>0</td>
          <td>26</td>
        </tr>

        <tr id="COVID-19 patients experience dynamic changes in immune and cellular function over time, similar to that in sepsis. However, there is insufficient research investigating, at the gene expression level, the mechanisms that become activated or suppressed over time as patients deteriorate or recover. This has potential prognostic and therapeutic implications. In this longitudinal study, 300 whole blood samples were analyzed from 128 adult patients throughout their COVID-19 hospitalization. Transcriptome sequencing (RNA-Seq), differential gene expression analysis, pathway enrichment, and drug-gene set enrichment analysis were performed to elucidate key mechanisms for therapeutic targeting during six distinct disease phases through the COVID-19 trajectory. Adaptive immune dysfunction, inflammation, and metabolic dysregulation were most pronounced during phases with higher disease severity. Hemostatic dysregulation was present early and persisted throughout the disease course, in contrast to an early antiviral response and late heme metabolism activity. Drug-gene set enrichment analysis predicted repurposed medications for potential use, including platelet inhibitors, antidiabetic medications, and dasatinib. Disease phases had distinct transcriptional signatures and were highly correlated to previously developed sepsis endotypes, indicating that severity and disease timing were significant contributors to heterogeneity observed in COVID-19 sepsis. These findings provide an opportunity for better prognostication of patients and potential time-dependent personalized treatments.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/730bda77c6f77da1330b66ac6126520d39d7c77d" target='_blank'>
              Longitudinal gene expression analysis in COVID-19 sepsis highlights dynamic immune, cellular, and metabolic dysfunction in high severity patients
              </a>
            </td>
          <td>
            Andy An, Arjun Baghela, Peter Zhang, Travis M. Blimkie, Jeff Gauthier, Daniel E Kaufmann, E. Acton, Amy H. Lee, Roger C. Levesque, Robert E. W. Hancock
          </td>
          <td>2025-12-19</td>
          <td>Scientific Reports</td>
          <td>0</td>
          <td>10</td>
        </tr>

        <tr id="The coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), continues to pose major health challenges despite effective vaccination efforts. The sustained occurrence of breakthrough infections and emerging variants of the virus highlights the need for additional therapeutic strategies. Given the anti-inflammatory role of the cannabinoid type 2 receptor (CB2R), we examined the effect of CB2R activation in SARS-CoV-2 spike protein subunit 1 (S1SP)-induced acute lung injury (ALI). ALI was induced in mice by intratracheal (i.t.) administration of S1SP, followed by treatment with the CB2R agonist HU308 (5 mg/kg, intraperitoneal: i.p.) 1 h post-S1SP and every 24 h thereafter. Lung function, bronchoalveolar lavage fluid (BALF) parameters, cytokine levels, and inflammatory signaling were assessed at 48 h following S1SP exposure. HU308 treatment significantly reduced S1SP-induced pulmonary dysfunction, immune cell infiltration, neutrophil activation, and proinflammatory cytokine production, while suppressing NF-κB and STAT3 activation. HU308 treatment restored the Nrf2 expression in the lung. CB2R activation ameliorates S1SP-induced lung inflammation and injury, suggesting its therapeutic potential against COVID-19-related ALI.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/a0c5aa6ea8b394f52a5f3db4df016d987190f9c3" target='_blank'>
              HU308, A Selective Cannabinoid Type-2 Receptor Agonist, Mitigates SARS-CoV-2 Spike Protein–Induced Acute Lung Injury in Mice
              </a>
            </td>
          <td>
            J. Lockett, G. Nicholson, Nicholas Richards, Ryan Washington, N. Nagre
          </td>
          <td>2026-02-09</td>
          <td>Lung</td>
          <td>0</td>
          <td>2</td>
        </tr>

        <tr id="Critical illness often leads to the development of intestinal dysbiosis, which can have a significant impact on disease outcome. Intestinal barrier dysfunction is a common problem in intensive care unit patients, particularly those with sepsis. Despite its importance, early and reliable diagnosis of barrier dysfunction and evaluation of therapeutic options remain lacking in clinical practice. Given that intestinal hyperpermeability is associated with increased translocation of luminal antigens and subsequent priming of naïve T cells, we hypothesized that analysis of circulating peripheral antigen-reactive T cells could provide insight into the functionality of the intestinal barrier. To test this hypothesis, 70 ICU patients were enrolled, including those with sepsis, those not meeting sepsis criteria, and COVID-19 patients, as well as 20 healthy volunteers. We identified a sepsis-specific T-helper cell signature in peripheral blood using the antigen-reactive T-cell enrichment (ARTE) technique followed by flow cytometric analysis. This signature was characterized by an expansion of gut trophic Bifidobacterium longum-reactive T-helper cells, indicating significant intestinal barrier dysfunction during sepsis. This approach allows the study of intestinal barrier functionality and provides a means to monitor the effects of potential therapeutic interventions over time using blood samples.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/43bca2de8a56fce85ec0fb9fafcd995828afcdf9" target='_blank'>
              “Bifidobacterium longum-reactive T helper cells as marker for intestinal barrier impairment in ICU patients with sepsis”
              </a>
            </td>
          <td>
            Lea-Maxie Haag, Markus Müller, J. Ziegler, M. Lehmann, Julia Hecker, R. Glauben, M. Heimesaat, Friederike Compton, B. Siegmund
          </td>
          <td>2025-12-24</td>
          <td>Gut Pathogens</td>
          <td>0</td>
          <td>53</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/267292fcda51fe6aa716329edd7ebaab70e35171" target='_blank'>
              Structural mimics of SARS-CoV-2.
              </a>
            </td>
          <td>
            Natasha Killassy, Patrick Arbuthnot, M. B. Maepa
          </td>
          <td>2026-01-22</td>
          <td>Infection</td>
          <td>0</td>
          <td>8</td>
        </tr>

        <tr id="The Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is characterized by profound immune dysregulation where interleukins play a central role in determining disease severity and response to interventions. This review summarizes the role of interleukins in the immunopathogenesis of COVID-19, with particular emphasis on differences observed across major SARS-CoV-2 variants. Pro-inflammatory interleukins like IL-1β, IL-6, IL-2, IL-17 and IL-18 are critically involved in cytokine storm, hyperinflammation, and acute respiratory distress syndrome, whereas anti-inflammatory cytokines like IL-10 contribute to immune regulation and resolution of inflammation. Elevated levels of IL-1α, IL-1β, IL-4, IL-8, IL-9, IL-16, IL-18 have been documented in the Delta variant as compared with the Omicron variant, with IL-6 being the most frequent interleukin reported to be increased across all SARS-CoV-2 variants relative to the ancestral Wuhan strain. Elevated IL-2, IL-4, IL-6, and IL-10 levels have been associated with Omicron sub-variants. The review encompasses interleukin-based therapeutic strategies, where several IL-1 and IL-6 inhibitors were studied across clinical trials, but only tocilizumab has shown some promise against severe COVID-19. IL-2, IL-6, IL-15 and IL-21 levels were positively correlated with IgG and neutralizing antibody activity after vaccination with longevity of post-vaccination immunity being determined by IL-2 and IL-7.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/2c954fc0069a67c9a88349d51dbdf125e173004d" target='_blank'>
              Interleukins in COVID-19 and SARS-CoV-2 Variants: Immunopathogenesis, Therapeutic Perspectives and Vaccine-Induced Immune Responses
              </a>
            </td>
          <td>
            Supriya Mahajan, Saurabh Mahajan, Akanksha Gusain
          </td>
          <td>2026-01-30</td>
          <td>International Journal of Molecular Sciences</td>
          <td>0</td>
          <td>1</td>
        </tr>

        <tr id="Simple Summary In addition to their primary role in oxygen transport, chicken erythroid cells have been shown to participate in immune responses. This study utilized advanced single-cell analysis alongside bulk RNA sequencing to explore the immune mechanisms of erythroid cells in chicks infected with avian pathogenic Escherichia coli (APEC). Through integrated multi-omics analysis, we identified immune-related genes and signaling pathways associated with antiviral defense. Preliminary single-cell analysis revealed heterogeneity within the erythroid cell population, unveiling four erythrocyte subtypes that exhibited significant quantitative changes following APEC infection, as well as key transcription factors potentially involved in pathogen defense. This research represents the first systematic characterization of the immune landscape of chick erythroid cells during infection, enhancing our understanding of avian immune mechanisms and providing a theoretical foundation for the development of novel disease-resistance strategies in poultry, thereby contributing to sustainable poultry production.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/ae761515b67cb163bbaf791f10075e94c68c7428" target='_blank'>
              Integrated Single-Cell and Bulk Transcriptomics Unveils Immune Profiles in Chick Erythroid Cells upon Avian Pathogenic Escherichia coli Infection
              </a>
            </td>
          <td>
            Fujuan Cai, Xianjue Wang, Chunzhi Wang, Yuzhen Wang, Wenguang Zhang
          </td>
          <td>2026-01-01</td>
          <td>Animals : an Open Access Journal from MDPI</td>
          <td>0</td>
          <td>3</td>
        </tr>

        <tr id="

 Multisystem inflammatory syndrome in children (MIS-C) is a severe condition that arises 4–6 weeks after SARS-CoV-2 exposure, marked by persistent fever, mucocutaneous symptoms, cardiac involvement, and shock. Natural killer (NK) cells are thought to contribute during the acute phase due to their antiviral and immunoregulatory roles, but their phenotype during recovery is not well defined. An expansion of TCR Vβ21.3+ T cells has been observed during acute MIS-C, though their long-term presence and significance remain unclear.



 Peripheral blood mononuclear cells (PBMCs) were collected from 4 healthy pediatric controls, 4 febrile (non-COVID) controls, 4 children with acute COVID-19, 9 with acute MIS-C, 8 MIS-C convalescents (6–12 months), and 6 long-term MIS-C convalescents (4 years). TCR Vβ21.3 expression was analyzed using a T cell panel (CD3, CD4, CD8, CD27, CD45RA, TCR Vβ21.3). NK cell phenotype was assessed after co-culture with K562 cells using markers including CD56, CD3, CD16, CXCR6, Ki67, NKG2D, NKG2C, and CD158.



 NK cells from acute MIS-C patients showed decreased CD57, CD158, and CD107a, along with increased NKG2D expression. Clustering analysis revealed a unique NK cell population exclusive to acute MIS-C, defined by absent CD107a and elevated CXCR6 and Ki67. Most alterations resolved within 6–12 months, except CD158, which remained low even after 4 years. TCR Vβ21.3+ T cells persisted for up to a year but were undetectable at 4 years.



 MIS-C triggers a transient NK phenotype marked by reduced cytotoxicity and increased activation, suggesting a hyperactivated or dysregulated immune profile. Persistent downregulation of the inhibitory receptor CD158 may indicate prolonged NK activation. TCR Vβ21.3+ T cells appear to be short lived. Further long-term studies with larger cohorts are needed to validate these findings.
">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/1c63e6c5c161a67863c64ce2aea0e118e09c3073" target='_blank'>
              Tracking NK and Memory T Cell Dynamics in Children Affected by Multisystem Inflammatory Syndrome (MIS-C)
              </a>
            </td>
          <td>
            Natalia González, Camila Astudillo, Yazmin Espinosa, Paz Cerda-Castro, Juan Pablo Araya, Grace Ayleen Silva, Martín Felipe Hernández, M. C. Poli, Emma Rey-Jurado
          </td>
          <td>2025-12-22</td>
          <td>Journal of Human Immunity</td>
          <td>0</td>
          <td>16</td>
        </tr>

        <tr id="The coronavirus disease 2019 (COVID-19) pandemic triggered by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has had a profound impact on global public health. The complexity of its pathogenic mechanisms and host interactions urgently requires high-fidelity animal models to support research. Humanized mouse models break the species barrier through gene editing and immune reconstitution technologies, providing a key tool to simulate human infection characteristics and pathological processes. A number of studies have reported the application of humanized mouse models in the fields of COVID-19 research, such as SARS-CoV-2 pathogenesis, anti-SARS-CoV-2 drug discovery and vaccine development, etc. The present review aimed to systematically document the latest advances in the application of humanized mouse models based on different construction strategies, such as receptor humanization, immune system humanization and composite humanization. These models have not only elucidated the pathogenicity differences and immune escape mechanisms of SARS-CoV-2 variants, but have also validated the efficacy of broad-spectrum anti-SARS-CoV-2 strategies, including angiotensin-converting enzyme 2-targeted therapies, antibody cocktail regimens and mucosal vaccines. Additionally, humanized mouse models have played a pivotal role in investigating the mechanisms underlying long COVID. By revealing the multi-system pathogenic mechanisms of pulmonary fibrosis, neurodegeneration and intestinal microbiota dysregulation, these models provide a theoretical foundation for the development of targeted intervention strategies.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/399fe2d5446f40067840cb324855582d1f670591" target='_blank'>
              Application of the humanized mouse model in research into SARS-CoV-2 infection (Review)
              </a>
            </td>
          <td>
            Xiaoyue Feng, Yadong Wang, Yuan Li, J. Long, Fang Liu, Haiyan Yang
          </td>
          <td>2025-12-29</td>
          <td>Medicine International</td>
          <td>0</td>
          <td>10</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/fad6a532c1ed287e6275dfd3c8ad86bdd9cf7997" target='_blank'>
              High-throughput epitope screening of the Human Cytomegalovirus immediate early protein 2 identifies promising antigenic T cell targets
              </a>
            </td>
          <td>
            Eleni Panagioti, M. Welters, Ramon Arens, S. H. van der Burg
          </td>
          <td>2026-01-26</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>83</td>
        </tr>

        <tr id="Backgrounds Asthma is a chronic inflammatory disease affecting airways, usually starting in childhood. Its cause remains unclear. Objective We aim to elucidate the role of immune dysregulation in the pathogenesis of pediatric asthma. Methods In this study, we used single-cell RNA sequencing to analyze peripheral blood mononuclear cells (PBMCs) from three pediatric asthma patients and four age-matched healthy controls to investigate the cellular etiology of childhood asthma. Results The overall expression patterns of PBMCs from the three asthma patients indicate that both innate and adaptive immunity are imbalanced and abnormally activated in childhood asthma. Analysis of hematopoietic stem and progenitor cells (HSPCs) expression profiles further reveals that HSPCs from asthma patients tend to express immunity-related genes earlier. The cell developmental trajectories observed in asthma patients show an abnormal immune cell development pattern. Dysregulated lymphoid lineage development is observed in all three patients but there is no identical abnormal pattern for each patient. Pseudo-time analysis of gene expression demonstrates that JUN, a gene controlling cell cycle progression, is repressed in asthma patients while SPI1, an essential gene for lymphoid lineage development along with six inflammatory response related genes (S100A8, S100A9, S100A12, IL7R, IL32, and CCL5), exhibit various aberrant expression trajectories in asthmatic individuals. S100A8, S100A9, S100A12, and RETN are universally upregulated in various cell types of asthma patients. The analyses of cell-cell communication further elucidate the contributory roles of dendritic cells and CD14+ monocytes in the development and heterogeneity of asthma, as they exhibit increased reception and transmission of annexin and resistin signals in the asthma group. The resistin protein-protein interaction network analysis further suggests that SQSTM1, HSPA5 and A2M might serve as the potential therapeutic targets in childhood asthma. Conclusions Our scRNA-Seq analyses unveil childhood asthma as a complex disease with immune-related heterogenicities, characterized by dysregulated lymphoid cell development, a common feature that may offer a novel research direction for comprehensively understanding the key molecular mechanisms underlying childhood asthma.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/7ac839354a116b4d2e6b2ef7d374214851cf6652" target='_blank'>
              Single-cell RNA sequencing unraveled immune-related expression heterogeneity and lymphoid cell development dysregulation in childhood asthma
              </a>
            </td>
          <td>
            Danying Zhu, Guang Li, Lang Yuan, Zeyu Zeng, Na Dong, Chao Wang, Ming Chen, Lijian Xie, Guohui Ding, Libing Shen, Xiaoyan Dong
          </td>
          <td>2026-01-02</td>
          <td>Frontiers in Immunology</td>
          <td>0</td>
          <td>3</td>
        </tr>

        <tr id="Influenza is an acute respiratory infectious disease caused by the influenza virus, which has been circulating in humans for over a century. In contrast, COVID-19, caused by the novel SARS-CoV-2, emerged recently in December 2019. Following nearly four years of pandemic, the acute phase of SARS-CoV-2 has transitioned towards an endemic state, suggesting a trend of long-term coexistence with humans. Concurrent or sequential coinfection with influenza and SARS-CoV-2 has been clinically observed to exacerbate pulmonary pathology and systemic inflammation in affected individuals. This review discusses the impact and elucidates the potential underlying mechanisms by which influenza and SARS-CoV-2 coinfection aggravates local lung injury and systemic host responses, aiming to inform improved prevention and clinical management strategies.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/2322642c46c964d010a337ffc642b56652fa15cc" target='_blank'>
              Local and systemic host responses to influenza and concurrent or sequential SARS-CoV-2 infection
              </a>
            </td>
          <td>
            Tong Zhu, Liying Wang, Chaoying Yan
          </td>
          <td>2026-01-21</td>
          <td>Frontiers in Cellular and Infection Microbiology</td>
          <td>0</td>
          <td>1</td>
        </tr>

        <tr id="Neuroinflammation, a key contributor to neurodegenerative diseases, results from excessive microglial activation. Microglia that respond to pathogenic molecules switch to the M1 type and secrete various immune cytokines, which can cause neuronal damage. Therefore, our study focused on molecules that can enhance the neuroprotective role of microglia and reduce neuronal damage. The adipocyte enhancer-binding protein 1 (AEBP1) gene is known for its role in regulating immune responses in macrophages. However, its role in neuroinflammation has not been fully explored. Therefore, we investigated the role of AEBP1 in microglial cells activated by lipopolysaccharide (LPS). First, we confirmed that AEBP1 is expressed in LPS-activated microglia and demonstrated that downregulation of AEBP1 using shRNA in activated microglia reduced the immune response via the nuclear factor-kappa-B (NFκB) pathway. These results promote a shift toward neuroprotective M2 microglia, thereby reducing neuronal damage. Next, we confirmed that the expression of AEBP1 was elevated in the brains of Alzheimer’s disease (AD) mice. Additionally, animal experiments to assess the therapeutic effects of AEBP1 showed that microglia gathered around amyloid beta (Aβ) and reduced its size. Taken together, our results provide the first evidence that AEBP1 can reduce inflammatory activity in microglia, suggesting its potential as a target molecule for immunotherapy.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/27a7166b217c32d7c41238f619a588f55a76b7d7" target='_blank'>
              Targeting Adipocyte Enhancer-Binding Protein 1 to Induce Microglial Phenotype Shift for Immunotherapy in Alzheimer’s Disease
              </a>
            </td>
          <td>
            Eun-Ji Kim, Byeong-Hyeon Kim, Ye-Bin Mun, Minho Moon, Pyung-Hwan Kim
          </td>
          <td>2025-12-27</td>
          <td>International Journal of Molecular Sciences</td>
          <td>0</td>
          <td>5</td>
        </tr>

        <tr id="Microglia are the main innate immune cells residing in the brain parenchyma. Their activation and resulting neuroinflammation have emerged as major pathogenic mechanisms in neurodegenerative disorders, particularly in Alzheimer's disease (AD). The accumulation of amyloid‐β oligomers (AβOs) and microglia activation play crucial roles in the pathogenesis of AD. In a second vein, the development of innate immune memory in response to different stimuli is a vital mechanism that enables microglia to adjust their response to subsequent inflammatory challenges. While there is increasing evidence that repeated bouts of peripheral inflammation lead to training or tolerance in microglia, the impact of tolerance on the inflammatory response induced by AβOs remains to be determined. In this study, we investigated whether lipopolysaccharide (LPS)‐induced tolerance affects microglial responses to AβOs. For that, organotypic hippocampal cultures were repeatedly challenged with LPS before being exposed to AβOs. We measured cytokine levels and evaluated changes in microglial activation and morphology following exposure of cultures to AβOs. A significant decrease in cytokine production was observed when hippocampal slice cultures were repeatedly challenged with LPS. Interestingly, microglial activation and the resulting inflammatory response induced by AβOs were prevented when these cultures had been previously challenged with LPS. Moreover, the changes in microglial morphology and cytokine production resulting from repeated LPS stimulation were associated with reduced activation of nuclear factor kappa B (NF‐κB). These results indicate that preconditioning microglia with LPS induces a physiological immune tolerance response rather than pathological inflammation, which may have implications for developing therapeutic strategies for AD aimed at modulating innate immune memory.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/f30b28f24e182dd29b261967df3617b845598fe7" target='_blank'>
              Innate Immune Tolerance Regulates Microglia Response to Aβ Oligomers
              </a>
            </td>
          <td>
            Rafaela Rodrigues Valerio, Áquila Rodrigues Costa Santos, Ana Helena Larangeira Nóbrega, Raquel Martins, F. D. De Felice, Sérgio T. Ferreira, Wilson Savino, Adriana Bonomo, Andressa Bernardi, R. Frozza
          </td>
          <td>2026-01-01</td>
          <td>Journal of Neurochemistry</td>
          <td>0</td>
          <td>58</td>
        </tr>

        <tr id="Long COVID affects a substantial proportion of survivors of acute infection with severe acute respiratory syndrome-associated coronavirus-2 (SARS-CoV-2), who suffer a variety of symptoms that limit their quality of life and economic activity. Although the aetiology of long COVID is obscure, it appears to be a chronic inflammatory condition. Complement dysregulation is a prevalent feature of long COVID. Specifically, markers of classical, alternative, and terminal pathway activation are often elevated in patients with this condition. Here, we used a sensitive assay for mannan-binding lectin-associated serine protease-2 (MASP-2)/C1Inh complexes to analyse lectin pathway activation in a previously characterised cohort of patients with long COVID (n = 159) and healthy convalescent individuals with no persistent symptoms after infection with SARS-CoV-2 (n = 76). The data were combined with those from the most predictive complement analytes identified previously to delineate potential biomarkers of long COVID. MASP-2/C1Inh complexes were significantly elevated in patients with long COVID (p = 0.0003). Generalised linear modelling further identified an optimal set of four markers, namely iC3b (alternative pathway), TCC (terminal pathway), MASP-2/C1Inh (lectin pathway), and the complement regulator properdin, which had a receiver operating characteristic predictive power of 0.796 (95% confidence interval = 0.664-0.905). Combinations of the classical pathway markers C4, C1q, and C1s/C1Inh were poorly predictive of long COVID. These findings demonstrate that activation of the lectin complement pathway, which occurs upstream of the alternative and terminal pathways and can be inhibited therapeutically, is a salient feature of long COVID.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/b12563fc298f770e8384104e312bcdfe7c924010" target='_blank'>
              Activation of the Lectin Pathway Drives Persistent Complement Dysregulation in Long COVID.
              </a>
            </td>
          <td>
            Sam Keat, Priyanka Khatri, Youssif M. Ali, Chanuka H Arachchilage, G. Demopulos, Kirsten Baillie, K. Miners, K. Ladell, Samantha A. Jones, Helen E. Davies, David A. Price, W. Zelek, B. P. Morgan, Wilhelm Schwaeble, Nicholas J Lynch
          </td>
          <td>2026-01-25</td>
          <td>Immunology</td>
          <td>0</td>
          <td>22</td>
        </tr>

        <tr id="Sepsis-induced immunosuppression is a phenomenon characterized by the development of several changes in immunophenotype which predispose to secondary infections and increased mortality risk. Immunomodulatory therapies have yet to reproducibly demonstrate benefit in large clinical trials. We propose that several changes consistent with an immunosuppressive phenotype in sepsis represent either adaptive changes or epiphenomenon, rather than direct drivers of outcome in infection and sepsis. We therefore conducted a prospective observational study of patients presenting with infections with a spectrum of illness severity, to evaluate canonical features of monocyte and lymphocyte immunosuppression using flow cytometry. Several features consistent with immunosuppression in sepsis are observed in mild infections and non-infectious acute conditions. These features may be better understood as markers along a continuum of illness severity rather than distinct features of critical illness. Monocyte HLA-DR and co-stimulatory molecules (CD80 and CD86), and an increase in soluble PD-L1, discriminate between critically ill patients, patients with mild infection, and patients with non-infectious illness. In contrast, CD4+ and CD8+ lymphocyte phenotype did not discriminate between patient groups. Immunotherapies targeting lymphocyte function may only be effective if simultaneously augmenting monocyte antigen presentation and co-stimulatory pathways. Combination immunotherapy in sepsis requires evaluation.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/7d340f2e07c32552040a896436c978ad25d0ed8d" target='_blank'>
              Immune signatures of sepsis from mild infection to critical illness - a prospective observational study
              </a>
            </td>
          <td>
            Timothy Arthur Chandos Snow, Francis Ryckaert, I. Hass, Holly Pan, S. Elkhodair, M. Singer, D. Brealey, N. Arulkumaran, , Naveed Saleem, Cesar Antonio, Alessia Waller, Deborah Smyth, G. Bercades, A. Z. Martinez, Laura Gallagher, G. Martir
          </td>
          <td>2026-01-16</td>
          <td>Frontiers in Immunology</td>
          <td>0</td>
          <td>32</td>
        </tr>

        <tr id="Epstein-Barr virus (EBV) infection shows the strongest causative association with multiple sclerosis (MS), but its contribution to disease progression and the mechanisms allowing for viral persistence in the MS brain are still elusive. Studies in post-mortem MS brain tissue indicate an ongoing yet ineffective antiviral immune reaction in advanced stages of the disease. EBV has evolved strategies to evade immune recognition and clearance by the host immune system during both the latency and lytic phase of its life cycle. Recent evidence demonstrates that cells expressing EBV latent membrane protein (LMP) 2A exploit the PD-1/PDL1 inhibitory immune checkpoint to escape immune surveillance and maintain a persistent latent infection in the MS brain. This study investigated whether the virus also utilizes this inhibitory mechanism during other phases of the viral life cycle. By using multiple immunostainings on highly inflamed MS brain tissues containing meningeal tertiary lymphoid structures (TLSs), we analyzed PD-L1 expression on EBV-infected cells expressing EBNA2, five EBV lytic gene products, BZLF1, BHRF1, BMRF1, BALF2, and gp350/220, as well as on follicular dendritic cells within the TLSs. This is the first study describing in secondary progressive MS brain tissue the expression and the cellular and tissue distribution of PD-L1 on EBV-infected cells being in different stages of the viral life cycle, and confirms the meningeal TLSs as immune-permissive habitats favoring the maintenance of an intracerebral EBV reservoir.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/870ad961c0e5c100c7165ed6e63b21a8a6ff2f43" target='_blank'>
              EBV Early Lytic Antigens, EBNA2 and PDL-1, in Progressive Multiple Sclerosis Brain: A Coordinated Contribution to Viral Immune Evasion
              </a>
            </td>
          <td>
            Lucia Benincasa, B. Rosicarelli, Chiara Meloni, B. Serafini
          </td>
          <td>2025-12-31</td>
          <td>International Journal of Molecular Sciences</td>
          <td>0</td>
          <td>38</td>
        </tr>

        <tr id="This review article attempts to provide a unifying hypothesis to explain the myriad of symptoms and predispositions underlying the development of PASC (Postacute Sequelae of COVID), often referred to as Long COVID. The hypothesis described here proposes that Long COVID is best understood as a disorder of persistent immune dysregulation, with chronic macrophage activation representing the fundamental underlying pathophysiology. Unlike transient post-viral syndromes, Long COVID involves a sustained innate immune response, particularly within monocyte-derived macrophages, driven by persistent spike protein (peripherally in MAIT cells and centrally in Microglial cells), epigenetic imprinting, and gut-related viral reservoirs. These macrophages are not merely activated temporarily but also become epigenetically “trained” into a prolonged inflammatory state, as demonstrated by enduring histone acetylation markers such as H3K27acDNA Reprogramming. It is proposed that recognizing macrophage activation as the central axis of Long COVID pathology offers a framework for personalized risk assessment, targeted intervention, and therapeutic recalibration.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/5b5f2903ed6d3bcbf8e560a451808bb27c9205bb" target='_blank'>
              The Central Role of Macrophages in Long COVID Pathophysiology
              </a>
            </td>
          <td>
            Philip Mcmillan, Anthony J Turner, B. Uhal
          </td>
          <td>2025-12-27</td>
          <td>International Journal of Molecular Sciences</td>
          <td>0</td>
          <td>45</td>
        </tr>

        <tr id="Peripheral inflammation is increasingly recognized as a critical driver of sustained neuroinflammation and cognitive dysfunction in neurodegenerative and inflammation-associated disorders. Systemic inflammatory mediators can compromise blood–brain barrier integrity, activate glial cells, and initiate maladaptive neuroimmune cascades that disrupt hippocampal–prefrontal circuits underlying learning and memory. Here, we investigated whether early systemic administration of human umbilical cord-derived mesenchymal stem cells (hUC-MSCs) mitigates inflammation-driven cognitive deficits in a chronic lipopolysaccharide (LPS) mouse model. Adult mice received daily LPS injections for seven days to induce persistent systemic and central inflammation, which was confirmed by serum and hippocampal cytokine analyses in a separate cohort at the time of MSC administration, followed by intravenous MSC treatment immediately after cessation of the inflammatory insult. Behavioral testing revealed significant impairments in spatial working memory, recognition memory, and associative learning. These deficits were accompanied by pronounced microglial activation, immune cell accumulation, astrocytosis, and a shift toward a pro-inflammatory cytokine milieu with suppression of IL-10 in the hippocampal CA1 region and medial prefrontal cortex. Early MSC treatment attenuated glial reactivity, reduced pro-inflammatory cytokines, restored IL-10 expression, and partially rescued cognitive performance. Collectively, these findings identify a post-inflammatory therapeutic window in which early MSC-based immunomodulation can rebalance neuroimmune signaling and limit inflammation-induced hippocampal–prefrontal circuit dysfunction, highlighting a clinically relevant strategy for targeting cognitive impairment associated with chronic systemic inflammation.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/5b1534efacf3ec454ba53341d456b8986603986a" target='_blank'>
              Mesenchymal Stem Cell Therapy Modulates Peripheral–Central Immune Interactions and Attenuates Neuroinflammation-Driven Cognitive Dysfunction
              </a>
            </td>
          <td>
            Gunel Ayyubova, Shahla A. Huseynova, Nigar Mustafayeva, Leyla Yildirim, Seher Ismayilova, Tarana Gasimova, Sabina Aliyeva
          </td>
          <td>2026-01-24</td>
          <td>International Journal of Molecular Sciences</td>
          <td>0</td>
          <td>7</td>
        </tr>

        <tr id="Viral load is a topic of interest among researchers, especially to estimate COVID-19's severity. The current research is performed to demonstrate the correlation between the viral load of SARS-CoV-2 in hospitalized patients and cytokine storm progression. A case-control study has been conducted from October 2022 to June 2023. Nasopharyngeal samples were taken from 89 patients for the assessment of the SARS-CoV-2 viral load. The virus was detected and quantified by molecular tests employing real-time polymerase chain reaction (qPCR). Serological assays were also done for the determination of inflammatory cytokine levels (IL-6, IL-8, and IL-1β) in the blood and the estimation of some biomarkers of inflammation (C-reactive protein, D-dimer, and ferritin). Fifty random samples of severe COVID-19 and forty mild cases of COVID-19 and apparently healthy individuals as a control group were selected for this purpose. The multiplexed RT-PCR confirmed the positive samples by detecting the ORF1ab gene of the virus. Viral load results reveal a range from one thousand (103) to one million (106) copies/ml of the virus in each sample depending on Ct values (a final dynamic range of 3.00 to 6.289 log10 copies/ml and an average of 4.425 log10 copies/ml). The inflammatory cytokines (IL-6, IL-8, and IL-1β) and inflammatory biomarkers (CRP, D-dimer, and ferritin) were increased during the disease. The correlation between log10 viral load and cytokine storm markers was positive. The number of viral particles present may impact the cytokine storm progression and extend the duration hospital stay.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/808f6c41add90a87644cb01632ec73da187b55df" target='_blank'>
              SARS-CoV-2 Viral Load Has an Impact on Cytokine Storm in Severe COVID-19 Patients
              </a>
            </td>
          <td>
            Bareq N. Al-Nuaimi, R. H. Al-azzawi
          </td>
          <td>2026-01-30</td>
          <td>Iraqi Journal of Science</td>
          <td>0</td>
          <td>5</td>
        </tr>

        <tr id="Considerable attention has been recently devoted to the involvement of immune cells in the central nervous system (CNS) during infections with neurotropic viruses, such as SARS-CoV-2, HIV-1, and ZIKV. These viruses are capable of infecting astrocytes and microglia, the main glial cells in the CNS, responsible for regulating neuronal activity. Here, we discuss how viral infections lead to metabolic reprogramming toward aerobic glycolysis in these cells, enhancing pro-inflammatory pathways, such as inflammasome activation, resulting in the secretion of inflammatory cytokines that favor the development of neuroinflammation. In this mini review, we discuss the pivotal interplay between metabolism and immunity towards viral pathogenesis in the CNS, pointing out the relevance of therapeutic strategies targeting both metabolic and immunological pathways to enhance antiviral and neuroprotective responses.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/c603076d92448698be2b3b34d399b974e9d4c131" target='_blank'>
              Viral reprogramming of glial metabolism as a driver of neuroinflammation
              </a>
            </td>
          <td>
            Tamara Rodrigues, Gabriel Salles Beltrão, Heloísa Girardi, Aguinaldo R. Pinto
          </td>
          <td>2025-12-19</td>
          <td>Frontiers in Immunology</td>
          <td>0</td>
          <td>0</td>
        </tr>

        <tr id="Cardiac arrhythmias increase during acute SARS-CoV-2 infection and in long COVID syndrome, by unknown mechanisms. This study explored the acute and long-term effects of COVID-19 on cardiac electrophysiology and the cardiac conduction system (CCS) in a hamster model. Electrocardiograms and subpleural pressures were recorded by telemetry for 4 weeks after SARS-CoV-2 infection, and interferon-stimulated gene expression and macrophage infiltration of the CCS were assessed at 4 days and 4 weeks postinfection. COVID-19 induced pronounced tachypnea and cardiac arrhythmias, including bradycardia and persistent atrioventricular block, though no viral protein expression was detected in the heart. Arrhythmias developed rapidly, partially reversed, and then redeveloped, indicating persistent CCS injury. COVID-19 induced cardiac cytokine expression, connexin mislocalization, and CCS macrophage remodeling. Interestingly, sterile innate immune activation by direct cardiac injection of polyinosinic:polycytidylic acid (PIC) induced arrhythmias similar to those of COVID-19. PIC strongly induced cytokine secretion and interferon signaling in hearts, human induced pluripotent stem cell–derived cardiomyocytes, and engineered heart tissues, accompanied by alterations in excitation-contraction coupling. Importantly, the pulmonary and cardiac effects of COVID-19 were blunted by JAK/STAT inhibition or a mitochondrially targeted antioxidant, indicating that SARS-CoV-2 infection indirectly leads to arrhythmias by innate immune activation and redox stress, which could have implications for long COVID syndrome.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/a92f76b73d2e82fbe68eed03e9d787580f7a5e73" target='_blank'>
              Innate immune activation and mitochondrial ROS induce acute and persistent cardiac conduction system dysfunction after COVID-19
              </a>
            </td>
          <td>
            D. Ashok, Ting Liu, Misato Nakanishi-Koakutsu, Joseph Criscione, Meghana Prakash, Alexis Tensfeldt, Byunggik Kim, Bryan Ho, Julian Chow, Morgan Craney, M. Ranek, Brian L. Lin, Kyriakos N. Papanicolaou, Agnieszka Sidor, D. Foster, Hee Cheol Cho, Andrew Pekosz, J. Villano, Deok-Ho Kim, Brian O'rourke
          </td>
          <td>2025-12-22</td>
          <td>JCI Insight</td>
          <td>0</td>
          <td>23</td>
        </tr>

        <tr id="The SARS-CoV-2 virus has shown incredible finesse in using the cellular machinery of its hosts to replicate itself while in addition escaping the host's immune system. This pivotal review covers the detailed and complex cellular mechanisms that SARS-CoV-2 employs to subvert various cellular processes within the host and focuses on some aspects of the virus cellular entry and replication processes and immune system evasion. After carefully collating the data that has been recently published, we have identified and described the virus mediated cellular subversion of the endoplasmic reticulum stress response, autophagy, innate immune system and its signalling, and cellular metabolism. Our thorough understanding of these processes cellular subverted by SARS-CoV-2 will guide future therapeutic interventions, and will illuminate some of the complex and devious host–pathogen interactions that drive the pathology of COVID-19.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/ac0103346ce84b0faadf6332e3a522b2fc6c2248" target='_blank'>
              Cellular pathways exploited by SARS-CoV-2 for replication and immune evasion: a comprehensive analysis of viral hijacking mechanisms
              </a>
            </td>
          <td>
            Shanmukha Madras
          </td>
          <td>2025-12-30</td>
          <td>International Journal of Therapeutic Innovation</td>
          <td>0</td>
          <td>1</td>
        </tr>

        <tr id="Phage therapy (PT) is a promising alternative for antibiotic-resistant infections, but its immunomodulatory effects in clinical settings remain poorly understood. This exploratory observational study aimed to characterize pro- and anti-inflammatory gene response patterns in ten patients undergoing personalized PT at the Phage Therapy Unit in Wrocław. Peripheral blood mononuclear cells (PBMCs) and granulocytes were analyzed to assess changes in the expression of 22 selected immune-related genes associated with innate and adaptive immune signaling pathways. While no uniform pattern of immune gene expression was observed across the cohort, individual cases exhibited significant up- or downregulation of specific genes. Interestingly, we identified biological age as a potential determinant of the host response. Specifically, older patients showed higher activation of the innate sensing machinery in PBMCs, characterized by a higher TLR4 fold change which may reflect the “inflammaging” phenomenon. These findings suggest that chronic exposure to bacterial viruses (bacteriophages), unlike many viral infections, does not trigger a predictable, significant systemic immune activation and that immune responses to PT are highly individualized by host- and phage-related biological factors. By documenting this spectrum of real-world responses, our work provides baseline data and hypotheses to guide the rational design of future preclinical and clinical investigations.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/5ab2b289866cbc1eb0a98219b4968f109c16e453" target='_blank'>
              Analysis of Pro- and Anti-Inflammatory Gene Response Patterns in Patients Receiving Phage Therapy
              </a>
            </td>
          <td>
            Hubert Kasprzak, Maciej Przybylski, W. Fortuna, Sławomir Letkiewicz, Paweł Rogóż, B. Bubak, Andrzej Górski, R. Międzybrodzki
          </td>
          <td>2025-12-23</td>
          <td>International Journal of Molecular Sciences</td>
          <td>0</td>
          <td>37</td>
        </tr>

        <tr id="

 Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection has a wide spectrum of clinical presentations ranging from asymptomatic viral replication to hyper-inflammatory syndrome and respiratory failure and can trigger immune disorders and long-COVID. Interleukin-32 (IL-32) is a pro-inflammatory cytokine induced during viral infections and chronic pulmonary disease.



 Aim of this study was to investigate the impact of the SARS-CoV-2 pandemic and severe COVID-19 on circulating IL-32 levels.



 Observational retrospective biomarker study.



 We analyzed 949 healthy blood donors (pre-pandemic and pandemic-era) and 212 patients hospitalized due to severe COVID-19 during the first five infection waves. IL-32 levels were measured by ELISA.




 Pandemic-era blood plasma donors showed a +0.78 ± 0.09 log
 10
 pg/ml mean increase in IL-32 (pandemic-era 2.91 ± 0.05 vs. pre-pandemic 2.14 ± 0.07 log
 10
 pg/ml, p<0.0001). COVID-19 patients exhibited a similar elevated IL-32 compared to unexposed controls (+0.29 ± 0.11 log
 10
 pg/ml, p=0.016; 2.43 ± 0.08 hospital admission vs. pre-pandemic). Among patients, mean IL-32 was higher in first-wave patients (2.68 ± 0.11 log
 10
 pg/ml) than later waves (2.12 ± 0.11 log
 10
 pg/ml). In setting of severe COVID-19, IL-32 levels were associated with corticosteroids administration (estimate1.99 ± 0.50; p<0.0001), whereas decreased during the later waves of infection (-0.56 ± 0.16; p=0.0005) and with age (estimate -0.01 ± 0.01; p=0.020). No links were found with sex, Intensive care unit admission, comorbidities, or mortality. A subset of the COVID patient cohort was tested for pro-inflammatory biomarkers: IL-32 displayed an inverse correlation with patients’ neutrophil-to-lymphocyte ratio (NLR) (estimate -0.23 ± 0.81; p=0.005) and not with IL-6 and biomarkers of endothelial dysfunction (n=42, p=NS). In patients with available follow-up (n=96), IL-32 remained stable up to one-year post-discharge (+0.03 ± 0.12 log
 10
 pg/ml, p=0.970; 2.55 ± 0.15 hospital admission vs. follow-up 3–12 months 2.58 ± 0.15 log
 10
 pg/ml).




 IL-32 levels increased following COVID-19, especially during the initial severe wave, and correlated with some markers of inflammation. IL-32 remained elevated up to one-year post-discharge, suggesting ongoing inflammation and supporting its potential as a biomarker for long-term sequelae.
">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/67f340a11b390c494c486d9c1df3c8cb8101cd97" target='_blank'>
              Association of SARS-CoV-2 infection with long-lasting increase in circulating IL-32 levels
              </a>
            </td>
          <td>
            L. Miano, Elena Sinopoli, Alessandro Cherubini, C. Suffritti, S. Pelusi, Fatima Rahmeh, G. Lamorte, F. Peyvandi, Francesco Blasi, Giacomo Grasselli, A. Bandera, Roberta Gualtierotti, Daniele Prati, Luca Valenti
          </td>
          <td>2026-02-06</td>
          <td>Frontiers in Immunology</td>
          <td>0</td>
          <td>35</td>
        </tr>

        <tr id="Effective T cell reconstitution in people living with HIV is central to durable immune control and cure strategies. Sustained thymic output underpins T cell recovery and requires continuous seeding by T cell-committed progenitors originating in the bone marrow (BM). Using the SIV/rhesus macaque model, we identified a thymus-seeding progenitor (TSP; CD4⁻CD8⁻CD34⁺CD38⁻CD7⁺) in BM declining rapidly following SIV infection. This loss closely associated with reduction in T cell lineage committed differentiation of BM-derived hematopoietic stem and progenitor cells (HSPCs). Importantly, both the decline in TSPs and the impairment of pre-thymic T cell potential were strongly associated with early loss of viral control, independent of peripheral T cell dynamics. Plasma interleukin-6 (IL-6) levels robustly predicted the magnitude of TSP loss and the restriction of T cell-biased HSPC differentiation. Integrated transcriptomic and proteomic analyses revealed inflammatory imprinting of HSPCs characterized by activation of the IL-6-JAK-STAT axis, inflammasome engagement, and coordinated suppression of key T cell specification factors, including RUNX1, FYN, and ZAP70. In a nonanimal model of thymopoiesis, IL-6 exposure of rhesus macaque and human HSPCs inhibited their transition from DN1 (CD38⁻) to DN2 (CD38⁺) TSP states, indicating an early block in T cell lineage commitment. Conversely, ex vivo IL-6 receptor blockade restored thymocyte differentiation to levels comparable to untreated controls. Collectively, these findings demonstrate that pathogenic inflammation restricts pre-thymic T cell development early after infection, directly contributing to loss of viral control. These findings have important implications for understanding the mediators of anti-viral T cell immunity and HIV cure.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/d1635d5db962d98f76f1b83fc5632d8a21ccd0a2" target='_blank'>
              Interleukin-6 restricts pre-thymic T cell lineage commitment of progenitors driving loss of SIV control
              </a>
            </td>
          <td>
            Saleem Anwar, Naseem Sadek, Christian M. Beusch, Ahmet F. Coskun, Mohamed S. Abdel-Hakeem, R. P. Johnson, Frank J. T. Staal, Vijayakumar Velu, Mirko Paiardini, Brandon F. Keele, Guido Silvestri, David E. Gordon, J. Tomalka, Sheikh Abdul Rahman
          </td>
          <td>2026-02-02</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>16</td>
        </tr>

        <tr id="Abstract Background Post-acute sequelae of SARS-CoV-2 infection (PASC) is a multifaceted condition with multiorgan symptoms affecting millions globally. Though its mechanisms remain poorly understood, persistent immunometabolic disruption is suspected. Given the known role of lipidomes in Alzheimer's disease, we aimed to identify lipidomic biomarkers of PASC. Sphingolipid levels Glycerophospholipid levels. Methods We performed targeted lipidomic analysis using a liquid chromatography tandem mass spectrometry on plasma samples from healthy controls and COVID-19 patients hospitalized and followed as outpatient at the University of Tokyo Hospital, 2020-2022. We focused on sphingolipid and glycerophospholipid metabolites, key regulators of cell survival, inflammation, and cytokine responses. Sparse partial least squares-discriminant analysis (sPLS-DA) and Kendall rank correlation were used to identify lipids characteristic of PASC and explore associations with clinical parameters. Multivariate analysis of Sphingolipids and Glycerophospholipid levels in COVID-19 PASC, sPLSDA-models. Kendall correlation analysis association with PASC. A: Clinical data, B: Sphingolipid, C: Glycerophospholipid, Columns represent the correlation coefficient Results A total of 859 samples from 215 COVID-19 patients and 115 samples from health controls were analyzed. Several sphingolipids, including sphingosine-1-phosphate, dihydro-sphingosine-1-phosphate, ceramide-1-phosphate, ceramide (Cer), sphingomyelin (SM)　was significantly reduced in the COVID-19 (with or without PASC) compared to healthy controls. Notably, Cer levels were significantly lower in PASC compared to COVID-19 without PASC (Figure 1). Glycerophospholipids such as lysophosphatidylcholine (LPC), lysophosphatidylserine (LPS), lysophosphatidylinositol (LPI), and phosphatidylserine (PS) were also reduced. However, phosphatidylglycerol (PG) levels showed a relative rebound in PASC, approaching control levels (Figure 2). sPLS-DA revealed distinct lipidomic clustering among groups, withCer and PG among key discriminators of PASC status (Figure 3). Correlation analysis further highlighted Cer 16:0, Cer 18:0, Cer20:0, Cer 20:2, Cer 22:0, SM 16:0, SM 18:2, and SM 22:2 negativity associated with PASC. Additionally, several glycerophospholipids, LPC 22:6, LPS 14:0, LPE 22:6, LPG 20:3, PE 44:0, PG 32:0, PI 30:0, PS 40:0, and PS 42:0 were associated with PASC (Figure 4). Conclusion Distinct sphingolipid and glycerophospholipid alterations characterize PASC and may serve as metabolic biomarkers for this condition. Disclosures Makoto Kurano, MD, PhD, Nihon Waters: The present study was a collaborative research project undertaken by The University of Tokyo and Nihon Waters. Koh Okamoto, MD, MS, PhD, Becton, Dickinson and Company: Honoraria|Shionogi: Honoraria|Terumo: Honoraria|Thermo Fisher Scientific: Honoraria">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/d872fc06b659acbf711dbde90da3b531dc3b80e2" target='_blank'>
              P-1658. Distinct Sphingolipid and Glycerophospholipid Signatures in Post-acute sequelae of SARS-CoV-2 infection
              </a>
            </td>
          <td>
            Shinya Yamamoto, Makoto Kurano, Koh Okamoto, Takeya Tsutsumi, Kyoji Moriya
          </td>
          <td>2026-01-01</td>
          <td>Open Forum Infectious Diseases</td>
          <td>0</td>
          <td>4</td>
        </tr>

        <tr id="Respiratory infectious pathogens such as influenza, respiratory syncytial virus (RSV), and SARS-CoV-2 persist as significant threats to global health. Most of the pathogens come in through the respiratory mucosa, with the local immune mechanisms as the first line of defense. Here, we explore the role of mucosal immunity, such as secretory immunoglobulin A (sIgA), tissue-resident memory T cells (TRM), and inducible bronchus-associated lymphoid tissue (iBALT), in the management of respiratory infections in this research. The mechanistic part illustrates how mucosal vaccination achieves these reactions by protecting within the zone of pathogen entry. There is now experimental data on live attenuated influenza vaccination (LAIV), studies on preclinical SARS-CoV-2 mucosal vaccine, and early human trials that demonstrate the possible role of mucosal vaccination in limiting viral replication and transmission. But the translational challenge is still with various aspects, such as uniform mucosal immune correlates, heterogeneity in formulation and delivery, and regulatory obstacles. Mucosal vaccines provide a compelling complement to systemic immunization but remain challenging to implement. By acting via both systemic and local immunity, these vaccines are likely to play a role in comprehensive respiratory disease control as well as preparing populations for pandemics. These results highlight the necessity for mucosal immunity to be considered as a pillar of future vaccine development and public health policy framework.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/389cc307d6027991211242f633790eb7033667cb" target='_blank'>
              The Role of Mucosal Immunity in the Control of Respiratory Infectious Diseases
              </a>
            </td>
          <td>
            Yue Zhang
          </td>
          <td>2025-12-19</td>
          <td>MedScien</td>
          <td>0</td>
          <td>0</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/436bf9880456701390ff5d79fb01556ece3f12f3" target='_blank'>
              Single-cell characterization of skin response to a bite by West Nile virus-infected mosquito reveals fibroblast-mediated barrier to transmission
              </a>
            </td>
          <td>
            Hacène Medkour, Federico Bocci, Norman Schneider, Idalba M Serrato-Pomar, Félix Rey-Cadilhac, Elliott F. Miot, Wilfried A. A. Saron, A. S. St. John, G. Maarifi, Yingzi Liu, D. Missé, Qing Nie, Duncan R. Smith, Sébastien Nisole, M. Plikus, J. Pompon
          </td>
          <td>2026-01-09</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>36</td>
        </tr>

        <tr id="Porcine reproductive and respiratory syndrome virus (PRRSV) causes devastating economic losses through complex immunopathology, yet the molecular mechanisms orchestrating host cell fate remain elusive. Here we conducted temporal transcriptomic profiling of PRRSV-infected MARC-145 cells at 0, 12, 24, 36, 48, and 72 h post-infection, revealing the dynamic and temporally coordinated regulation of distinct regulated cell death (RCD) pathways. We discovered that PRRSV employs a sophisticated temporal strategy. The ferroptosis-related modules responsible for regulating lipid peroxidation (including ACSL4, LPCAT3, ALOX15, NOX1, and NCOA4) were largely downregulated, whereas cytoprotective elements (such as HSPB1, SLC40A1, HSPA5, GCLC, and later SLC7A11) were upregulated. Pathway scores remained negative up to approximately 48 h.p.i., gradually approaching neutrality by 72 h.p.i., suggesting that viral mechanisms may inhibit iron-dependent lethal lipid damage. Notably, we identified novel engagement of emerging RCD modalities-cuproptosis showed biphasic regulation with late activation through ATP7A/B suppression, while disulfidptosis signatures peaked at 36 h.p.i. via SLC3A2/SLC7A11 induction. Immunogenic cell death signatures persisted throughout infection with sustained HMGB1 elevation. These findings reveal PRRSV extensively modulates cell death transcriptional programs through temporally coordinated strategies: early inflammatory priming with lytic pathway suppression (12–24 h.p.i.), mid-phase ER stress and organellar remodeling (24–48 h.p.i.), and late metabolic and pH vulnerabilities (48–72 h.p.i.). These transcriptional profiles, pending functional validation, suggest how the virus may balance replication permissiveness with controlled cytopathology. These insights into temporal staging of RCD pathway modulation guide targeted interventions timed to specific infection phases to reduce disease while enhancing antiviral immunity.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/3d3f67e9f9b33889c5d8e31c0a37f8005232f21a" target='_blank'>
              Temporal transcriptomic atlas reveals sequential engagement of classical and emerging regulated cell death pathways during PRRSV infection
              </a>
            </td>
          <td>
            Shinuo Cao, Li Zhang, Rui Zhu, Nannan Nie, Zhi Wu, Shanyuan Zhu
          </td>
          <td>2026-01-06</td>
          <td>Frontiers in Veterinary Science</td>
          <td>0</td>
          <td>5</td>
        </tr>

        <tr id="Dengue virus (DENV) is the causative agent of dengue, a mosquito-borne disease that represents a significant and growing public health burden around the world. A unique pathophysiological feature of dengue is immune-mediated enhancement, wherein preexisting immunity elicited by a primary infection can enhance the severity of a subsequent infection by a heterologous DENV serotype. A leading mechanistic explanation for this phenomenon is antibody dependent enhancement (ADE), where sub-neutralizing concentrations of DENV-specific IgG antibodies facilitate entry of DENV into FcγR expressing cells. Accordingly, this model posits that phagocytic mononuclear cells are the primary reservoir of DENV. However, multiple independent groups have shown that B cells are the largest reservoir of virally infected cells in circulation during acute dengue, representing a disconnect in our understanding of immune-mediated DENV tropism. In response to this persistent knowledge gap, our team has previously identified a novel mechanism of immune-mediated enhancement we have termed BCR-dependent enhancement (BDE) of DENV infection. In this study, we show that DENV infection of DENV-reactive B cells is highly sensitive to BCR/DENV envelope (E) protein interactions. DENV entry into this subset of B cells is dynamin-mediated and requires proximal BCR signaling. Finally, we show that DENV-reactive B cells are productively infected by live DENV, capable of supporting active viral replication and dissemination. We propose that BDE provides an additional layer of pathogen-specific immune-mediated infection risk that complements existing models of ADE and offers additional insight into potential mechanisms of DENV immunopathogenesis.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/6e623512c4d44d160e5f7f9707687b24d41d2ed8" target='_blank'>
              Molecular and biophysical requirements for B cell receptor dependent enhancement of dengue virus infection
              </a>
            </td>
          <td>
            Gaby Madrigal, Chad Gebo, Benjamin D McElvany, Sean A. Diehl, A. Waickman
          </td>
          <td>2026-01-05</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>10</td>
        </tr>

        <tr id="SUMMARY Humans with autoantibodies to type I interferons (IFNs) are at higher risk for neurological disease after West Nile virus (WNV) infection. IFN signaling deficient WNV-infected mice develop greater inflammation in the brain, which correlates with loss of gut barrier integrity. Here, we investigate the immune pathways that mediate this virus-gut-brain axis of inflammation. Myd88−/− mice administered anti-IFNAR1 antibody and infected with WNV exhibit reduced GI tract damage and inflammation. GI tract injury caused by WNV infection requires gasdermins or IL-1 receptor expression in hematopoietic cells and MyD88 signaling in myeloid cells. Blocking monocyte trafficking also reduces WNV-induced GI tract permeability and brain inflammation. Finally, WNV infection of mice lacking IFNAR1 only in myeloid cells results in enhanced GI tract and brain inflammation. In the context of attenuated type I IFN signaling, WNV infection in the GI tract results in barrier disruption, inflammasome activation, MyD88-dependent systemic inflammation, and enhanced brain pathogenesis.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/048f0013558737b8276df33d01b076201632e534" target='_blank'>
              MyD88 signaling in myeloid cells induces gastrointestinal tract injury and systemic inflammation after West Nile virus infection
              </a>
            </td>
          <td>
            Shih-Ching Lin, Fang R. Zhao, Matthias Mack, Gabriel Mbalaviele, Michael S. Diamond
          </td>
          <td>2026-01-01</td>
          <td>Cell reports</td>
          <td>0</td>
          <td>7</td>
        </tr>

        <tr id="The effect of human coronaviruses (HCoVs) on airway epithelial cells is known and very well described. However, their influence on the human lung endothelium remains poorly understood. In this study, we assess the effect of low pathogenic HCoV‐229E on the inflammatory and antiviral response of Human Lung Microvascular Endothelial Cells (HMVEC‐L). Human Lung Microvascular Endothelial Cells were infected with HCoV‐229E and then mRNA expression, protein release, cell viability, apoptosis rate, and presence of AP‐N in flow cytometry were assessed. The infection of HMVEC‐L with HCoV‐229E led to the massive replication picked at 96 h post infection (hpi); however, the virus efficiently replicated at 48 hpi. Despite the inflammatory (IL‐8, IL‐6) and antiviral (IFN‐β, OAS‐1, PKR, MX‐1) response, as well as the pattern recognition receptors activation (TLR3, TLR7/8, RIG‐I, MDA5) occurred only at hour 72. Additionally, the cytopathic effect and the increase in apoptosis were observed. AP‐N blockade inhibited inflammatory and antiviral induction, as well as decreased HCoV‐229E genome copy numbers in HMVEC‐L. We proved that the lung microvascular endothelium may be infected by human coronavirus 229E and that this infection may lead to a robust, but delayed inflammatory and antiviral response. Secondly, HMVEC‐L may play an important role during Coronaviridae upper and lower airway infections.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/60df68fff5ccc846c3dfbe14d1954e07bc5ca731" target='_blank'>
              Human Coronavirus 229E May Infect Human Lung Vascular Endothelium and Induce Delayed Inflammatory and Antiviral Response
              </a>
            </td>
          <td>
            Robert Szewczyk, M. Gawrysiak, Jolanta Kalinowska, A. Gajewski, Sylwia Michlewska, M. Chałubiński
          </td>
          <td>2026-01-01</td>
          <td>APMIS</td>
          <td>0</td>
          <td>18</td>
        </tr>

        <tr id="Background/Objectives: Notwithstanding the declaration by the World Health Organization in May 2023 regarding the conclusion of the COVID-19 pandemic, new cases of this potentially lethal infection continue to be documented globally, exerting a sustained influence on the worldwide economy and social structures. Contemporary SARS-CoV-2 variants, while associated with a reduced propensity for severe acute pathology, retain the capacity to induce long-term post-COVID syndrome, including in ambulatory patient populations. This clinical phenomenon may be attributable to potential autoimmune reactions hypothetically triggered by antiviral antibodies, thereby underscoring the need for developing novel, universal vaccines against COVID-19. The nucleocapsid protein (N), being one of its most conserved and highly immunogenic components of SARS-CoV-2, presents a promising target for such investigative efforts. However, the protective role of anti-N antibodies, generated during natural infection or through immunization with N-based vaccines, alongside the potential adverse effects associated with their production, remains to be fully elucidated. In the present study, we aim to identify potential sites of homology in structures or sequences between the SARS-CoV-2 N protein and human antigens detected using hyperimmune sera against N protein obtained from mice, rabbits, and hamsters. Methods: We employed Western blot analysis of lysates from human cell lines (MCF7, HEK293T, THP-1, CaCo2, Hep2, T98G, A549) coupled with mass spectrometric identification to assess the cross-reactivity of polyclonal and monoclonal antibodies generated against recombinant SARS-CoV-2 N protein with human self-antigens. Results: We showed that anti-N antibodies developed in mice and rabbits exhibit pronounced immunoreactivity towards specific components of the human proteome. In contrast, anti-N immunoglobulins from hamsters showed no non-specific cross-reactivity with either hamster or human proteomic extracts because of the lack of autoreactivity or immunogenicity differences. Subsequent mass spectrometric analysis of the immunoreactive bands identified principal autoantigenic targets, which were predominantly heat shock proteins (including HSP90-beta, HSP70, mitochondrial HSP60, and HSPA8), histones (H2B, H3.1–3), and key metabolic enzymes (G6PD, GP3, PKM, members of the 1st family of aldo-keto reductases). Conclusions: The results obtained herein highlight the differences in the development of anti-N humoral responses in humans and in the Syrian hamster model. These data provide a foundational basis for formulating clinical recommendations to predict possible autoimmune consequences in COVID-19 convalescents and are of critical importance for the rational design of future N protein-based, cross-protective vaccine candidates against novel coronavirus infections.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/313d9d3a801fa8c844cca98ae433671df465c85a" target='_blank'>
              Antibodies Against SARS-CoV-2 Nucleocapsid Protein Possess Autoimmune Properties
              </a>
            </td>
          <td>
            A. Rak, Y. Zabrodskaya, P. Wong, I. Isakova-Sivak
          </td>
          <td>2025-12-22</td>
          <td>Antibodies</td>
          <td>0</td>
          <td>13</td>
        </tr>

        <tr id="ABSTRACT The outcomes of viral infections typically correlate with viral load in host tissues. In this study, we identified a H3N2 strain A/Environment/Guangxi/44461/2019 (GX19) that induced rapid mortality in mice by 4 days post-infection despite exhibiting low pulmonary replication capacity. Pathological analysis revealed that GX19 at 106 TCID50 (GX19-6) caused more severe lung damage than GX19 at 105 TCID50 (GX19-5), while inducing pulmonary pathology comparable to a H3N8 virus A/Changsha/1000/2022 at 106 TCID50 (CS-6). Both GX19-6 and CS-6 triggered greater cardiac damage than GX19-5. Notably, GX19-6 displayed unique neurovirulence, eliciting significantly more severe brain damage than GX19-5 and CS-6, accompanied by evident cerebral haemorrhage. Gene Set Variation Analysis (GSVA) revealed distinct cardiac gene expression profiles among viral infections. Specifically, GX19-5 up-regulated gene sets associated with arrhythmia, whereas GX19-6 triggered pathways involved in cardiac arrest. Neither of these effects was present in CS-6 infection. In the brain, GX19-6 specifically induced stronger upregulation of cerebral venous thrombosis and acute ischaemic stroke gene sets compared to other groups, consistent with its pronounced neuropathology. Transcriptomic profiling demonstrated significant alterations across all three organs in GX19-6-infected mice, showing suppression of T-cell immunity in the lungs and brain alongside elevated systemic inflammation. In the heart, increased inflammation and apoptosis were accompanied by impaired energy metabolism and reduced cardiac function, potentially contributing to the observed hypoxic responses in the heart, lungs, and brain. Collectively, these findings reveal an inflammation-driven lung-heart–brain axis in influenza virus pathogenicity.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/2e56245dc34ffd8e8a606bf4ea56c2f32ff69f1a" target='_blank'>
              Low-replication influenza virus mediates high pathogenicity through an inflammation-driven lung–heart–brain axis in mice
              </a>
            </td>
          <td>
            Wenfei Zhu, Zhuoya Xu, Xinglian Wang, Xi-yan Li, Zi Li, Guolin Dong, Lei Yang, Ye Zhang, Ruina You, Yousong Peng, Dayan Wang
          </td>
          <td>2026-01-07</td>
          <td>Emerging Microbes & Infections</td>
          <td>0</td>
          <td>26</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/38a0f5816cdbca641c12e802430b062f1ffdb077" target='_blank'>
              Acute IFN-γ elicits long-term proteomic IFN-γ signature in melanoma cells
              </a>
            </td>
          <td>
            Agnete W. P. Jensen, A. Rasmussen, Ilaria Piga, Anne Weiss, Marta Sanchez Sanchez, Marco Donia, G. Franciosa, J. Olsen
          </td>
          <td>2025-12-25</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>17</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/0279cf5b40cd2dad6bdd151b9a4c3b0b07c5a9a1" target='_blank'>
              Chemogenetic activation induces persistent transcriptomic remodeling and functional plasticity in cultured astrocytes
              </a>
            </td>
          <td>
            Momono Segawa, Hajime Yamamoto, Kentaro Abe
          </td>
          <td>2026-01-21</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>4</td>
        </tr>

        <tr id="Congenital viral infections can have severe consequences for pregnancy and fetal outcomes. Remarkably, the fetal-derived placenta serves as a robust barrier to infection through meticulous regulation by immune effectors and cytokines. Yet, the regulatory roles of many cytokines remain undefined at the maternal-fetal interface, including Interleukin-27 (IL-27). Here, we show that trophoblast organoids derived from human placentas constitutively express both IL-27 and its receptor, and restrict Zika virus infection through IL-27 signaling. Through bulk RNA-sequencing of trophoblast organoids in the absence and presence of IL-27 signaling, we demonstrate IL-27-mediated upregulation of antiviral genes. Finally, we show that IL-27 signaling is critical to restricting placental viral burdens and protecting against pathologic fetal outcomes during murine congenital Zika virus infection. In this work, we demonstrate a novel role for IL-27 in the placenta and establish IL-27 as an innate antiviral defense at the maternal-fetal interface during congenital viral infection. Merlino et al. demonstrate that the cytokine Interleukin-27 contributes to innate antiviral immunity in the placenta and is an important defense against congenital Zika virus infection.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/af04db4e672049b38d44c3e517de2ea7e8270e8e" target='_blank'>
              Interleukin-27 is antiviral against Zika virus at the maternal-fetal interface
              </a>
            </td>
          <td>
            Madeline S Merlino, Briah Barksdale, S. Negatu, Drake T. Philip, Rebecca L. Clements, Taylor Miller-Ensminger, Alexandra H. Lopez, S. Mani, Monica N. Mainigi, Christopher A. Hunter, K. Jurado
          </td>
          <td>2025-12-19</td>
          <td>Nature Communications</td>
          <td>0</td>
          <td>11</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/7e057854c34b05a1eb2f21f2c62c2dbb657b5f1d" target='_blank'>
              Nipah virus Malaysia and Bangladesh strain-induced pathogenesis in mice lacking type I interferon receptor signaling
              </a>
            </td>
          <td>
            Lucia Amurri, O. Reynard, Ilona Ronco, Dániel Déri, B. Pályi, Julia Spanier, Jennifer Skerra, Olivia Terceve, Thibaut Larcher, Ulrich Kalinke, Zoltan Kis, Branka Horvat, M. Iampietro
          </td>
          <td>2025-12-25</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>21</td>
        </tr>

        <tr id="Sepsis, a life-threatening condition triggered by a dysregulated immune response to infection, remains one of the leading causes of mortality worldwide. Thrombocytopenia, a common sepsis complication, is linked to poor outcomes and reflects disease severity and specific immunological changes affecting patient outcomes. This study aimed to investigate transcriptomic differences between septic patients with and without thrombocytopenia and to explore immune features related to clinical outcomes using whole-transcriptome RNA sequencing (RNA-Seq). We conducted a prospective study on 52 patients who were admitted to ICU for sepsis, including 22 with thrombocytopenia and 30 without. Blood samples were collected on both day 1 and 8, and RNA-Seq was performed to analyze transcriptomic profiles. Differentially expressed genes (DEGs) were identified, and functional enrichment analyses were conducted to explore biological pathways and processes. T-cell receptor (TCR) diversity was assessed using MiXCR and VDJTools software. Thrombocytopenic critically ill septic patients exhibited significantly higher Sequential Organ Failure Assessment (SOFA) scores and mortality rates compared to non-thrombocytopenic patients. Transcriptomic analysis revealed distinct gene expression profiles between the two groups, with marked upregulation of myeloproliferative and T-cell activation signaling pathways in thrombocytopenic patients on day 1. Additionally, TCR diversity counts showed no statistically significant differences between thrombocytopenic and non-thrombocytopenic patients at day 1 or day 8. Thrombocytopenia in septic ICU patients is associated with altered heme/porphyrin metabolism, erythrocyte development, and immune activation. Lower TCR diversity on day 1 in thrombocytopenic patients suggests early immune repertoire perturbations; however, these findings should be interpreted cautiously and validated with targeted immune repertoire sequencing.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/8fe7b0e0807bf970cf37def1ec815b50292dd4fc" target='_blank'>
              Whole transcriptome analysis reveals T cell signaling activation in septic patients with thrombocytopenia
              </a>
            </td>
          <td>
            I-Chieh Chen, Yu-han Jiang, Tzu-Hung Hsiao, Wen-Cheng Chao
          </td>
          <td>2025-12-24</td>
          <td>Scientific Reports</td>
          <td>0</td>
          <td>5</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/c9a4d60e3ce8fa663f1d09db3d981625a6e6c4a6" target='_blank'>
              P2X4 receptors on myeloid cells mediate tissue injury in a model of trauma and hemorrhagic shock in male mice
              </a>
            </td>
          <td>
            T. Kelestemur, Zoltán H. Németh, Pal Pacher, Burhan Yokus, H. T. Lee, Mihwa Kim, Mehmet S Aydin, U. Akcan, G. Haskó
          </td>
          <td>2026-02-01</td>
          <td>Purinergic Signalling</td>
          <td>0</td>
          <td>68</td>
        </tr>

        <tr id="General Background Parasitic infections remain a major challenge in human and veterinary health due to their systemic physiological and immunological consequences. Specific Background Beyond tissue damage, parasites induce metabolic disturbances and immune modulation that influence disease progression. Knowledge Gap Integrated experimental evidence linking physiological alterations with immune cell activation and cytokine regulation remains limited. Aims This study aimed to investigate host physiological responses and immune dynamics during experimental Toxoplasma gondii and Plasmodium berghei infections. Results Infected hosts exhibited significant weight loss, fever, hypoglycemia, elevated CD4+ and CD8+ T cell activation, increased pro-inflammatory cytokines IL-6, TNF-α, IFN-γ, and concurrent upregulation of IL-10. Gene expression analysis confirmed significant modulation of IL-6 and IL-10. Novelty The study provides an integrated assessment of physiological parameters, immune activation, cytokine production, and gene expression within a single experimental framework. Implications These findings highlight the complex balance between immune activation and regulation during parasitic infections and support the need for therapeutic strategies targeting immune modulation to improve parasite control while limiting immunopathology. 
Keywords: Parasitic Infection, Host Physiology, Immune Response, Cytokine Regulation, Experimental Model 
Key Findings Highlights: 


Experimental infection induced marked metabolic and thermoregulatory alterations in hosts. 


Adaptive immune activation involved significant CD4+ and CD8+ T cell responses. 


Concurrent pro- and anti-inflammatory signaling reflected immune regulation during infection.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/d13266d3422b83b381056bacac987b552d895ee5" target='_blank'>
              Physiological and Parasitological Interactions: Investigating Host Responses to Parasitic Infections through Experimental Analysis
              </a>
            </td>
          <td>
            Aliaa Kadhem Mohsin
          </td>
          <td>2026-01-05</td>
          <td>Academia Open</td>
          <td>0</td>
          <td>0</td>
        </tr>

        <tr id="
 Introduction:
 Ischemic stroke is one of the potential neurological complications of COVID-19. Clinical evidence demonstrates that SARS-CoV-2 infection considerably increases stroke risk. The interplay between endothelial dysfunction, exaggerated systemic inflammation, and activation of the coagulation cascade are the key determinants of the pathology. Although direct viral neurotropism in the brain remains incompletely understood, current evidence suggests that viral proteins—such as the spike (S1) subunit cleaved by host cells proteases, may infiltrate the brain via the circulation and contribute to cerebrovascular pathology. Here, we hypothesize that the SARS-CoV-2 S1-spike protein exacerbates stroke outcomes and cerebrovascular complications in standard wild type laboratory mice


 Methods:
 3-month-old male C57BL/J6 mice were injected with recombinant SARS-CoV-2 S1 spike protein (9ug/animal, Sino Biologicals USA) intravenously which was followed by photothrombotic stroke 7 days later. Mice were tested for motor function (rotarod and adhesive removal) and were sacrificed at 72h for stroke infarct size analysis and estimation of inflammation, blood-brain barrier (BBB) permeability, endothelial dysfunction and coagulation.


 Results:
 Rotarod and adhesive removal tests showed that spike protein administration impaired post-stroke motor function. Administration of S1 spike protein aggravated infarct volume (Fig.1), neuro inflammation and BBB permeability. Ongoing plasma analysis is expected to show that S1 spike protein induces post-stroke hypercogulation activation.


 Conclusion:
 Taken together, these data indicate that SARS-CoV-2 S1 spike protein accelerates post stroke motor dysfunction, stroke severity and hypercoagulation. Further investigation into the mechanisms of action of SARS-CoV-2 spike protein is needed to develop effective therapy for COVID-19-impacted stroke patients.
">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/d59a43893404251e31cc60ec0d7dc8fafc66f9a1" target='_blank'>
              Abstract DP367: SARS CoV-2 S1 spike protein aggravates ischemic stroke injury in C57BL/6J mice.
              </a>
            </td>
          <td>
            Saifudeen Ismael, Meenakshi Umar, Blake Ouvrier, A. White, Gregory J. Bix
          </td>
          <td>2026-02-01</td>
          <td>Stroke</td>
          <td>0</td>
          <td>17</td>
        </tr>

        <tr id="Five years after the onset of the SARS-CoV-2 pandemic, post-COVID-19 condition continues to affect millions of subjects with persistent symptoms that significantly impair quality of life. Post-COVID-19 pain, particularly in women, has emerged as a frequent yet underestimated symptom. The validation and identification of animal models that reproduce persistent symptoms after an acute SARS-CoV-2 infection is crucial for a better understanding of the underlying mechanisms. The aim of the current study was to evaluate thermal nociception, biomarkers of inflammation, and nerve tissue damage in a female animal model of post-COVID-19 condition. A SARS-CoV-2 infection model was established by intranasal administration of the Omicron variant (BA.1.17 lineage) in transgenic female C57BL/6 mice expressing the human ACE2 receptor (hACE2). Nociception was assessed using the hot-plate test for 28 days post-infection. Afterwards, animals were sacrificed to analyze plasma inflammatory biomarkers by multiplex analysis. In addition, IL-6, IL-18, and IL-1β expression were evaluated by immunohistochemistry to analyze neural inflammation in the saphenous nerve. The results revealed that heat nociceptive thresholds in infected mice did not significantly differ from those of non-infected, but a trend toward lower thresholds was observed in the infected group (days 14 and 28 post-infection). In addition, a slight modification in pro- and anti-inflammatory cytokines/chemokines in plasma was detected, but no changes in the expression of IL-6, IL-1β, or IL-18 were observed in the saphenous nerve. Based on all the analyses conducted, infection with the Omicron variant of SARS-CoV-2 did not induce thermal sensitization in animals nor alterations in the expression of inflammatory biomarkers in the saphenous nerve. Finally, a slight state of systemic inflammation was present in the infected animals. The absence of detectable changes in this animal model underscores the need for further research to clarify the discrepancies observed in human patients and to explore alternative pathways potentially involved in post-COVID-19 pain syndromes.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/c5891963e60492cf50fdb97401736f4c20927eb7" target='_blank'>
              Assessment of Nociception and Inflammatory/Tissue Damage Biomarkers in a Post-COVID-19 Animal Model
              </a>
            </td>
          <td>
            Eva M Sánchez-Robles, C. Rodríguez-Rivera, Nancy Paniagua Lora, Esperanza Herradón Pliego, Carlos Goicoechea Garcia, L. Arendt-Nielsen, C. Fernández‐de‐las‐Peñas, Visitación López-Miranda
          </td>
          <td>2025-12-29</td>
          <td>International Journal of Molecular Sciences</td>
          <td>0</td>
          <td>87</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/3fc8ff2573897e0ada53acc75e2ba0024f6203b5" target='_blank'>
              Natural killer cells mediated antibody dependent cellular cytotoxicity response in acute and recovery phases of chikungunya
              </a>
            </td>
          <td>
            Diptee Trimbake, M. Ganu, A. Ganu, Anuradha S. Tripathy
          </td>
          <td>2026-01-02</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>5</td>
        </tr>

        <tr id="Simple Summary Porcine circovirus type 2 (PCV2), the primary causative agent of postweaning multisystemic wasting syndrome, inflicts substantial economic losses on the global swine industry. C1QTNF6 has emerged as a novel immunoregulatory factor attracting significant interest due to its dual functionality in mediating both pro-inflammatory and antiviral immune responses. In the study, we focused on the C1QTNF6 on PCV2 infection in porcine alveolar macrophages (3D4/21). We found that C1QTNF6 could inhibit PCV2 replication by activating ISGs. Our study provides important insights into PCV2-host interactions and the development of novel antiviral strategies.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/9a6d74611b72dd5e38f75d849720f56e2c536b48" target='_blank'>
              The C1QTNF6–MX2 Antiviral Axis Inhibits Porcine Circovirus Type 2 Replication in Porcine Macrophages
              </a>
            </td>
          <td>
            Xiaolei Chen, Jiayao Jiang, Xiaocheng Bao, Chao Xu, Shuai Chen, Zhengchang Wu, Haifei Wang, Hairui Fan, Wen-hua Bao
          </td>
          <td>2025-12-21</td>
          <td>Veterinary Sciences</td>
          <td>0</td>
          <td>14</td>
        </tr>

        <tr id="ABSTRACT Epstein‐Barr virus (EBV) infection has been studied at single‐cell resolution for six decades and counting. Such investigations can reveal virus‐host interactions and their dependence on viral strain, cellular niche, infection program, immune response regulation, and time. Understanding these factors is paramount to treating EBV‐associated cancers and autoimmune diseases. This review examines the state of the field in EBV single‐cell and spatial‐omics spanning experimental models and clinical samples. Topics of primary interest include the growing adoption and emerging biological themes from single‐cell assays and analyses, the shift from characterization toward functional single‐cell studies, and strategies to maximize clinically relevant insights from dense single‐cell and spatial datasets. Ancillary topics include the historical evolution of the single‐cell EBV field and end‐to‐end single‐cell sequencing workflows. Special attention is given to open questions in molecular mechanisms of EBV pathogenesis and how they might be resolved by future studies utilizing single‐cell techniques.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/e0066a9dbc4d3e08b9d29c0f78fd36900086ca38" target='_blank'>
              Epstein‐Barr Virus Infection at Single‐Cell Resolution
              </a>
            </td>
          <td>
            Elliott D. SoRelle
          </td>
          <td>2026-02-01</td>
          <td>Journal of Medical Virology</td>
          <td>0</td>
          <td>0</td>
        </tr>

        <tr id="COVID, or post-acute sequelae of SARS-CoV-2 infection (PASC), is clinically defined by persistent symptoms that endure beyond acute infection and affect multiple organ systems, including the immune, cardiopulmonary, neurological, and metabolic axes. The underlying mechanisms remain poorly resolved, limiting the development of targeted diagnostics and therapeutics. MicroRNAs (miRNAs), as key post-transcriptional regulators of gene expression, control inflammatory networks, antiviral responses, mitochondrial bioenergetics, and fibrotic pathways, all of which are implicated in long COVID pathogenesis. Recent studies show durable changes in circulating miRNA signatures months after recovery from the acute phase, suggesting a role in maintaining chronic immune activation and metabolic dysfunction. Importantly, circulating miRNAs are stable, quantifiable in biofluids, and reflect systems-level dysregulation, positioning them as promising biomarker candidates for patient stratification, symptom clustering, and disease monitoring. Moreover, miRNA-directed interventions, such as mimics and antagomiRs, represent an emerging precision-medicine strategy to correct sustained molecular disturbances. This review summarizes current evidence linking miRNAs to long COVID, highlights their biomarker potential, and discusses therapeutic avenues that may help advance mechanism-based interventions for this globally emerging chronic condition.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/d36d9bf602ce92fcc01a4dbcafd07803497971d3" target='_blank'>
              MicroRNAs in Long COVID: Key Regulators, Biomarkers, and Therapeutic Targets of Post-SARS-CoV-2 Sequelae
              </a>
            </td>
          <td>
            R. Makki, Sondos Kassem-Moussa, Fatima Al Nemer, Rania El Majzoub, Hussein Fayyad-Kazan, Walid Rachidi, B. Badran, M. Fayyad-kazan
          </td>
          <td>2026-02-11</td>
          <td>Biomolecules</td>
          <td>0</td>
          <td>20</td>
        </tr>

        <tr id="Post-COVID syndrome comprises persistent neuropsychiatric manifestations for more than 12 weeks after recovery from acute SARS-CoV-2 infection, yet its underlying pathophysiology is unclear. Ferroptosis, an iron-dependent form of cell death with three hallmarks, iron dysregulation, antioxidant failure, and lipid peroxidation, seems to be involved in COVID-19/post-COVID-19 pathophysiology. Here, we administered the SARS-CoV-2 spike protein S1 subunit intranasally to K18-hACE2 transgenic mice and quantified ferroptotic marker protein expression in four brain regions (hippocampus, prefrontal cortex, cerebellum, and olfactory bulb) at 2, 6, and 12 weeks post-administration, alongside ultrastructural assessment by transmission electron microscopy (TEM) that was limited to the hippocampus and prefrontal cortex. Two-way ANOVA revealed region- and time-dependent modulation of iron-handling, antioxidant, and lipid peroxidation markers. In the hippocampus, FPN1 was significantly increased at 2 weeks, while TFR1 showed a time-dependent pattern without significant week-specific differences. In the prefrontal cortex, DMT1 significantly increased at 2 weeks, and GPx4 showed an overall treatment effect with a trend of increase at 6 weeks. The cerebellum exhibited early increases in FPN1 and GPx4 and a delayed increase in MDA-conjugated proteins. In the olfactory bulb, FPN1 increased at 12 weeks, with GPx4 showing an overall treatment effect and an early trend of decrease. TEM identified ferroptosis-consistent features in the hippocampus and prefrontal cortex at all time points. These findings suggest that spike protein exposure may be associated with time-dependent and brain-region-specific alterations of ferroptosis-related markers. These preliminary findings are based on a limited sample size, which needs further research to elucidate the clinical implication and to study the mechanism in more depth as well as future validation with pharmacological inhibitors.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/0e83e3856663d97a9a81f221681b6b3eda2972a4" target='_blank'>
              SARS-CoV-2 Spike Protein Induces Time-Dependent and Brain-Region-Specific Alterations in Ferroptosis Markers: A Preliminary Study in K18-hACE2 Mice
              </a>
            </td>
          <td>
            Asmaa Yehia, Chirine Toufaily, Dalia M. Abdel Ghaffar, Gehan El Wakeel, Mohamed Adel, Abeer F. Mostafa, Osama A. Abulseoud
          </td>
          <td>2026-02-01</td>
          <td>International Journal of Molecular Sciences</td>
          <td>0</td>
          <td>5</td>
        </tr>

        <tr id="The current clinical classification of coronavirus disease 2019 (COVID-19) does not adequately capture the biological heterogeneity observed among patients. To address this gap, the present study aimed to identify distinct subtypes of severe COVID-19 through unsupervised clustering analysis. We analyzed nine publicly available RNA sequencing datasets of peripheral blood samples from the GEO database. After identifying differentially expressed genes (DEGs), we applied a consensus clustering algorithm to classify the samples into distinct subtypes. To further characterize these subtypes, we performed gene set enrichment analysis and assessed immune cell infiltration to understand their underlying biological mechanisms. Based on the 139 upregulated DEGs of severe COVID-19 infection, patients were divided into subtype A, subtype B, and subtype C, each with different molecular and cellular characteristics. Subtype A was characterized by activated neutrophils that undergo degranulation and respond to bacteria or fungi. Subtype B showed significant activation in canonical pathways associated with interferon-alpha/beta signaling. Subtype C was characterized by immune cell activation associated with pathways of mitotic and cell cycle. These results facilitate the development of a precise classification framework, which informs the design of molecular diagnosis and provides actionable guidelines for stratified therapy in severe COVID-19 infection in the future.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/ce56640a371ed5e84a6541bceca8535ac6f9ec8a" target='_blank'>
              Transcriptomic subtyping of COVID-19 reveals three distinct immune response profile.
              </a>
            </td>
          <td>
            Feifei Qiao, Yuhui Zhao, Kaixin Yao, Shan Song, Leilei Zheng, Qian Wang, Jingxi Hu, Yongqiang Lv, Feng Han, Feng Li
          </td>
          <td>2026-01-30</td>
          <td>Autoimmunity</td>
          <td>0</td>
          <td>2</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/a5202c459f047030b9f06949c952c72232f640fd" target='_blank'>
              Dengue virus-specific memory B cell subsets differ as a function of infection history
              </a>
            </td>
          <td>
            Tulika Singh, Amir Balakhmet, Jenny M. Granera, Rohan Shinkre, J. V. Zambrana, Nharae E. Lee, A. Graber, Elias M. Duarte, S. Bos, Federico Narvaez, Á. Balmaseda, Eva Harris
          </td>
          <td>2026-02-02</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>67</td>
        </tr>

        <tr id="During the COVID-19 pandemic, the prevalence of death in men was higher than in women. Using transgenic mice expressing the human angiotensin-converting enzyme 2 (hACE2), we demonstrated that SARS-CoV-2 infects Leydig cells and uses its steroidogenic machinery for replication. This study investigates the impact of SARS-CoV-2 in the seminiferous epithelium of K18-hACE2 mice, focusing on the immune response, junctional proteins, and spermatogenesis. The seminiferous tubules (STs) and epithelial (EA) areas were measured. The number of Sertoli cells (SCs), spermatocytes, and damaged ST was quantified. Ultrastructural analysis was performed under transmission electron microscopy. Angiotensin II levels and immunolocalization of hACE2, spike, and nucleocapsid were evaluated. TUNEL and immunoreactions for Ki-67, TNF-α, INF-γ, iNOS, NF-κB, and Conexin-43 were performed and correlated with Jam-α, Stat1, Stat3, and iNOS expressions. hACE2, spike, and nucleocapsid immunolabeling were detected in the epithelium along with high angiotensin II levels in the infected mice. The infection caused a significant reduction in ST, EA, spermatocytes, SCs, Ki-67+ cells, Cx43 immunoexpression, and Jam-a expression. In the epithelium, TNF-α, IFN-γ, iNOS, and nuclear NF-κB immunolabeling increased along with Stat1 upregulation. These findings, combined with the increased epithelial hACE2 and high angiotensin II levels, confirm epithelial responsiveness to the infection and explain the spermatogenic failure and impaired junctional proteins. The presence of viral particles, increased TNF-α immunolabeling, and apoptotic features in Sertoli cells suggests that these sustentacular cells are targets for viral infection in the epithelium, and, due to their extensive projections and ability to phagocytize dying infected germ cells, they may disseminate the viruses throughout the epithelium.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/4ac206a3daceae8b19267fdee44e6f5851e8f764" target='_blank'>
              Ultrastructural Features, Immune Response, and Junctional Proteins in the Seminiferous Epithelium of SARS-CoV-2-Infected Mice
              </a>
            </td>
          <td>
            Salmo Azambuja de Oliveira, André Acácio Souza da Silva, Barry T. Hinton, Paulo Sérgio Cerri, E. Sasso-Cerri
          </td>
          <td>2026-01-01</td>
          <td>International Journal of Molecular Sciences</td>
          <td>0</td>
          <td>28</td>
        </tr>

        <tr id="Introduction Microglia reactivity has been described as a driver of brain tissue damage in multiple neurodegenerative pathologies. One of the key features of reactive microglia is the transcriptional upregulation of in ammatory markers, including components of the NLRP3 inflammasome such as Nlrp3, Casp1, and Il1b. The NLRP3 inflammasome is a multiprotein complex that plays an important role in several neurodegenerative diseases, being essential for cleavage and subsequent release of IL1b from activated microglia. Transforming growth factor β1 (TGFβ1) is a potent immunoregulatory cytokine with fundamental roles in microglial development, maintenance, and regulation of microglia reactivity. Methods Using BV2 cells, primary microglia, qPCR, and western blotting the effect of TGFβ1 on LPS-induced inflammasome priming and activation was addressed. Cx3cr1CreERT2:R26-YFP: Tgfbr2flox/flox mice were used to elucidate priming in the absence of microglial TGFβ signalling. Results In the present study, we demonstrate that TGFβ1 is able to abrogate LPS-induced transcriptional upregulation of the inflammasome-associated genes Nlrp3, Casp1, and Il1b in microglia. Moreover, we provide evidence that TGFβ1 attenuates microglial IL1b release after nigericin-triggered NLRP3 inflammasome activation as a consequence of reduced priming.Finally, we demonstrate that silencing of microglial TGFβ signalling in vivo results in upregulation of Casp1, Il18, and Il1b. Discussion Together, our data enhance the understanding of how TGFβ1 and microglial TGFβ signaling regulate microglial reactivity, further highlighting the essential functions of TGFβ1 as a potentimmunoregulatory factor for microglia.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/1b723691c47dc4c900852820b5929ad0988ef01d" target='_blank'>
              TGFβ1 attenuates microglial IL1β release through inhibition of NLRP3 inflammasome priming
              </a>
            </td>
          <td>
            Christopher Kalischer, P. Potru, Nele Lehmann, Jannik Jahn, Nikolai Leander Rupp, Natascha Vidovic, Tamara Heike Ruß, Susanne Wiemann, Björn Spittau
          </td>
          <td>2026-01-05</td>
          <td>Frontiers in Immunology</td>
          <td>0</td>
          <td>7</td>
        </tr>

        <tr id="Taking COVID-19 as an illustrative example, this review systematically elucidates the central pathological mechanism of viral sepsis, termed the endothelial-immunothrombotic storm. This mechanism is initiated by the direct viral infection of endothelial cells, which provokes excessive immune activation and disrupts coagulation through immunothrombosis, including cytokine storms, NETosis, and complement activation. Meanwhile, these processes establish a vicious cycle leading to multiple organ failure. Compared with classical bacterial sepsis, viral sepsis exhibits distinctive features such as interferon dysregulation, direct endothelial damage, a hypercoagulable state, and T-cell exhaustion. This review integrates the latest research findings, contrasts the pathophysiological differences between viral and bacterial sepsis, and proposes precision strategies focused on endothelial protection, immune modulation, and anticoagulation. Finally, we discuss the clinical translational prospects of these approaches and suggests directions for future research.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/90d991dae38228c25a5a0a1a6a1e4b25d0b7a3e8" target='_blank'>
              The endothelial-immunothrombotic storm in viral sepsis: lessons from COVID-19
              </a>
            </td>
          <td>
            Kaihuan Zhou, Yin Chen, Jielong Pang, Jianfeng Zhang, Junyu Lu
          </td>
          <td>2026-01-06</td>
          <td>Frontiers in Immunology</td>
          <td>1</td>
          <td>11</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/4c1cd10ff0be51c9e63ce5128a1ec73dc7ab00b6" target='_blank'>
              NRF2-Dependent Anti-Inflammatory Activity of Indole via Cell Surface Receptor Signaling in Murine Macrophages
              </a>
            </td>
          <td>
            Clint Cheng, Siddanagouda R. Shivanagoudra, Aniruddh Mukunth, Sumathi Biradar, Yadeliz Serrano Matos, Cory Klemashevich, Da Mi Kim, G. Wright, Sweta Ghosh, V. Jala, Stephen H. Safe, R. Alaniz, Arul Jayaraman
          </td>
          <td>2025-12-23</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>38</td>
        </tr>

        <tr id="Sepsis is a life-threatening condition characterised by an overwhelming immune response and high fatality. While most research has focused on its acute phase, many sepsis survivors remain immunologically weakened leaving them susceptible to serious complications from even mild infections. The mechanisms underlying this prolonged immune dysregulation remain unclear, limiting effective interventions. Here, we analysed whether sepsis induced long-term “training” in hematopoietic stem and progenitor cells (HSPCs), imprinting changes that persist in their myeloid progeny. Peripheral blood analysis of 8 sepsis survivors, 12 patients with septic shock, and 10 healthy donors revealed a significant expansion of CD38 + progenitors in survivors, with increased megakaryocyte-erythroid progenitors and a near significant reduction in mature neutrophil counts. This shift suggests impaired granulopoiesis, favouring immature, immunosuppressive granulocytes. Differentiated macrophages from survivors’ HSPCs exhibited impaired metabolic pathways after lipopolysaccharide stimulation, with downregulation of tricarboxylic acid cycle and glycolysis genes, indicating altered immune metabolism. Pathway analysis revealed enhanced type-I interferon (IFN) and JAK-STAT signalling in survivors’ macrophages, reflective of potentially tolerance-prone reprogramming. Finally, exposing healthy donor HSPCs to IFNβ during macrophage differentiation reduced HSPC proliferation, increased apoptosis, and induced a metabolic shift towards glycolysis over mitochondrial respiration. Together, these findings suggest that sepsis induces lasting reprogramming in HSPCs leading to myeloid progeny with altered immune memory that might drive immune dysregulation in survivors. These data open avenues to explore potential targets to better manage long-term immune alterations in sepsis survivors.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/3b2a8d81995cb59f3b91651194f51e71a9857048" target='_blank'>
              Sepsis induces long-term reprogramming of human HSPCs and drives myeloid dysregulation in sepsis survivors
              </a>
            </td>
          <td>
            Marco De Zuani, Petra Lázničková, Marcela Hortová Kohoutková, V. Bosáková, I. Andrejčinová, Natália Vadovičová, V. Tomášková, Alexandra Mýtniková, J. Štíchová, Tomáš Tomáš, Jiří Hrdý, K. Boráková, S. Uldrijan, M. Vlková, Vladimír Šrámek, M. Helán, K. Bendíčková, J. Frič
          </td>
          <td>2026-01-27</td>
          <td>Journal of Inflammation (London, England)</td>
          <td>0</td>
          <td>20</td>
        </tr>

        <tr id="Purpose: Microglial cells play a crucial role in responding to brain hypoxia. This study aimed to evaluate the effect of RNA-binding proteins (RBPs) on the resistance of microglial cells to hypoxia. Methods: Newborn rats were subjected to hypoxia under four conditions: hypoxia (H), one week after hypoxia induction (H1), control (C), and control one week after hypoxia induction (C1). Microglial cells were isolated and cultured, and exosomes were extracted from brain samples of healthy newborn rats of C1 group. RBPs were extracted from the aforementioned groups and transferred into the microglial cells using exosomes from the C1 group. Cell viability, expression of specific RBP genes, and innate immune factors were evaluated in the studied groups. Additionally, exosomes containing RBPs were injected into the hypoxic rats to investigate behavioral changes in-vivo. Results: The treatment of microglial cells with C1 exosomes elevated the viability rate. The RBP-H proteins significantly elevated the expression of the CPE, HIF-1α, PDI, and VEGF-A genes. Improvements in anti-protease activity, along with decreases in lysozyme and myeloperoxidase activity, were observed in hypoxic microglial cells following treatment with RBP-H and exosomes containing RBP-H. In vivo evaluations revealed that the hypoxic group treated with exosome loading with RBP-H exhibited significant improvements in recognition and balance maintenance. Conclusion: The RBPs may be considered a promising option for further studies in the treatment of brain disorders resulting from hypoxia.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/1f3072af7515330412addf1c3d71eb09ce17f3f4" target='_blank'>
              The RNA-binding proteins promote resistance of microglial cells to hypoxia
              </a>
            </td>
          <td>
            Mohamad Khosravi, Z. Ghotbeddin, Sorour Chinipardaz
          </td>
          <td>2025-12-23</td>
          <td>Advanced Pharmaceutical Bulletin</td>
          <td>0</td>
          <td>8</td>
        </tr>

        <tr id="ABSTRACT SARS-CoV-2 infection causes neurological manifestations in 30%–40% of patients, with reinfection exacerbating sequelae risks. Elucidating neuroinvasion mechanisms requires optimized animal models overcoming limitations of existing systems. This study establishes the Syrian hamster as a neuroanatomically optimized model to investigate SARS-CoV-2 variant-specific neuropathogenesis. Syrian hamsters subjected to primary infection and reinfection with WH-09 and Omicron subvariants (XBB.1, BA.1, or BF.7) were investigated using multimodal MRI and histopathology. We demonstrate that SARS-CoV-2 variants exhibit strikingly differential neuroinvasive capacities following primary infection and reinfection. Notably, immune-evasive variants like XBB.1 and WH-09 induced significant, unresolved damage in olfactory-limbic regions, correlating with clinical symptoms such as hyposmia. BF.7 and BA.1 exhibited minimal neurostructural alterations in both primary and reinfection models. These variant-specific neuropathological profiles, precisely mapped via MRI-histopathology correlation, underscore the model’s utility in delineating the neurological threats posed by evolving variants. IMPORTANCE This study demonstrates that Syrian hamsters offer advantages for modeling SARS-CoV-2 neuropathogenesis. WH-09 and XBB.1’s persistent olfactory and hippocampus damage, which was quantified through integrated MRI and histopathology, underscores the neurological threat posed by immune-evasive variants. Conversely, Omicron’s attenuated phenotype provides a blueprint for virulence-modifying interventions. This work establishes multimodal imaging in hamsters as an effective strategy for evaluating emerging viral variants. This study demonstrates that Syrian hamsters offer advantages for modeling SARS-CoV-2 neuropathogenesis. WH-09 and XBB.1’s persistent olfactory and hippocampus damage, which was quantified through integrated MRI and histopathology, underscores the neurological threat posed by immune-evasive variants. Conversely, Omicron’s attenuated phenotype provides a blueprint for virulence-modifying interventions. This work establishes multimodal imaging in hamsters as an effective strategy for evaluating emerging viral variants.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/cda64f8b3f7924093f52107f3a79d646713af54b" target='_blank'>
              MRI of Syrian hamsters reveals SARS-CoV-2 variant-specific neuroinflammation
              </a>
            </td>
          <td>
            Yisi Tang, Xiaohui Wei, Kai Gao, Bowen Guan, Jiangning Liu, Xudong Shi
          </td>
          <td>2026-02-03</td>
          <td>Microbiology Spectrum</td>
          <td>0</td>
          <td>3</td>
        </tr>

        <tr id="Introduction The role of Regulatory T cells (Tregs) in severe COVID-19 remains unclear. Some authors reported that Tregs increased in peripheral circulation, while other investigators reported that these cells decreased in severe COVID-19 patients. The expression of FoxP3 in Tregs remains inconsistent and controversial. These observations have been made using immune phenotyping via flow cytometry and T-cell sequencing; however, none of these data provide a clear indication of what Tregs are doing in this chaotic hyperactivated immune response. Methods We conducted a comprehensive characterization of the Treg compartment in a longitudinal cohort of patients with acute COVID-19, including individuals with mild or severe disease. Using RNA-seq, we analyzed gene expression across the cohort, while flow cytometry enabled us to determine Treg phenotype and observe changes during disease progression. Furthermore, we assessed Treg activity through a suppression assay. Results Gene expression analysis revealed significant downregulation of genes involved in regulatory pathways supporting T regs' functional activities, consistent across the severe patients analyzed. In contrast, we found increased expression of these genes in patients with mild disease. This finding was further confirmed by phenotyping analysis, which showed significant differences in CD25+CD127- Treg cells between mild and severe patients, positively associated with CTLA-4 and PD-1 inhibitory markers. Surprisingly, these results did not correlate with FoxP3 expression. Furthermore, a high frequency of CD25+CD127- Treg cells was associated with young, mild patients. In contrast, a lower frequency of CD25+CD127- cells and a higher frequency of FoxP3+ cells were associated with elderly patients. Finally, a Treg functional assay showed a lower capacity for suppression in Tregs obtained from severe patients compared to those from mild patients in the acute phase of the disease. Discussion Our findings offer critical insights into the role of Tregs in SARS-CoV-2, with implications that extend beyond this viral infection. Understanding how Tregs contribute to immune responses in COVID-19 could inform therapeutic strategies to modulate immune regulation in infectious diseases more broadly.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/375e622ef27c7342cf0c8ff5baa1cafe0077df24" target='_blank'>
              Longitudinal immune profiling uncovers regulatory T cell signatures associated with the progression of COVID-19
              </a>
            </td>
          <td>
            Camila Kossack, Felipe Bravo, Francisco Fuentes-Villalobos, Claudio Quevedo, Matias A. Medina, Raúl Riquelme, M. Rioseco, Mario Calvo, Karina Pino-Lagos, Felipe Aguilera, M. I. Barria, J. Garrido
          </td>
          <td>2025-12-19</td>
          <td>Frontiers in Immunology</td>
          <td>0</td>
          <td>17</td>
        </tr>

        <tr id="Simple Summary Transmissible gastroenteritis virus (TGEV) is an enteric coronavirus, and numerous studies have focused on the interaction between TGEV and the intestinal tract. In our experiment, breathlessness was observed in TGEV-infected piglets, suggesting impaired oxygen uptake by RBCs. The effects of TGEV infection on red blood cells (RBCs) and its pathophysiological implications were explored. TGEV was found to bind to, but not replicate in, RBCs. TGEV binding to RBCs causes membrane structure damage, impairs oxygen-carrying capacity, promotes macrophage-mediated phagocytosis of damaged RBCs, and reduces serum iron levels, thereby facilitating viral infection. These findings highlight the importance of diagnostic technologies targeting RBCs and suggest new avenues for drug development and vaccine design for TGEV prevention. Further exploration of the mechanisms by which RBCs contribute to viral infection is warranted.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/62c4f61e3eacfb20f07663822540a6007c7afdbc" target='_blank'>
              Transmissible Gastroenteritis Virus Binding to Red Blood Cells Disrupts Iron Homeostasis and Promotes Viral Infection
              </a>
            </td>
          <td>
            Lu Xia, Ziqi Wang, Yeqing He, Jingwen Wang, Junyuan Ren, Erhao Zhang, Zhonghu Liu, Yilei Li, Zi Li, Zhanyong Wei
          </td>
          <td>2026-01-01</td>
          <td>Veterinary Sciences</td>
          <td>0</td>
          <td>4</td>
        </tr>

        <tr id="Background: The SARS-CoV-2 spike protein, a key component in viral entry, has been implicated in modulating inflammatory responses even in the absence of complete viral infection. Spike protein exposure can alter signaling pathways in colon epithelial cells, leading to increased expression of proinflammatory cytokines and disruption of epithelial barrier integrity. Objectives: This study evaluates the time-dependent effects of recombinant spike protein on proinflammatory gene expression and cytokine release in lung (BEAS-2B) and colon (CRL-1831) epithelial cells. Methods: BEAS-2B and CRL-1831 cells were treated with varying doses of spike protein, and samples were collected at 12, 24, 48, and 72 hours. Cell viability was assessed via XTT assay. Quantitative PCR (qPCR) was used to measure IFN-γ, TNF-α, IL-6, and IL-1β mRNA levels. Cytokine secretion was analyzed via ELISA. Results: In BEAS-2B cells, spike protein induced a transient increase in IFN-γ at early time points, followed by a reduction in IFN-γ and IL-6 at later times. Conversely, CRL-1831 cells demonstrated sustained or delayed increases in TNF-α and IFN-γ expression, with notable IL-6 fluctuation. ELISA data confirmed these trends in cytokine secretion profiles. No significant cytotoxicity was observed across the tested conditions. Conclusions: The spike protein elicits distinct temporal inflammatory responses in lung and colon epithelial cells, underscoring tissue-specific susceptibility and regulatory mechanisms in SARS-CoV-2 pathogenesis. While some previous studies have examined individual components of SARS-CoV-2, the present study's specific focus on the time-dependent, differential effects of the spike protein on two distinct epithelial cell types (lung and colon) appears to be a unique contribution to the field. These findings may contribute to understanding gastrointestinal and respiratory complications observed in COVID-19 patients.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/086ae9b91adf96682acd853601717da84d62a49d" target='_blank'>
              Time-Dependent Differential Effects of SARS CoV 2 Spike Protein in Lung and Colon Epithelial Cell Lines
              </a>
            </td>
          <td>
            A. Yilmaz, Utku Yaka, S. Turk, U. Malkan, S. Gocer, I. Haznedaroglu, Sukru Volkan Ozguven, C. Turk
          </td>
          <td>2025-12-23</td>
          <td>Jundishapur Journal of Microbiology</td>
          <td>0</td>
          <td>38</td>
        </tr>

        <tr id="Psoriasis is a chronic autoimmune skin disorder characterized by keratinocyte hyperproliferation, persistent inflammation, and frequent relapse. Tissue-resident memory T (TRM) cells, particularly IL-17– and phosphorylated STAT3 (pSTAT3)–expressing CD8+ subsets, have been established as central drivers of disease persistence and recurrence. These pathogenic TRM cells maintain local inflammatory circuits that are poorly targeted by current therapies, which helps to explain the limited durability of clinical remission in many patients. Therefore, strategies for selective suppression of these immune subsets are urgently needed. In this study, we investigated the therapeutic potential of nano-sized graphene oxide (NGO), a biocompatible material with emerging anti-inflammatory properties. NGO treatment significantly enhanced mitochondrial function in immune cells, reflected by improved oxygen consumption rate and reduced mitochondrial reactive oxygen species production. Restoration of mitochondrial homeostasis led to robust suppression of pSTAT3 and IL-17 signaling pathways. Importantly, NGO induced a dose-dependent reduction in the numbers of pathogenic CD8+ TRM17 cells in both murine models of psoriasis and human-patient-derived immune cells. Beyond its direct effects on pathogenic TRM cells, NGO treatment alleviated epidermal hyperplasia and inflammatory infiltration in psoriatic lesions and promoted the expansion of regulatory T cells, thereby fostering an immune environment more conducive to tissue resolution. Taken together, these findings show that NGO exerted potent therapeutic effects by coupling mitochondrial reprogramming with immune modulation. By attenuating pSTAT3–IL-17–driven TRM cell responses and enhancing regulatory T cell activity, NGO has emerged as a promising candidate for durable immunometabolic therapy in psoriasis.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/c1eab6b63a141e7d3850b86aa1954f05cbf4fe8f" target='_blank'>
              NGO ameliorates psoriasis by modulating mitochondrial function and suppressing pSTAT3–IL-17–expressing CD8+ TRM cells
              </a>
            </td>
          <td>
            Chul Hwan Bang, krMi-La Cho, Tae Ho, Chae Rim Lee, Kyoung Min Choi, SoonJin Choi, Seon-Yeong Lee, A. R. Lee, Jung Won Choi, Young Mi Moon, Joonhyuck Park, Haeyoun Choi, Jaechul Ryu
          </td>
          <td>2026-01-16</td>
          <td>Journal of Nanobiotechnology</td>
          <td>0</td>
          <td>33</td>
        </tr>

        <tr id="Cannabinoids are increasingly used for medical application, yet the impact of specific cannabinoids on innate immune cells and the underlying molecular mechanisms remain controversial. In this study, we investigated the effect of cannabinoid, cannabidiol (CBD) on macrophage polarization toward M1 and M2 using murine bone marrow-derived macrophages (BMDM). CBD markedly inhibited IL-6 production and nitric oxide production without affecting TNF-α production in M1 polarized (LPS + IFN-γ-treated) macrophages. CBD treatment of M1 macrophages, however, increased expression of MHC II and CD86. On the other hand, CBD decreased key M2 markers, including CD206 and arginase-1, in IL-4-treated M2 macrophages. Mechanistically, CBD did not alter signaling downstream of TLR4 or IFN-γR (NF-κB, MAPK, and STAT1 pathways) but inhibited Akt phosphorylation in M1 macrophages. Metabolic flux analysis further revealed that CBD significantly enhanced glycolysis in M1 macrophages while reducing oxidative phosphorylation (OXPHOS) in M2 macrophages. Collectively, our findings revealed the multi-faceted effect of CBD on macrophage polarization by interfering with PI3K/Akt signaling and altering the metabolic flux. Taken together, our findings provide mechanistic insights into how CBD interferes with innate immune functions during macrophage polarization that may inform future therapeutic strategies utilizing cannabinoids.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/476948835b003140ab8075a8fa7eded96a3b545c" target='_blank'>
              Cannabidiol perturbs macrophage polarization by interfering with the metabolic flux and PI3K/Akt pathway
              </a>
            </td>
          <td>
            Thadaphong Sukdee, Benjawan Wongprom, Thitiporn Pattarakarnkul, A. Leelahavanichkul, A. Charoensappakit, Kritsanawan Sae-khow, Phanomsak Yukhet, T. Vilaivan, T. Palaga
          </td>
          <td>2025-12-24</td>
          <td>Scientific Reports</td>
          <td>0</td>
          <td>40</td>
        </tr>

        <tr id="Background. Post-viral vasculitis represents a heterogeneous inflammatory condition in which persistent immune dysregulation following acute infection or viral reactivation contributes to vascular pathology. SARS-CoV-2, Epstein–Barr virus (EBV), human herpesvirus 6 (HHV-6), and human herpesvirus 7 (HHV-7) are capable of inducing prolonged immune alterations, particularly in mature individuals. 
Objective. To characterize immune dysregulation in patients with post-viral vasculitis associated with SARS-CoV-2 and herpesvirus reactivation, with emphasis on regulatory T cells, adaptive immune remodeling, innate immune activation, and age-related differences. 
Methods. Fifty-eight patients with post-viral vasculitis (post–COVID-19, n = 26; EBV/HHV-6/HHV-7, n = 32) and 20 healthy controls underwent extended immunophenotyping by multiparametric flow cytometry. Patients were additionally stratified by age (19–45 and 45–63 years). 
Results. Post–COVID-19 vasculitis was characterized by reduced regulatory T-cell frequencies and expansion of memoryCD4+  T cells compared with herpesvirus-associated vasculitis. Herpesvirus-associated cases demonstrated pronounced memory T-cell predominance, reduced memory B-cell compartments, and increased cytotoxic NK-cell subsets. Age stratified analysis revealed more severe immune dysregulation in patients aged 45–63 years, with the most pronounced regulatory T-cell depletion observed in post–COVID-19 vasculitis. 
Conclusions. Post-viral vasculitis exhibits virus-specific and age-dependent immune signatures. SARS-CoV-2–associated vasculitis is marked by profound impairment of immunoregulatory mechanisms, particularly in mature patients, whereas herpesvirus-associated vasculitides demonstrate distinct patterns of adaptive and innate immune activation.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/5ffa2838d42060f9645ebd356c40df1bad9138e9" target='_blank'>
              REGULATORY T-CELL ACTIVITY AS A MARKER OF POST–COVID-19 AND HERPETIC SECONDARY VASCULITIS IN YOUNG AND MATURE PATIENTS
              </a>
            </td>
          <td>
            K. Lishchuk-Yakymovych, Valentyna Chopyak, Omelian Synenkyi, R. Pukalyak
          </td>
          <td>2025-12-31</td>
          <td>Anti-Aging Eastern Europe</td>
          <td>0</td>
          <td>2</td>
        </tr>

        <tr id="Simple Summary This study systematically characterized the innate immune and inflammatory pathways activated during early BTV infection through transcriptome sequencing of BTV-infected ovine type II alveolar epithelial cells at 8 and 12 h post-infection (hpi), integrated with bioinformatics analysis and qPCR validation. Furthermore, we demonstrate that early BTV infection disrupts cellular structural integrity. These findings not only enhance our understanding of the host’s early immune response to BTV-1, but also provide critical insights into virus–host interactions and the molecular mechanisms underlying bluetongue disease pathogenesis, thereby establishing a solid experimental basis for the development of antiviral intervention strategies.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/6bd604e0fe66dcebcca07e0eb902792c9b2dc801" target='_blank'>
              Transcriptomic Analysis of the Antiviral Responses in Ovine Type II Alveolar Epithelial Cells During Early Stage of Bluetongue Virus Infection
              </a>
            </td>
          <td>
            Yunyi Chen, Nijing Lei, Zhenghao Ye, Shaohua Pu, Shimei Luo, Xianping Ma, Shaoyu Yang, Guanghua Wang, Huaijie Jia, Huashan Yi
          </td>
          <td>2026-01-01</td>
          <td>Animals : an Open Access Journal from MDPI</td>
          <td>0</td>
          <td>5</td>
        </tr>

        <tr id="Human cytomegalovirus (CMV), a member of the Herpesviridae family, is a ubiquitous pathogen that causes mild or asymptomatic infection in healthy individuals but leads to severe complications in immunocompromised patients and congenitally infected newborns. CMV exhibits marked neurotropism, and infection of the central nervous system (CNS) can result in a broad spectrum of neurological manifestations, including encephalitis, cognitive impairment, and developmental anomalies such as microcephaly, cerebral palsy, and sensorineural hearing loss. Though the clinical importance of CMV on the nervous system is well known and studied, the molecular mechanisms underlying CMV neuropathogenesis remain incompletely understood. In this review we present current knowledge on CMV infection of the CNS, highlighting the viral and host determinants that influence neurotropism, latency, immune evasion, and neural injury. We discuss important molecular pathways involved in viral entry, replication, and host immune modulation that contribute to CNS pathology. The article summarises recent insights from in vitro and in vivo models elucidating how CMV interacts with cells of CNS to disrupt neurodevelopment and brain homoeostasis. Furthermore, we review the neurological manifestations of CMV with emphasis on long term neurological sequelae of congenital and acquired CMV infection, as well as characteristic radiological findings associated with CMV neuroinfection. Understanding the complex interplay between CMV and the host nervous system is essential for identifying therapeutic targets and developing effective preventive strategies. This review aims to provide a comprehensive overview of CMV neuropathogenesis and to identify critical knowledge gaps that can guide future research on CMV‐associated neurological disease.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/23ebcfc05abf795314ae418f12610fb2a47a0d98" target='_blank'>
              Neurological Consequences of CMV Infection: Overview of Pathogenesis and Host Responses
              </a>
            </td>
          <td>
            Vijaylakshmi Reddy, Lonika Lodha, Shipra Gupta, Reeta S. Mani, M. Ashwini
          </td>
          <td>2025-12-30</td>
          <td>Reviews in Medical Virology</td>
          <td>0</td>
          <td>4</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/1908b3b3226f8c7878c6e6b6c337b73f90a53429" target='_blank'>
              Dual-function cytokines as modulators of autophagy: reprogramming inflammatory resolution in severe COVID-19
              </a>
            </td>
          <td>
            Sohrab Khan, Ping Tang, Pingchang Yang, Jing Li, Haiqiang Wu
          </td>
          <td>2026-01-08</td>
          <td>Inflammation Research</td>
          <td>0</td>
          <td>5</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/35aff404da55ae0bb54cac1e03e3786b46aa9b61" target='_blank'>
              Single-cell RNA sequencing of CTLA-4 and PD-1 blockade in pulmonary paracoccidioidomycosis highlights a protective transcriptional program mediated by activated Th17 cells, neutrophils and macrophages
              </a>
            </td>
          <td>
            S. Muxel, D. Fonseca, I. A. F. Bahia, Patrick da Silva, Leonardo Mandu-Gonçalves, Emanuella Sarmento, Jonathan Miguel Zanatta, Clara Andrade Teixeira, Kathia Terumi Kato, Manoela O.R. Sales, Carlos Neandro Cordeiro Lima, Bruno Prado Eleuterio, Luciana dos Santos Barros Manhães, Bernardo de Castro Oliveira, N. Preite, B. Borges, V. Kaminski, M. Ayupe, B. V. dos Santos, Maria Regina D’Império Lima, D. M. da Fonseca, F. V. Loures, V. L. G. Calich
          </td>
          <td>2026-01-23</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>26</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/a9c874d0006e899e6598554f886e173671eef5c2" target='_blank'>
              Opposing effects of SARS-CoV-2/COVID-19 infection and recombinant zoster vaccination on the risk of late-onset Alzheimer disease
              </a>
            </td>
          <td>
            C. M. Rose, S. Liu, W. S. Bush, J. L. Haines, S. M. Williams, D. C. Crawford
          </td>
          <td>2026-01-23</td>
          <td>medRxiv : the preprint server for health sciences</td>
          <td>0</td>
          <td>0</td>
        </tr>

        <tr id="ABSTRACT Astrocytes are central to lipid metabolism in the central nervous system. Due to their morphological and functional characteristics, astrocytes can uptake fatty acids (FAs) from the bloodstream and extracellular space and store them in lipid droplets (LD). LD are dynamic organelles, whose accumulation in astrocytes has been shown to occur upon exposure to various stress stimuli. Different hypotheses proposed to explain motor neuron degeneration in amyotrophic lateral sclerosis (ALS) implicate mitochondrial dysfunction and oxidative stress. Mitochondrial dysfunction in astrocytes is associated with elevation of cytoplasmic lipids and lipid‐binding proteins. We observed increased LD in the spinal cord of symptomatic ALS mice, as well as in human transdifferentiated astrocytes obtained from ALS patients. Using a co‐culture model, we examined the effect of FA overload and its impact on astrocyte–motor neuron interaction. LD accumulation was tightly coupled with an NF‐κB‐driven proinflammatory response in nontransgenic astrocytes, correlating with motor neuron toxicity. These results provide additional evidence to the notion that altered energy balance may contribute to neuronal death in ALS. Furthermore, pharmacological inhibition of lactate dehydrogenase (LDH) reversed LD accumulation in mouse and human astrocytes expressing ALS‐linked mutations. Genetic ablation of LDHA similarly reduced LD accumulation in response to FA treatment. Collectively, our data underscore the role of lipid metabolism in astrocyte–neuron interactions in ALS models and suggest that LD accumulation, rather than serving solely as a protective mechanism, reflects a metabolic stress state linked to a detrimental phenotypic transformation in astrocytes.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/5605fe78a98aec0380a589f4afae28a324a82f4d" target='_blank'>
              Lactate Dehydrogenase Inhibition Reverts the Fatty Acid‐Induced Neurotoxic Phenotype of Astrocytes
              </a>
            </td>
          <td>
            Daniel Esteve, Mariana Bresque, Daniel Okhuevbie, Sandhya Ramachandran, Mariana Pehar, Marcelo R. Vargas
          </td>
          <td>2026-01-06</td>
          <td>Glia</td>
          <td>0</td>
          <td>36</td>
        </tr>

        <tr id="Microglia, the resident immune cells of the central nervous system (CNS), play a pivotal role in health and disease maintaining homeostasis and mediating neuroinflammatory responses. Their activation is a dynamic and context-dependent process characterized by diverse phenotypic states defined by transcriptomic, proteomic, and morphological characteristics. While lipopolysaccharide (LPS) is widely used as an inflammatory stimulus in microglial research, its physiological relevance remains debated. Interferon gamma (IFNγ), a key pro-inflammatory cytokine involved in immune priming, more closely mimics CNS inflammatory conditions. In this study, we systematically investigated the temporal activation profiles of human iPSC-derived microglia (hiMG) in response to LPS, IFNγ, and their combination. Transcriptomic analysis at 24 h revealed robust differential gene expression, with over 7,000 genes altered by LPS and more than 8,500 by LPS/IFNγ co-stimulation. These profiles partially overlapped with disease-associated microglia (DAM) signatures, including upregulation of S100A9, CD44, ACSL1, and HIF1A, and downregulation of TREM2, GPNMB, FABP3, LGMN, and LPL. Cytokine expression changes were detectable as early as 1 h post-treatment, predominantly following LPS exposure, and displayed distinct early (≤2 h), mid (4–12 h), and late (24–96 h) temporal patterns. IFNγ alone induced modest transcriptomic and cytokine responses but contributed to sustained inflammatory signatures when combined with LPS. Morphological analysis showed marked LPS- and LPS/IFNγ-induced structural remodeling of hiMG consistent with activation. To assess protein-level dynamics, targeted mass spectrometry quantified secreted ApoE, CD44, FUCA1, Galectin-3, and Osteopontin, all relevant to microglial activation, which were compared to cellular protein expression measured by western blot. Time-dependent increases were most prominent following LPS and LPS/IFNγ treatment, although secreted Osteopontin levels were highest with IFNγ alone, highlighting stimulus-specific effects. Collectively, these data demonstrate that microglial activation is highly time- and stimulus-dependent, with LPS eliciting the strongest responses, and IFNγ modulating these effects. Our findings underscore the importance of temporal resolution in modeling microglial activation and provide insight into the mechanistic underpinnings of microglial activation relevant to neurodegeneration and therapeutic targeting.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/ecfc039046b3ca19a9e392eb4db5e460c2d2f4eb" target='_blank'>
              The temporal and stimuli-specific effects of LPS and IFNγ on microglial activation
              </a>
            </td>
          <td>
            Christina N. Heiss, Andrew S. Naylor, Ida Pesämaa, Arketa Meshi, Benjamin Céspedes-Cortés, Chiméne Lounès, Ayat Taki, Katarina Türner Stenström, D. Vizlin-Hodzic, H. Zetterberg, Verónica Palma, G. Brinkmalm, A. Brinkmalm, Stefanie Fruhwürth
          </td>
          <td>2026-01-29</td>
          <td>Frontiers in Aging Neuroscience</td>
          <td>0</td>
          <td>45</td>
        </tr>

        <tr id="

 The crosstalk between immune cells through plasma extracellular vesicles (EVs) during SARS-CoV-2 infection may represent a significant determinant of clinical course in COVID-19 patients. EVs from SARS-CoV-2 virus-infected cells deliver their informational content to immune cells implicated in COVID-19 pathogenesis, thereby modulating pro-inflammatory immune responses during infection. γδ T cells are innate cells known for their pleiotropic properties spanning both innate and adaptive immunity and for their possible contribution to inflammation. This study aimed to characterize the biophysical profile and protein content of EVs derived from patients with severe and mild COVID-19, and to analyze their impact on the functional activity of Vδ2 T cells.



 Plasma samples from 42 COVID-19 hospitalized patients (17 severe and 25 mild) were enrolled at the National Institute for Infectious Diseases Lazzaro Spallanzani in Rome. Twenty-three healthy donors (HD) served as the control group. Plasma cytokines were quantified by an automated multiplex immunoassay. EVs were purified using nickel-based isolation (NBI) and analyzed by quantitative LC-MS proteomics. Data are available via ProteomeXchange with identifier PXD072061. Characterization of EVs was performed using multiparametric flow cytometry, as well as the Vδ2 T cell functional assays. Peripheral blood mononuclear cells from 10 HD were utilized for immunological assays.



 Cytometric characterization revealed that EVs from severe COVID-19 patients were enriched in platelet components compared to HD and mild patients. Protein expression of EVs from severe patients clustered differently in PCA and heatmap analyses with respect to HD and mild patients. A volcano plot revealed several proteins that were differentially expressed between EVs from mild and severe patients. A significant induction of several processes, including platelet degranulation, complement, coagulation, and innate immunity, was observed in the pathway analysis. EVs from severe COVID-19 patients enhanced the responsiveness of Vδ2 T cells to phosphoantigen, increasing their activation and proinflammatory cytokine production (TNF-α).



 Proteomic differential analysis reveals the expression/regulation of innate immune-related proteins in EVs from severe patients compared to mild patients/HD and supports their potential role in modulating innate immunity. Specifically, functional analysis of Vδ2 T cells suggests that EVs may contribute to the pathogenesis of severe COVID-19 by delivering molecular signals that exacerbate innate immune-driven inflammation.
">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/a0ae9035ae2cb7ade5294e8ad5cee3c480d9d274" target='_blank'>
              Proteomic profiling of circulating extracellular vesicles from COVID-19 patients and their impact on innate Vdelta2 T-cell response
              </a>
            </td>
          <td>
            C. Montaldo, E. Cimini, Eleonora Tartaglia, Manuela Antonioli, V. Bordoni, S. Notari, M. Notarangelo, Eleonora Torchia, G. Canarutto, S. Piazza, Vito Giuseppe D’Agostino, V. Mazzotta, L. Marchioni, A. Antinori, Chiara Agrati, Raffaele Strippoli
          </td>
          <td>2026-02-11</td>
          <td>Frontiers in Immunology</td>
          <td>0</td>
          <td>28</td>
        </tr>

        <tr id="The obligate intracellular parasite Toxoplasma gondii infects nearly one-third of the global population, yet its impact on human blood–brain barrier (BBB) function remains poorly defined. In this study, we use human induced pluripotent stem cell-derived (iPSC) brain-like microvascular endothelial cells (BMECs), a physiologically relevant BBB model, to investigate if T. gondii infection directly compromises barrier integrity. We show that infection induces robust monocyte chemotactic protein-1 (also known as CCL2) secretion from BMECs, and that CCL2 itself serves as a previously unrecognized driver of BBB dysfunction. Notably, interferon-gamma (IFN-γ) limits BMEC-derived CCL2 release and protects against parasite-mediated barrier damage. These findings identify an IFN-γ-dependent, BMEC-intrinsic defense mechanism that helps preserve central nervous system (CNS) integrity during infection. Collectively, this work establishes a mechanistic foundation for understanding how T. gondii disrupts the human BBB and reveals a novel protective role for IFN-γ in mitigating CNS barrier dysfunction.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/9aaadc61f7c5964a06ffb07ec1403f026f817c76" target='_blank'>
              IFN-γ protects the human blood-brain barrier from Toxoplasma gondii-mediated dysfunction via CCL2 suppression
              </a>
            </td>
          <td>
            Mia C Somenzi, Kameron T. Bell, Abigail M Bitters, Collin S Stratton, Samantha R Springston, Kamryn E Zadeii, Rylee J Anderson, Daisy Woellner-Santos, Scott G. Canfield, A. López-Yglesias
          </td>
          <td>2026-01-14</td>
          <td>Research Square</td>
          <td>0</td>
          <td>9</td>
        </tr>

        <tr id="Yes‐associated protein (YAP) and transcriptional coactivator with PDZ‐binding motif (TAZ), core effectors of the Hippo pathway, are emerging as mechanosensitive regulators of inflammation and tissue repair. However, their roles in neuroinflammation remain poorly understood. Here, we investigated the spatial and temporal expression of YAP/TAZ in glial cells under lipopolysaccharide (LPS)‐induced neuroinflammation in mice. Immunofluorescence revealed selective upregulation and nuclear translocation of YAP/TAZ in astrocytes within the spinal cord and specific brain regions following LPS injection, while microglial expression remained negligible. To further elucidate YAP/TAZ‐related molecular responses, we performed RNA‐sequencing of spinal cord tissue on Day 3 post‐LPS injection. Transcriptomic analysis revealed significant upregulation of glial activation markers (Aif1, Tmem119, Vim) and YAP/TAZ‐associated genes involved in mechanosensation (Piezo1), inflammasome signaling (Nlrp3), and immune cell adhesion (Icam1, Vcam1). These results suggest that YAP/TAZ may integrate mechanical and immune‐inflammatory cues in astrocytes and contribute to glial activation and neurovascular modulation under inflammatory conditions. Our study highlights the context‐dependent role of YAP/TAZ in central nervous system inflammation and underscores their potential as therapeutic targets in neuroinflammatory diseases.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/79df164df8c7849934d26299e21763922d3cb879" target='_blank'>
              Regional and Cell‐Type‐Specific Activation of YAP/TAZ Underlies Glial Responses in LPS‐Induced Neuroinflammation
              </a>
            </td>
          <td>
            T. Kwon, Yujeong Ha, Hyo-Sung Jo, Ik-Hyun Cho
          </td>
          <td>2025-12-25</td>
          <td>Glia</td>
          <td>0</td>
          <td>6</td>
        </tr>

        <tr id="
 Post-acute sequelae of COVID-19 (PASC), a multisystem disorder with prevalent respiratory manifestations, affecting millions of individuals worldwide, yet the organ/system-specific PASC pathogenesis and targeted interventions remain largely undefined. In this longitudinal cohort study of individuals followed up at 4- (n=57) and 7-months (n=54) after the Omicron BA.5 outbreak in China, we comprehensively analyzed physician-administered PASC symptom assessments, clinical respiratory evaluations (pulmonary function and Chest CT), immunological response profiles, and inflammatory markers. Our findings demonstrated that patients with respiratory system-specific PASC (R-PASC) endure long-term pulmonary function impairment (restrictive ventilation and diffusion dysfunction), sustained severe residual lung lesions (predominant fibrosis), and chronic systemic inflammatory responses. R-PASC patients exhibited enhanced SARS-CoV-2-specific T cell responses, whereas in the control group, moderate-magnitude and polyfunctional virus-specific T cell response correlated with improved lung function and alleviated inflammation. Sustained neutralizing antibody titers were also observed in R-PASC patients, whereas humoral responses showed minimal association with disease pathophysiology. Moreover, prolonged activation of complement classical and alternative pathway in R-PASC patients is associated with worsening respiratory parameters, while mannose-binding lectin (MBL) within the lectin pathway exhibits protective correlations with pulmonary tissue-function preservation. Overall, our study delineates the extensively perturbed immune–inflammation–organ dysfunction in R-PASC patients, thereby providing valuable insights into the pathogenesis of this condition and highlighting potential targets for therapeutic intervention.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/540238d2e7d8bc5ad5be4ed3749eeff1660773b3" target='_blank'>
              Extensive immunological and inflammatory perturbation underpins the respiratory sequelae of post-acute COVID-19
              </a>
            </td>
          <td>
            Gang Yang, Jinpeng Cao, Shidong Deng, Yingjiao Xia, Jun Zhao, Jian Qin, Xiaoyun Yang, Min Sun, Daxiang Chen, Ping Sun, Yunhui Zhang, Zheng Deng, Deyi Huang, Shiqin Jin, Tianyang Fu, Nanshan Zhong, Zhongfang Wang
          </td>
          <td>2026-02-05</td>
          <td>Open Forum Infectious Diseases</td>
          <td>0</td>
          <td>6</td>
        </tr>

        <tr id="Multiple sclerosis (MS) is a chronic, heterogeneous, multifactorial, immune-mediated neurodegenerative disease of the central nervous system that affects the working-age population. Its development is influenced by both genetic and environmental factors. A pathological hallmark of MS is the formation of demyelinating lesions in the brain and spinal cord, which are associated with neuronal damage caused by autoaggressive immune factors (T cells, B cells, and myeloid cells). Focal lesions are believed to be caused by the infiltration of immune cells into the central nervous system (CNS) parenchyma with concomitant tissue damage. Multiple sclerosis represents a significant social problem due to the high cost of available treatments, as well as the deterioration of employment prospects and job retention for both patients and their caregivers. Advances in MS diagnostic methods have enabled disease detection at early stages and correction of immune response impairments. Concurrently, treatments for MS patients are actively being studied, with the ongoing development of novel methods for targeted and cellular immunotherapy. This review primarily discusses approaches to cellular immunotherapy and methods of influencing the cellular arm of immunopathogenesis in multiple sclerosis.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/a6695b5f99c2acf5bc6365cb8b8b966222816815" target='_blank'>
              Cellular Immunotherapies for Multiple Sclerosis: Mechanistic Insights and Clinical Advances
              </a>
            </td>
          <td>
            V. Kurilin, M. Fisher, I. Obleukhova, S. Sennikov
          </td>
          <td>2026-01-01</td>
          <td>International Journal of Molecular Sciences</td>
          <td>0</td>
          <td>10</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/62a04a0381701a296bb8ca11863bbc1a7909a057" target='_blank'>
              IFITM3 deficiency drives SARS-CoV-2 adaptation while preserving variant-specific traits.
              </a>
            </td>
          <td>
            Parker J. Denz, Samuel Speaks, Matthew I McFadden, Jana M. Cable, Ahmed K Aladhami, Jonathan L. Papa, R. Rayner, Prerana R. Rao, Steve Leumi, Jack E Roettger, M. Dhariwala, E. Cormet-Boyaka, Adriana Forero, Jacob S. Yount
          </td>
          <td>2026-01-29</td>
          <td>Nature communications</td>
          <td>0</td>
          <td>30</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/883e75d902a0b52abb5752535d1ccd22cc16fa5f" target='_blank'>
              DGAT1-dependent lipid droplet synthesis in microglia attenuates neuroinflammatory responses to lipopolysaccharides
              </a>
            </td>
          <td>
            Frédérick Boisjoly, Danie Majeur, J. Robb, D. Rodaros, T. Alquier
          </td>
          <td>2025-12-20</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>32</td>
        </tr>

        <tr id="This review aims to provide an overview of dengue–COVID–19 co-infection, emphasizing recently described immunological, genomic, and eco-epidemiological interactions that may influence clinical outcomes and viral evolution. It brings together molecular evidence, immunological perspectives, and epidemiological insights to summarize current hypotheses and working models of these complex disease interactions. We summarize and critically discuss evidence on antibody-dependent enhancement (ADE), cross-reactive immune responses, and cytokine amplification pathways, and propose mechanisms that could underlie exacerbated disease severity. Published clinical data indicate heterogeneity in co-infection outcomes globally, from mild presentations to severe complications, such as hemorrhagic stroke, acute kidney injury, and increased mortality, particularly among populations with prior dengue exposure. Diagnostic complexities arising from serological cross-reactivity underscore the need for simultaneous molecular testing to ensure accurate pathogen identification. Additionally, we review current evidence on reciprocal selective pressures between SARS-CoV-2 variants and dengue serotypes, highlighting potential evolutionary impacts arising from their co-circulation. The available evidence suggests that co-infection may exacerbate inflammatory pathways, lead to increased vascular and organ damage, and complicate patient management. However, definitive clinical evidence for ADE remains inconclusive, underscoring an ongoing need for targeted mechanistic studies. By outlining significant knowledge gaps and summarizing proposed research directions, this review aims to provide a valuable reference for clinicians, immunologists, epidemiologists, and policymakers managing concurrent dengue and COVID-19 outbreaks.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/e551ffde3a6e384bfa215adc73e41f9723c18185" target='_blank'>
              Dengue–SARS-CoV-2 interactions: immune crosstalk, variant emergence, and clinical outcomes
              </a>
            </td>
          <td>
            Mariana Parra-González, Lucio Nájera-Maldonado, Esperanza Peralta-Cuevas, Ashley J. Gutierrez-Onofre, Luis A. Jaimes-López, Juan A. Juarez-Antonio, Nahomi Y. Degollado-Hernández, Igor Garcia-Atutxa, Francisca Villanueva-Flores
          </td>
          <td>2026-02-05</td>
          <td>Frontiers in Immunology</td>
          <td>0</td>
          <td>5</td>
        </tr>

    </tbody>
    <tfoot>
      <tr>
          <th>Abstract</th>
          <th>Title</th>
          <th>Authors</th>
          <th>Publication Date</th>
          <th>Journal/Conference</th>
          <th>Citation count</th>
          <th>Highest h-index</th>
      </tr>
    </tfoot>
    </table>
    </p>
  </div>

</body>

<script>

  function create_author_list(author_list) {
    let td_author_element = document.getElementById();
    for (let i = 0; i < author_list.length; i++) {
          // tdElements[i].innerHTML = greet(tdElements[i].innerHTML);
          alert (author_list[i]);
      }
  }

  var trace1 = {
    x: ['2025', '2026'],
    y: [0, 4],
    name: 'Num of citations',
    yaxis: 'y1',
    type: 'scatter'
  };

  var data = [trace1];

  var layout = {
    yaxis: {
      title: 'Num of citations',
      }
  };
  Plotly.newPlot('myDiv1', data, layout);
</script>
<script>
var dataTableOptions = {
        initComplete: function () {
        this.api()
            .columns()
            .every(function () {
                let column = this;

                // Create select element
                let select = document.createElement('select');
                select.add(new Option(''));
                column.footer().replaceChildren(select);

                // Apply listener for user change in value
                select.addEventListener('change', function () {
                    column
                        .search(select.value, {exact: true})
                        .draw();
                });

                // keep the width of the select element same as the column
                select.style.width = '100%';

                // Add list of options
                column
                    .data()
                    .unique()
                    .sort()
                    .each(function (d, j) {
                        select.add(new Option(d));
                    });
            });
    },
    scrollX: true,
    scrollCollapse: true,
    paging: true,
    fixedColumns: true,
    columnDefs: [
        {"className": "dt-center", "targets": "_all"},
        // set width for both columns 0 and 1 as 25%
        { width: '7%', targets: 0 },
        { width: '30%', targets: 1 },
        { width: '25%', targets: 2 },
        { width: '15%', targets: 4 }

      ],
    pageLength: 10,
    layout: {
        topStart: {
            buttons: ['copy', 'csv', 'excel', 'pdf', 'print']
        }
    }
  }
  new DataTable('#table1', dataTableOptions);
  new DataTable('#table2', dataTableOptions);

  var table1 = $('#table1').DataTable();
  $('#table1 tbody').on('click', 'td:first-child', function () {
    var tr = $(this).closest('tr');
    var row = table1.row( tr );

    var rowId = tr.attr('id');
    // alert(rowId);

    if (row.child.isShown()) {
      // This row is already open - close it.
      row.child.hide();
      tr.removeClass('shown');
      tr.find('td:first-child').html('<i class="material-icons">visibility_off</i>');
    } else {
      // Open row.
      // row.child('foo').show();
      tr.find('td:first-child').html('<i class="material-icons">visibility</i>');
      var content = '<div class="child-row-content"><strong>Abstract:</strong> ' + rowId + '</div>';
      row.child(content).show();
      tr.addClass('shown');
    }
  });
  var table2 = $('#table2').DataTable();
  $('#table2 tbody').on('click', 'td:first-child', function () {
    var tr = $(this).closest('tr');
    var row = table2.row( tr );

    var rowId = tr.attr('id');
    // alert(rowId);

    if (row.child.isShown()) {
      // This row is already open - close it.
      row.child.hide();
      tr.removeClass('shown');
      tr.find('td:first-child').html('<i class="material-icons">visibility_off</i>');
    } else {
      // Open row.
      // row.child('foo').show();
      var content = '<div class="child-row-content"><strong>Abstract:</strong> ' + rowId + '</div>';
      row.child(content).show();
      tr.addClass('shown');
      tr.find('td:first-child').html('<i class="material-icons">visibility</i>');
    }
  });
</script>
<style>
  .child-row-content {
    text-align: justify;
    text-justify: inter-word;
    word-wrap: break-word; /* Ensure long words are broken */
    white-space: normal; /* Ensure text wraps to the next line */
    max-width: 100%; /* Ensure content does not exceed the table width */
    padding: 10px; /* Optional: add some padding for better readability */
    /* font size */
    font-size: small;
  }
</style>
</html>







  
  




  



                
              </article>
            </div>
          
          
<script>var target=document.getElementById(location.hash.slice(1));target&&target.name&&(target.checked=target.name.startsWith("__tabbed_"))</script>
        </div>
        
          <button type="button" class="md-top md-icon" data-md-component="top" hidden>
  
  <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M13 20h-2V8l-5.5 5.5-1.42-1.42L12 4.16l7.92 7.92-1.42 1.42L13 8v12Z"/></svg>
  Back to top
</button>
        
      </main>
      
        <footer class="md-footer">
  
  <div class="md-footer-meta md-typeset">
    <div class="md-footer-meta__inner md-grid">
      <div class="md-copyright">
  
  
    Made with
    <a href="https://squidfunk.github.io/mkdocs-material/" target="_blank" rel="noopener">
      Material for MkDocs
    </a>
  
</div>
      
    </div>
  </div>
</footer>
      
    </div>
    <div class="md-dialog" data-md-component="dialog">
      <div class="md-dialog__inner md-typeset"></div>
    </div>
    
    
    <script id="__config" type="application/json">{"base": "..", "features": ["navigation.top", "navigation.tabs"], "search": "../assets/javascripts/workers/search.b8dbb3d2.min.js", "translations": {"clipboard.copied": "Copied to clipboard", "clipboard.copy": "Copy to clipboard", "search.result.more.one": "1 more on this page", "search.result.more.other": "# more on this page", "search.result.none": "No matching documents", "search.result.one": "1 matching document", "search.result.other": "# matching documents", "search.result.placeholder": "Type to start searching", "search.result.term.missing": "Missing", "select.version": "Select version"}}</script>
    
    

      <script src="../assets/javascripts/bundle.c8d2eff1.min.js"></script>
      
    
<script>
  // Execute intro.js when a button with id 'intro' is clicked
  function startIntro(){
      introJs().setOptions({
          tooltipClass: 'customTooltip'
      }).start();
  }
</script>
<script>
  

  // new DataTable('#table1', {
  //   order: [[5, 'desc']],
  //   "columnDefs": [
  //       {"className": "dt-center", "targets": "_all"},
  //       { width: '30%', targets: 0 }
  //     ],
  //   pageLength: 10,
  //   layout: {
  //       topStart: {
  //           buttons: ['copy', 'csv', 'excel', 'pdf', 'print']
  //       }
  //   }
  // });

  // new DataTable('#table2', {
  //   order: [[3, 'desc']],
  //   "columnDefs": [
  //       {"className": "dt-center", "targets": "_all"},
  //       { width: '30%', targets: 0 }
  //     ],
  //   pageLength: 10,
  //   layout: {
  //       topStart: {
  //           buttons: ['copy', 'csv', 'excel', 'pdf', 'print']
  //       }
  //   }
  // });
  new DataTable('#table3', {
    initComplete: function () {
        this.api()
            .columns()
            .every(function () {
                let column = this;
 
                // Create select element
                let select = document.createElement('select');
                select.add(new Option(''));
                column.footer().replaceChildren(select);
 
                // Apply listener for user change in value
                select.addEventListener('change', function () {
                    column
                        .search(select.value, {exact: true})
                        .draw();
                });

                // keep the width of the select element same as the column
                select.style.width = '100%';
 
                // Add list of options
                column
                    .data()
                    .unique()
                    .sort()
                    .each(function (d, j) {
                        select.add(new Option(d));
                    });
            });
    },
    // order: [[3, 'desc']],
    "columnDefs": [
        {"className": "dt-center", "targets": "_all"},
        { width: '30%', targets: 0 }
      ],
    pageLength: 10,
    layout: {
        topStart: {
            buttons: ['copy', 'csv', 'excel', 'pdf', 'print']
        }
    }
  });
  new DataTable('#table4', {
    initComplete: function () {
        this.api()
            .columns()
            .every(function () {
                let column = this;
 
                // Create select element
                let select = document.createElement('select');
                select.add(new Option(''));
                column.footer().replaceChildren(select);
 
                // Apply listener for user change in value
                select.addEventListener('change', function () {
                    column
                        .search(select.value, {exact: true})
                        .draw();
                });

                // keep the width of the select element same as the column
                select.style.width = '100%';
 
                // Add list of options
                column
                    .data()
                    .unique()
                    .sort()
                    .each(function (d, j) {
                        select.add(new Option(d));
                    });
            });
    },
    // order: [[3, 'desc']],
    "columnDefs": [
        {"className": "dt-center", "targets": "_all"},
        { width: '30%', targets: 0 }
      ],
    pageLength: 10,
    layout: {
        topStart: {
            buttons: ['copy', 'csv', 'excel', 'pdf', 'print']
        }
    }
  });
</script>


  </body>
</html>